Processing 00000000.tx.1: The Rockefeller University Press, 0021-9525 $8.00 JCB, Volume 165, Number 2, 263-273 This Article Abstract PDF (Full Text) Supplemental Material Index Alert me when this article is cited Citation Map Services Alert me to new content in the JCB Download to citation manager Cited by other online articles Google Scholar Articles by Wrobel, C. 

Phrase: "The Rockefeller University Press,"

Phrase: "0021-9525 $8.00 JCB,"

Phrase: "Volume 165,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "Number 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "263-273"

Phrase: "This Article Abstract PDF (Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1527021:Text [Intellectual Product]
   804   C1554111:Text [Idea or Concept]
   804   C1705606:Text [Intellectual Product]
   804   C3541382:Text [Intellectual Product]

Phrase: ")"

Phrase: "Supplemental Material Index"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0918012:Index [Intellectual Product]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Citation Map Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0557854:Services [Occupational Activity]
   793 E C2825316:Service [Manufactured Object]
   793 E C3245478:service [Idea or Concept]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new content"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205314:New [Temporal Concept]
   770   C0423896:Content [Mental Process]
   770   C0456205:Content [Conceptual Entity]

Phrase: "in the JCB Download"

Phrase: "to citation manager"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0335141:manager [Professional or Occupational Group]
   861   C1546507:Manager [Idea or Concept]

Phrase: "Cited by other online articles Google Scholar Articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0684017:scholar [Professional or Occupational Group]
   711   C1706852:Article [Intellectual Product]

Phrase: "by Wrobel,"

Phrase: "C."
Processing 00000000.tx.2: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.3: Articles by Brugge, J. 

Phrase: "Articles by Brugge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.4: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.5: Articles citing this Article PubMed PubMed Citation Articles by Wrobel, C. 

Phrase: "Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706852:Article [Intellectual Product]

Phrase: "citing"

Phrase: "this Article PubMed PubMed Citation Articles by Wrobel,"

Phrase: "C."
Processing 00000000.tx.6: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.7: Articles by Brugge, J. 

Phrase: "Articles by Brugge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.8: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.9: Article Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture Carolyn N. 

Phrase: "Article Autocrine CSF-1R activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   879   C1516703:Colony Stimulating Factor Activation [Physiologic Function]
   818   C1514758:Receptor Activation [Cell Function]
   795   C1879547:Activation [Activity]
   710   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "Src-dependent disruption of mammary epithelial architecture Carolyn N."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0332453:Disruption [Functional Concept]
Processing 00000000.tx.10: Wrobel1, Jayanta Debnath1,2, Eva Lin1, Sean Beausoleil1, Martine F. 

Phrase: "Wrobel1,"

Phrase: "Jayanta Debnath1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Eva Lin1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413217:LIN1 [Gene or Genome]

Phrase: "Sean Beausoleil1,"

Phrase: "Martine F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.11: Roussel3, and Joan S. 

Phrase: "Roussel3,"

Phrase: "and"

Phrase: "Joan S."
Processing 00000000.tx.12: Brugge1 1 Department of Cell Biology, Harvard Medical School, Boston, MA 02115 2 Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115 3 Department of Tumor Cell Biology and Genetics, St. 

Phrase: "Brugge1 1 Department of Cell Biology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704729:Department [Organization]

Phrase: "Harvard Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA 02115 2 Department of Pathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0587487:Pathology department [Health Care Related Organization]
   753   C1704729:Department [Organization]

Phrase: "Brigham and Women's Hospital,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   812   C0043210:Women [Population Group]
   812   C1510665:Hospital [Qualitative Concept]
   729 E C1609061:Hospitals [Intellectual Product]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA 02115 3 Department of Tumor Cell Biology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017398:Genetics [Biomedical Occupation or Discipline]
  1000   C0017399:genetics [Biologic Function]

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.13: Jude Children's Research Hospital, Memphis, TN 38105 Address correspondence to Joan S. 

Phrase: "Jude Children's Research Hospital,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   875   C0020017:Children's hospital [Health Care Related Organization]
   812   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   812   C1510665:Hospital [Qualitative Concept]
   729 E C1609061:Hospitals [Intellectual Product]

Phrase: "Memphis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1061320:Memphis [Eukaryote]

Phrase: "TN 38105 Address correspondence to Joan S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0282413:Correspondence [Intellectual Product]
Processing 00000000.tx.14: Brugge, Dept. of Cell Biology, Harvard Medical School, 240 Longwood Ave., Boston, MA 02115. 

Phrase: "Brugge,"

Phrase: "Dept."

Phrase: "of Cell Biology,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Harvard Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "240 Longwood Ave.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0108844:AVE [Therapeutic or Preventive Procedure]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA 02115."
Processing 00000000.tx.15: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.16: 617-432-3974. 

Phrase: "617-432-3974."
Processing 00000000.tx.17: Fax: 617-432-3969. 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "617-432-3969."
Processing 00000000.tx.18: email: joan_brugge{at}hms.harvard.edu  Abstract Top Abstract Introduction Results Discussion Materials and methods References  Elevated coexpression of colony-stimulating factor receptor (CSF-1R) and its ligand, CSF-1, correlates with invasiveness and poor prognosis of a variety of epithelial tumors (Kacinski, B.M. 

Phrase: "email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "joan_brugge{at}hms.harvard.edu  Abstract Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   786   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Elevated coexpression of colony-stimulating factor receptor (CSF-1R)"

Phrase: "and"

Phrase: "its ligand,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligand [Chemical]

Phrase: "CSF-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "correlates with invasiveness"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1301757:Invasiveness [Qualitative Concept]
   718 E C0205281:Invasive [Qualitative Concept]

Phrase: "and"

Phrase: "poor prognosis of a variety of epithelial tumors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0278252:Poor prognosis [Finding]
   744   C0033325:Prognosis [Health Care Activity]

Phrase: "(Kacinski,"

Phrase: "B.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.19: 1995. 

Phrase: "1995."
Processing 00000000.tx.20: Ann. 

Phrase: "Ann."
Processing 00000000.tx.21: Med. 

Phrase: "Med."
Processing 00000000.tx.22: 27:7985). 

Phrase: "27"

Phrase: ":"

Phrase: "7985"

Phrase: ")."
Processing 00000000.tx.23: Apart from recruitment of macrophages to the tumor site, the mechanisms by which CSF-1 may potentiate invasion are poorly understood. 

Phrase: "Apart from recruitment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2949735:Recruitment [Activity]

Phrase: "of macrophages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024432:Macrophages [Cell]
  1000   C1546706:Macrophages [Intellectual Product]
  1000   C1550652:Macrophages [Body Substance]

Phrase: "to the tumor site,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0475445:Tumor site [Spatial Concept]
   861   C0027651:Tumor [Neoplastic Process]
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C1578706:Tumor [Intellectual Product]
   861   C2825164:Site [Spatial Concept]
   861   C3273930:Tumor [Finding]

Phrase: "the mechanisms by which CSF-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441712:Mechanisms [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "may"

Phrase: "potentiate"

Phrase: "invasion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1269955:Invasion [Finding]
  1000   C2699153:Invasion [Pathologic Function]

Phrase: "are"

Phrase: "poorly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Poorly [Qualitative Concept]

Phrase: "understood."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]
Processing 00000000.tx.24: We show that autocrine CSF-1R activation induces hyperproliferation and a profound, progressive disruption of junctional integrity in acinar structures formed by human mammary epithelial cells in three-dimensional culture. 

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that autocrine CSF-1R activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1516703:Colony Stimulating Factor Activation [Physiologic Function]
   827   C1514758:Receptor Activation [Cell Function]
   799   C1879547:Activation [Activity]
   734   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "hyperproliferation"

Phrase: "and"

Phrase: "a profound, progressive disruption of junctional integrity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332453:Disruption [Functional Concept]

Phrase: "in acinar structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]

Phrase: "formed by human mammary epithelial cells"
Meta Candidates (Total=16; Excluded=6; Pruned=0; Remaining=10)
   790   C0014597:Epithelial Cells [Cell]
   790   C1273342:Epithelial Cells [Laboratory Procedure]
   783   C0427861:Human cells [Laboratory or Test Result]
   753   C0006141:Mammary [Body Part, Organ, or Organ Component]
   753   C0007634:Cells [Cell]
   753   C0086418:Human [Human]
   753   C0205431:Formed [Functional Concept]
   753   C0221908:Epithelial [Qualitative Concept]
   753   C0929301:Mammary [Body Part, Organ, or Organ Component]
   753   C3282337:Cells [Cell]
   719 E C0348078:Form [Qualitative Concept]
   719 E C0376315:Form [Manufactured Object]
   719 E C1269647:Cell [Cell]
   719 E C1522492:Form [Functional Concept]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "in three-dimensional culture."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C2242979:Culture [Laboratory Procedure]
   734   C0450363:3-Dimensional [Spatial Concept]
Processing 00000000.tx.25: Acini coexpressing receptor and ligand exhibit a dramatic relocalization of E-cadherin from the plasma membrane to punctate intracellular vesicles, accompanied by its loss from the Triton-insoluble fraction. 

Phrase: "Acini"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C0935597:Acinus [Body Part, Organ, or Organ Component]
   966   C1442495:ACINUS [Gene or Genome]
   916 E C0332207:Acinar [Spatial Concept]

Phrase: "coexpressing"

Phrase: "receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligand [Chemical]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a dramatic relocalization of E-cadherin"

Phrase: "from the plasma membrane to punctate intracellular vesicles,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0333262:VESICLES [Acquired Abnormality]
   766 E C1622418:vesicle [Cell Component]
   716 E C0205378:Vesicular [Qualitative Concept]

Phrase: "accompanied by its loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "from the Triton-insoluble fraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.26: Interfering with Src kinase activity, either by pharmacological inhibition or mutation of the Y561 docking site on CSF-1R, prevents E-cadherin translocation, suggesting that CSF-1R disrupts cell adhesion by uncoupling adherens junction complexes from the cytoskeleton and promoting cadherin internalization through a Src-dependent mechanism. 

Phrase: "Interfering with Src kinase activity,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C1150423:kinase activity [Molecular Function]
   765   C0282625:src Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0521102:interfering [Qualitative Concept]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "either by pharmacological inhibition"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C0031330:Pharmacological [Biomedical Occupation or Discipline]
   770   C0205464:pharmacological [Functional Concept]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "or"

Phrase: "mutation of the Y561 docking site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "on CSF-1R,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "E-cadherin translocation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0040715:Translocation [Cell or Molecular Dysfunction]
   827   C2987521:Translocation [Activity]
   734   C0042172:E-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0694872:E-CADHERIN [Gene or Genome]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "disrupts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "cell adhesion by"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0007577:Cell Adhesion [Cell Function]
   790   C0001511:Adhesion [Pathologic Function]
   790   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "uncoupling"

Phrase: "adherens junction complexes from the cytoskeleton"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C1704241:Complexes [Chemical Viewed Structurally]
   737   C0230612:Junctional complex [Cell Component]
   719 E C0439855:Complex [Qualitative Concept]

Phrase: "and"

Phrase: "promoting cadherin internalization through a Src-dependent mechanism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0871786:internalization [Mental Process]
Processing 00000000.tx.27: These findings provide a mechanistic basis whereby CSF-1R could contribute to invasive progression in epithelial cancers. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a mechanistic basis whereby CSF-1R"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   877   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   795   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "could"

Phrase: "contribute to invasive progression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205281:Invasive [Qualitative Concept]
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]
   770   C1880177:Contribute [Activity]

Phrase: "in epithelial cancers."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0006826:Cancer [Neoplastic Process]
   861   C0221908:Epithelial [Qualitative Concept]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]
Processing 00000000.tx.28: Key Words: CSF-1 receptor; 

Phrase: "Key Words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "CSF-1 receptor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0080092:Receptor, CSF-1 [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor,Receptor]
   913   C0080095:CSF Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   734   C1150625:CSF-1 [Molecular Function]

Phrase: ";"
Processing 00000000.tx.29: autocrine signaling; 

Phrase: "autocrine signaling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0525010:Autocrine Signaling [Cell Function]
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: ";"
Processing 00000000.tx.30: Src; 

Phrase: "Src"

Phrase: ";"
Processing 00000000.tx.31: cadherins; 

Phrase: "cadherins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006631:Cadherins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C1413274:cadherin [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.32: mammary neoplasms The online version of this article contains supplemental material. 

Phrase: "mammary neoplasms"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0024667:Neoplasms, Mammary [Neoplastic Process]
  1000   C1458155:Mammary Neoplasms [Neoplastic Process]
   861   C0027651:NEOPLASMS, NOS [Neoplastic Process]
   827 E C2981607:NEOPLASM [Intellectual Product]

Phrase: "The online version of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "supplemental material."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   950   C2936424:Supplementary Material [Intellectual Product]
   861   C0520510:Material [Substance]
Processing 00000000.tx.33: Abbreviations used in this paper: 3D, three dimensional; 

Phrase: "Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used in this paper"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0030351:Paper [Manufactured Object]
   770   C1273517:used [Finding]
   770   C1547566:Paper [Idea or Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "3D, three dimensional"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0450363:3D - Three-dimensional [Spatial Concept]
           3-Dimensional
   827   C0205449:Three [Quantitative Concept]
   755   C0439534:Dimension [Quantitative Concept]
   755   C1707753:Dimensionality [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.34: CSF-1R, colony-stimulating factor receptor; 

Phrase: "CSF-1R,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "colony-stimulating factor receptor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ";"
Processing 00000000.tx.35: RTK, receptor tyrosine kinase.  

Phrase: "RTK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206364:RTK [Amino Acid, Peptide, or Protein,Enzyme,Receptor]

Phrase: "receptor tyrosine kinase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0206364:Receptor Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   901   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.36: Introduction Top Abstract Introduction Results Discussion Materials and methods References  Glandular morphogenesis is directed by a convergence of diverse extracellular signals, including secreted trophic factors, interaction with the ECM, and contact with neighboring cells (Alford and Taylor-Papadimitriou, 1996; Niemann et al., 1998; Schmeichel et al., 1998). 

Phrase: "Introduction Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Glandular morphogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026559:Morphogenesis [Organism Function]

Phrase: "is"

Phrase: "directed by a convergence of diverse extracellular signals,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0443193:Convergence [Spatial Concept]
   744   C0521119:Extracellular [Cell Component]
   744   C1446614:Convergence [Finding]
   744   C1880371:Diverse [Qualitative Concept]
   744   C2700387:Convergence [Activity]
   711   C0439851:Direct [Qualitative Concept]
   711   C1710082:Signal [Phenomenon or Process]
   711   C1947931:Direct [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "secreted trophic factors,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
   771   C0028707:Nutrition [Biomedical Occupation or Discipline]
   771   C0392209:nutrition [Organism Attribute]
   771   C1442959:Nutrition [Organism Function]
   734 E C1521739:Nutritional [Qualitative Concept]
   734 E C2707262:Nutritional [Clinical Attribute]

Phrase: "interaction with the ECM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "contact with neighboring cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0332158:Contact with [Functional Concept]
           contact
   770   C0337611:Contact [Population Group]
   770   C1705415:Contact [Idea or Concept]

Phrase: "(Alford"

Phrase: "and"

Phrase: "Taylor-Papadimitriou,"

Phrase: "1996"

Phrase: "; Niemann et al.,"

Phrase: "1998"

Phrase: "; Schmeichel et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.37: One essential class of soluble factors acts as ligands for receptor tyrosine kinases (RTKs), initiating signaling cascades that promote the proliferation and differentiation of epithelial cells and orchestrate the assembly of polarized glandular structures. 

Phrase: "One essential class of soluble factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0456387:Class [Intellectual Product]
   753   C1705943:Class [Classification]

Phrase: "acts as ligands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0023688:Ligands [Chemical]
   790   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "for receptor tyrosine kinases (RTKs),"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0206364:Receptor Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   867   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "initiating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1548602:Initiate [Idea or Concept]
   966   C1704686:Initiate [Functional Concept]

Phrase: "signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]

Phrase: "cascades"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707310:Cascade [Manufactured Object]

Phrase: "that"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "differentiation of epithelial cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   865   C1326057:epithelial cell differentiation [Cell Function]
   819   C0007589:cells differentiation [Cell Function]
           Differentiation
   819   C1707934:Epithelial Differentiation [Finding]
   770   C1511938:Differentiation [Clinical Attribute]
   770   C2945687:Differentiation [Functional Concept]

Phrase: "and"

Phrase: "orchestrate"

Phrase: "the assembly of polarized glandular structures."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1706853:Assembly [Activity]
   753   C1879748:Assembly [Manufactured Object]
Processing 00000000.tx.38: Appropriate regulation of receptor activity is crucial for the establishment and maintenance of normal epithelial architecture, and aberrant activation of such signals can promote tumor progression. 

Phrase: "Appropriate regulation of receptor activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   926   C2265601:regulation of receptor activity [Physiologic Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "is"

Phrase: "crucial for the establishment"

Phrase: "and"

Phrase: "maintenance of normal epithelial architecture,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0024501:Maintenance [Activity]

Phrase: "and"

Phrase: "aberrant activation of such signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "can"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "tumor progression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178874:Tumor Progression [Neoplastic Process]
   861   C0242656:progression [Pathologic Function]
   861   C0449258:Progression [Functional Concept]
Processing 00000000.tx.39: Several RTKs, including c-Met and EGFR, have been implicated in the growth and morphogenesis of the mammary epithelium, an arborized ductal network composed of hollow tubules that terminate in secretory acinar units (Niemann et al., 1998). 

Phrase: "Several RTKs,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   890   C0206364:Receptor Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   827   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "c-Met"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456828:C-MET [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1704823:C-MET [Gene or Genome]

Phrase: "and"

Phrase: "EGFR,"

Phrase: "have"

Phrase: "been"

Phrase: "implicated in the growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0018270:'growth' NOS [Organism Function]
   770   C0220844:growth [Physiologic Function]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "morphogenesis of the mammary epithelium,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0026559:Morphogenesis [Organism Function]

Phrase: "an arborized ductal network"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1513822:Network [Professional or Occupational Group]
   827   C1705739:Network [Manufactured Object]
   827   C1882071:Network [Conceptual Entity]

Phrase: "composed of hollow tubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332484:Hollow [Spatial Concept]

Phrase: "that"

Phrase: "terminate in secretory acinar units"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0332207:Acinar [Spatial Concept]
   760   C0439148:Units [Quantitative Concept]
   760   C1327616:Secretory [Cell Function]
   760   C1519795:Units [Quantitative Concept]
   726 E C1704753:Unit [Manufactured Object]
   726 E C1880519:Unit [Quantitative Concept]
   704   C0011065:Expired [Organism Function]
   704   C0231800:Expired [Organ or Tissue Function]
   704   C1704631:Expire [Idea or Concept]

Phrase: "(Niemann et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.40: Unlike many quiescent adult tissues, the mammary epithelium must retain a broad spectrum of developmental capacities for the duration of the mammalian reproductive lifetime, to facilitate rapid lobuloaveolar outgrowth and lactogenic differentiation during pregnancy. 

Phrase: "Unlike many quiescent adult tissues,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0040300:Tissues [Tissue]
   793 E C1547928:Tissue [Intellectual Product]

Phrase: "the mammary epithelium"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0596882:Mammary Epithelium [Body Part, Organ, or Organ Component]
   861   C0014609:Epithelium [Tissue]
   789 E C0221908:Epithelial [Qualitative Concept]

Phrase: "must"

Phrase: "retain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "a broad spectrum of developmental capacities"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0332464:Broad [Spatial Concept]
   753   C1883073:Spectrum [Quantitative Concept]
   753   C2827424:Spectrum [Conceptual Entity]

Phrase: "for the duration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449238:Duration [Temporal Concept]
  1000   C2926735:Duration [Pharmacologic Substance]

Phrase: "of the mammalian reproductive lifetime,"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "facilitate"

Phrase: "rapid lobuloaveolar outgrowth"

Phrase: "and"

Phrase: "lactogenic differentiation during pregnancy."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007589:Differentiation [Cell Function]
   770   C1511938:Differentiation [Clinical Attribute]
   770   C2945687:Differentiation [Functional Concept]
Processing 00000000.tx.41: Colony-stimulating factor receptor (CSF-1R) is an RTK required for outgrowth of the mammary ductal network and lactation (Dai et al., 2002). 

Phrase: "Colony-stimulating factor receptor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: "is"

Phrase: "an RTK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206364:RTK [Amino Acid, Peptide, or Protein,Enzyme,Receptor]

Phrase: "required for outgrowth of the mammary ductal network"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0006141:Mammary [Body Part, Organ, or Organ Component]
   744   C0929301:Mammary [Body Part, Organ, or Organ Component]
   744   C1512083:Ductal [Qualitative Concept]
   744   C1513822:Network [Professional or Occupational Group]
   744   C1514873:Required [Functional Concept]
   744   C1705739:Network [Manufactured Object]
   744   C1882071:Network [Conceptual Entity]
   735   C0222613:Mammary duct [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "lactation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006147:Lactation [Organism Function]
  1000   C0022925:Lactation [Organ or Tissue Function]

Phrase: "(Dai et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.42: In the absence of CSF-1R or its ligand, CSF-1, expansion of the mammary epithelium into the surrounding fatty stroma is restricted, a defect that has been attributed to the loss of macrophage recruitment to the developing gland (Pollard and Hennighausen, 1994; Van Nguyen and Pollard, 2002). 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or"

Phrase: "its ligand,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligand [Chemical]

Phrase: "CSF-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "expansion of the mammary epithelium"

Phrase: "into the surrounding fatty stroma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0927195:Stroma [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "restricted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443288:Restricted [Functional Concept]

Phrase: ","

Phrase: "a defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1457869:Defect [Functional Concept]
  1000   C1861101:DEFECT [Disease or Syndrome]

Phrase: "that"

Phrase: "has"

Phrase: "been"

Phrase: "attributed to the loss of macrophage recruitment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0024432:macrophage [Cell]
   748   C1517945:Loss [Quantitative Concept]
   748   C2949735:Recruitment [Activity]
   714   C0449234:Attribute [Idea or Concept]
   714   C1704772:Attribute [Conceptual Entity]
   714   C1882133:Attribute [Qualitative Concept]

Phrase: "to the developing gland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1285092:Gland [Body Part, Organ, or Organ Component]

Phrase: "(Pollard"

Phrase: "and"

Phrase: "Hennighausen,"

Phrase: "1994"

Phrase: "; Van Nguyen"

Phrase: "and"

Phrase: "Pollard,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.43: Elevated expression of CSF-1R has been described for a variety of malignancies of epithelial origin, including breast, prostate, and ovarian carcinomas, but the mechanisms by which the receptor contributes to tumor development and progression remain incompletely understood (Kacinski, 1995; Ide et al., 2002). 

Phrase: "Elevated expression of CSF-1R"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0597360:receptor expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "described for a variety of malignancies of epithelial origin,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   742   C0006826:MALIGNANCIES [Neoplastic Process]
   742   C0079946:origin [Classification]
   742   C0221908:Epithelial [Qualitative Concept]
   742   C0439659:Origin [Temporal Concept]
   742   C1550512:origin [Intellectual Product]
   742   C1552738:described [Idea or Concept]
   742   C1883525:Variety [Conceptual Entity]
   742   C2346866:Variety [Conceptual Entity]
   708 E C1306459:Malignancy [Finding]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "breast,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0006141:Breast [Body Part, Organ, or Organ Component]
  1000   C1268990:Breast [Body Part, Organ, or Organ Component]
   944 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   944 E C1521735:Pectoral [Qualitative Concept]
   916 E C0817096:Chest [Body Location or Region]
   916 E C1527391:Chest [Body Location or Region]

Phrase: "prostate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033572:Prostate [Body Part, Organ, or Organ Component]
  1000   C1278980:Prostate [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "ovarian carcinomas,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0029925:ovarian carcinomas [Neoplastic Process]
   966 E C0677886:carcinoma, ovarian [Neoplastic Process]
   861   C0007097:Carcinomas [Neoplastic Process]
   861   C0205065:Ovarian [Body Part, Organ, or Organ Component]

Phrase: "but"

Phrase: "the mechanisms by which"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0441712:Mechanisms [Functional Concept]
   737 E C1706376:Mechanism [Manufactured Object]

Phrase: "the receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "contributes to tumor development"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0027651:Tumor [Neoplastic Process]
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]
   770   C1578706:Tumor [Intellectual Product]
   770   C1880177:Contribute [Activity]
   770   C3273930:Tumor [Finding]

Phrase: "and"

Phrase: "progression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242656:progression [Pathologic Function]
  1000   C0449258:Progression [Functional Concept]

Phrase: "remain"

Phrase: "incompletely"

Phrase: "understood"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]

Phrase: "(Kacinski,"

Phrase: "1995"

Phrase: "; Ide et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.44: While invasive tumors may rely on cooperation with inflammatory cells, both in vivo and in vitro data support a multifaceted role for CSF-1R in tumorigenesis. 

Phrase: "While"

Phrase: "invasive tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "may"

Phrase: "rely on cooperation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392337:cooperation [Social Behavior]

Phrase: "with inflammatory cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0440752:inflammatory cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0333348:Inflammatory [Functional Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "both in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in vitro data"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "a multifaceted role for CSF-1R"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "in tumorigenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007621:Tumorigenesis [Neoplastic Process]
  1000   C0596263:Tumorigenesis [Neoplastic Process]
Processing 00000000.tx.45: In addition to macrophages, CSF-1R is expressed in the mammary epithelium of pregnant and lactating women (Sapi et al., 1998a). 

Phrase: "In addition to macrophages,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024432:Macrophages [Cell]
  1000   C1546706:Macrophages [Intellectual Product]
  1000   C1550652:Macrophages [Body Substance]

Phrase: "CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "expressed in the mammary epithelium of pregnant"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0596882:Mammary Epithelium [Body Part, Organ, or Organ Component]
   748   C0006141:Mammary [Body Part, Organ, or Organ Component]
   748   C0014609:Epithelium [Tissue]
   748   C0549206:Pregnant [Finding]
   748   C0553641:Pregnant [Functional Concept]
   748   C0600457:PREGNANT [Finding]
   748   C0929301:Mammary [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "lactating women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043210:Women [Population Group]

Phrase: "(Sapi et al.,"

Phrase: "1998a"

Phrase: ")."
Processing 00000000.tx.46: Furthermore, elevated epithelial coexpression of CSF-1R and CSF-1 has been described for >50% of mammary tumors, and correlates with invasiveness in both tumors and several mammary carcinoma cell lines (Kacinski et al., 1991). 

Phrase: "Furthermore,"

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "epithelial coexpression of CSF-1R"

Phrase: "and"

Phrase: "CSF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "described for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]

Phrase: ">50% of mammary tumors,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0024667:mammary tumors [Neoplastic Process]
   799 E C1458155:mammary tumor [Neoplastic Process]
   770   C0006141:Mammary [Body Part, Organ, or Organ Component]
   770   C0027651:Tumors [Neoplastic Process]
   770   C0929301:Mammary [Body Part, Organ, or Organ Component]
   737 E C1578706:Tumor [Intellectual Product]
   737 E C3273930:Tumor [Finding]

Phrase: "and"

Phrase: "correlates with invasiveness"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1301757:Invasiveness [Qualitative Concept]
   718 E C0205281:Invasive [Qualitative Concept]

Phrase: "in both tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027651:Tumors [Neoplastic Process]
   966 E C1578706:Tumor [Intellectual Product]
   966 E C3273930:Tumor [Finding]

Phrase: "and"

Phrase: "several mammary carcinoma cell lines"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   921   C0596890:mammary carcinoma cell line [Cell]
   858   C0230087:Mammary line [Body Location or Region]
   840   C0007600:Cell lines [Cell]
   840   C1518174:Carcinoma Cell [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:lines [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]

Phrase: "(Kacinski et al.,"

Phrase: "1991"

Phrase: ")."
Processing 00000000.tx.47: These data imply that CSF-1 may also act in an autocrine fashion to potentiate tumor cell invasion. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "imply"

Phrase: "that CSF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "also"

Phrase: "act in an autocrine fashion to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079613:ACT [Therapeutic or Preventive Procedure]
   753   C0596138:Autocrine [Organ or Tissue Function]

Phrase: "potentiate"

Phrase: "tumor cell invasion."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1269955:Tumor Cell Invasion [Finding]
           Tumor invasion
           Invasion
   901   C2699153:Cell Invasion [Pathologic Function]
           Invasion
   734   C0431085:Tumor cell [Cell]
   734   C0597032:Tumor Cell [Cell]
Processing 00000000.tx.48: In support of this, introduction of CSF-1R in noninvasive HC11 murine mammary epithelial cells, which express CSF-1, enhanced invasion through a MatrigelTM barrier by 100-fold (Sapi et al., 1996). 

Phrase: "In support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "of this,"

Phrase: "introduction of CSF-1R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1293116:Introduction [Health Care Activity]
   753   C1875307:INTRODUCTION [Manufactured Object]
   716   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "in noninvasive HC11 murine mammary epithelial cells,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   827   C0014597:Epithelial Cells [Cell]
   827   C1273342:Epithelial Cells [Laboratory Procedure]
   799   C0006141:Mammary [Body Part, Organ, or Organ Component]
   799   C0007634:Cells [Cell]
   799   C0221908:Epithelial [Qualitative Concept]
   799   C0929301:Mammary [Body Part, Organ, or Organ Component]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "express"

Phrase: "CSF-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "enhanced invasion through a MatrigelTM barrier"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1269955:Invasion [Finding]
   753   C2699153:Invasion [Pathologic Function]

Phrase: "by 100-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "(Sapi et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.49: In contrast, a complete inhibition of the invasive activity of BT20 breast tumor cells, which express high levels of both receptor and ligand, was achieved by expression of a dominant-negative mutant of Ets-2, a transcription factor that acts as a key mediator of the cellular response to CSF-1 (Langer et al., 1992; Sapi et al., 1998b). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "a complete inhibition of the invasive activity of BT20 breast tumor cells,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   736   C0021467:Inhibition [Mental Process]
   736   C0021469:Inhibition [Molecular Function]
   736   C1628982:% inhibition [Quantitative Concept]
   736   C3463820:Inhibition [Activity]

Phrase: "which"

Phrase: "express"

Phrase: "high levels of both receptor"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "ligand,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligand [Chemical]

Phrase: "was"

Phrase: "achieved by expression of a dominant-negative mutant of Ets-2,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   775   C1512032:Dominant-Negative Mutant [Cell or Molecular Dysfunction]
           Dominant Negative
   738   C0185117:Expression [Therapeutic or Preventive Procedure]
   738   C0205160:Negative [Qualitative Concept]
   738   C0596988:Mutant [Cell or Molecular Dysfunction]
   738   C1513916:Negative [Finding]
   738   C1527180:Dominant [Functional Concept]
   738   C2825415:Negative [Conceptual Entity]
   738   C2825491:Negative [Qualitative Concept]

Phrase: "a transcription factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040649:Transcription [Genetic Function]
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "that acts as a key mediator of the cellular response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "to CSF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "(Langer et al.,"

Phrase: "1992"

Phrase: "; Sapi et al.,"

Phrase: "1998b"

Phrase: ")."
Processing 00000000.tx.50: However, such studies do not assess the impact of autocrine CSF-1R signaling in the context of intact glandular structures, and little is known about the critical downstream signals that may be involved in potentiating invasive behavior. 

Phrase: "However,"

Phrase: "such studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the impact of autocrine CSF-1R signaling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1825598:IMPACT [Gene or Genome]

Phrase: "in the context"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "of intact glandular structures,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:structures [Spatial Concept]

Phrase: "and"

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "is"

Phrase: "known about the critical downstream signals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205309:Known [Qualitative Concept]
   753   C0522506:Downstream [Spatial Concept]
   753   C1511545:Critical [Qualitative Concept]
   719   C1710082:Signal [Phenomenon or Process]

Phrase: "that"

Phrase: "may"

Phrase: "be"

Phrase: "involved in potentiating invasive behavior."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004927:Behavior [Individual Behavior]
   760   C0205281:Invasive [Qualitative Concept]
   760   C1314939:Involved [Functional Concept]
   760   C2707008:Behavior [Clinical Attribute]
Processing 00000000.tx.51: While the essential role for CSF-1 in mammary development was revealed through mouse knockout studies, detection of the receptor in the murine gland has thus far been restricted to infiltrating macrophages. 

Phrase: "While"

Phrase: "the essential role for CSF-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in mammary development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "was"

Phrase: "revealed through mouse knockout studies,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   797   C0206745:Knock-Out Mouse [Mammal]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0443289:Revealed [Qualitative Concept]
   760   C0560617:knock out [Injury or Poisoning]
   760   C0947630:studies [Laboratory Procedure]
   760   C1522225:Knock-out [Experimental Model of Disease]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "detection of the receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in the murine gland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1285092:Gland [Body Part, Organ, or Organ Component]

Phrase: "has"

Phrase: "thus far"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205108:far [Spatial Concept]

Phrase: "been"

Phrase: "restricted to infiltrating macrophages."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0024432:Macrophages [Cell]
   770   C0332448:Infiltrating [Pathologic Function]
   770   C0443288:Restricted [Functional Concept]
   770   C1546706:Macrophages [Intellectual Product]
   770   C1550652:Macrophages [Body Substance]
   737 E C1546677:Infiltrate [Intellectual Product]
   737 E C1549537:Infiltrate [Functional Concept]
Processing 00000000.tx.52: Interestingly, epithelial expression of the CSF-1R transcript in human mammary epithelium is hormonally regulated via a glucocorticoid response element that is absent from the murine locus (Flick et al., 2002). 

Phrase: "Interestingly,"

Phrase: "epithelial expression of the CSF-1R transcript"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0597360:receptor expression [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in human mammary epithelium"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1257977:Mammary Epithelium, Human [Tissue]
   901   C0596882:Mammary Epithelium [Body Part, Organ, or Organ Component]
   827   C0014609:Epithelium [Tissue]
   755 E C0221908:Epithelial [Qualitative Concept]

Phrase: "is"

Phrase: "hormonally"

Phrase: "regulated via a glucocorticoid response element"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0013879:Element [Element, Ion, or Isotope]
   753   C0017710:Glucocorticoid [Hormone,Steroid]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1705248:Element [Conceptual Entity]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "that"

Phrase: "is"

Phrase: "absent from the murine locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:Absent [Quantitative Concept]
   760   C2699517:ABSENT [Finding]

Phrase: "(Flick et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.53: Thus, while mouse models have contributed much to an understanding of the role that macrophages, recruited to the mammary gland by CSF-1 secretion, can play in tumor progression, other model systems may be needed to reveal the mechanisms by which autocrine signaling can contribute to invasion in human tumors. 

Phrase: "Thus,"

Phrase: "while"

Phrase: "mouse models"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C2986594:Mouse Model [Experimental Model of Disease]
   861   C3161035:Models [Intellectual Product]

Phrase: "have"

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "much to an understanding of the role"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0035820:Role [Social Behavior]
   748   C0162340:Understanding [Mental Process]
   748   C1705810:Role [Conceptual Entity]

Phrase: "that macrophages,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024432:Macrophages [Cell]
  1000   C1546706:Macrophages [Intellectual Product]
  1000   C1550652:Macrophages [Body Substance]

Phrase: "recruited to the mammary gland"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0929301:Mammary gland [Body Part, Organ, or Organ Component]
           Mammary
   806   C1521747:GLAND, MAMMARY [Tissue]
   760   C0006141:Mammary [Body Part, Organ, or Organ Component]
   760   C1285092:Gland [Body Part, Organ, or Organ Component]

Phrase: "by CSF-1 secretion,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C2246740:CSF secretion [Cell Function]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   734   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   734   C1150625:CSF-1 [Molecular Function]

Phrase: "can"

Phrase: "play in tumor progression,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0178874:Tumor Progression [Neoplastic Process]
   770   C0027651:Tumor [Neoplastic Process]
   770   C0032214:Play [Daily or Recreational Activity]
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]
   770   C0600138:play [Finding]
   770   C1578706:Tumor [Intellectual Product]
   770   C3273930:Tumor [Finding]

Phrase: "other model systems"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   983   C0026339:Model System [Intellectual Product,Research Device]
   983   C3161035:Model System [Intellectual Product]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "the mechanisms by which autocrine signaling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441712:Mechanisms [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "can"

Phrase: "contribute to invasion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1269955:Invasion [Finding]
   790   C1880177:Contribute [Activity]
   790   C2699153:Invasion [Pathologic Function]

Phrase: "in human tumors."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]
Processing 00000000.tx.54: Therefore, we have examined the consequences of CSF-1R signaling on epithelial cell behavior in the nontransformed human mammary cell line MCF-10A. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "have"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the consequences of CSF-1R signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "on epithelial cell behavior"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0004927:Behavior [Individual Behavior]
   827   C2707008:Behavior [Clinical Attribute]
   755 E C2986890:Behavioral [Idea or Concept]
   734   C0014597:Epithelial cell [Cell]

Phrase: "in the nontransformed human mammary cell line MCF-10A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1553642:10a [Medical Device]
Processing 00000000.tx.55: To enable a careful dissection of specific alterations in epithelial physiology induced by CSF-1R, we have employed a three-dimensional (3D) basement membrane culture system in which MCF-10A cells assemble into spherical structures that recapitulate many features of lobular acini in vivo (Barcellos-Hoff et al., 1989). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562342:enable [Mental Process]
  1000   C1171285:enable [Mental Process]

Phrase: "a careful dissection of specific alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0012737:Dissection [Therapeutic or Preventive Procedure]

Phrase: "in epithelial physiology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1516940:Epithelial Physiology [Biomedical Occupation or Discipline]
   861   C0031842:Physiology [Biomedical Occupation or Discipline]
   861   C0031843:physiology [Physiologic Function]
   789 E C0205463:Physiologic [Functional Concept]

Phrase: "induced by CSF-1R,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   882   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   833   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0205263:Induced [Functional Concept]
   753   C0439158:colony [Quantitative Concept]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1521761:Factor [Functional Concept]
   753   C1947989:Colony [Cell]
   753   C1948023:Stimulating [Natural Phenomenon or Process]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "we"

Phrase: "have"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "a three-dimensional"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0450363:3-Dimensional [Spatial Concept]
   861   C0205449:Three [Quantitative Concept]
   789   C0439534:Dimension [Quantitative Concept]
   789   C1707753:Dimensionality [Spatial Concept]

Phrase: "(3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450363:3D [Spatial Concept]
  1000   C2986797:3D [Functional Concept]

Phrase: ")"

Phrase: "basement membrane culture system in which MCF-10A cells"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   767   C1516329:Cell Culture System [Molecular Biology Research Technique]
   762   C0007585:cells culture [Laboratory Procedure]
   742   C0010453:Culture [Idea or Concept]
   742   C0220814:culture [Functional Concept]
   742   C0430400:Culture [Laboratory Procedure]
   742   C0449913:System [Functional Concept]
   742   C1553451:System [Manufactured Object]
   742   C1704459:System [Medical Device]
   742   C2242979:Culture [Laboratory Procedure]

Phrase: "assemble into spherical structures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332501:Spherical [Spatial Concept]
   770   C0678594:structures [Spatial Concept]
   770   C1706853:Assemble [Activity]

Phrase: "that"

Phrase: "recapitulate"

Phrase: "many features of lobular acini"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   726   C1521970:Feature [Qualitative Concept]
   726   C1706388:Feature [Conceptual Entity]
   726   C2346469:Feature [Qualitative Concept]
   726   C2348519:Feature [Qualitative Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(Barcellos-Hoff et al.,"

Phrase: "1989"

Phrase: ")."
Processing 00000000.tx.56: This system is tractable to biochemical and cell biological analysis, and has been used previously by our laboratory to analyze the biological activities of various oncogenes (Muthuswamy et al., 2001; Debnath et al., 2002). 

Phrase: "This system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0449913:System [Functional Concept]
  1000   C1553451:System [Manufactured Object]
  1000   C1704459:System [Medical Device]
   928 E C0205373:Systemic [Functional Concept]

Phrase: "is"

Phrase: "tractable to biochemical"

Phrase: "and"

Phrase: "cell biological analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "has"

Phrase: "been"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "previously by our laboratory to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0022877:Laboratory [Manufactured Object,Organization]
   760   C3244292:laboratory [Functional Concept]

Phrase: "analyze"

Phrase: "the biological activities of various oncogenes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0005532:Biological [Biomedical Occupation or Discipline]
   753   C0205460:biological [Qualitative Concept]
   753   C0441655:Activities [Activity]
   719 E C0205177:Activity [Functional Concept]
   719 E C0439167:% activity [Quantitative Concept]
   719 E C1561536:*Activity [Idea or Concept]

Phrase: "(Muthuswamy et al.,"

Phrase: "2001"

Phrase: "; Debnath et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.57: Here we demonstrate that constitutive CSF-1R activation results in a striking and progressive disruption of cellcell adhesion in MCF-10A acini. 

Phrase: "Here"

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that constitutive CSF-1R activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1516703:Colony Stimulating Factor Activation [Physiologic Function]
   827   C1514758:Receptor Activation [Cell Function]
   799   C1879547:Activation [Activity]
   734   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "results in a striking"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0038452:striking [Occupational Activity]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "and"

Phrase: "progressive disruption of cellcell adhesion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332453:Disruption [Functional Concept]

Phrase: "in MCF-10A acini."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C0935597:Acinus [Body Part, Organ, or Organ Component]
   793   C1442495:ACINUS [Gene or Genome]
   743 E C0332207:Acinar [Spatial Concept]
Processing 00000000.tx.58: In cells expressing either a constitutively active form of the receptor, or coexpressing wild-type receptor and CSF-1 ligand, initial acinar development proceeds normally. 

Phrase: "In cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "either"

Phrase: "a constitutively active form of the receptor,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "or"

Phrase: "coexpressing wild-type receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "CSF-1 ligand,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0023688:Ligand [Chemical]
   734   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   734   C1150625:CSF-1 [Molecular Function]

Phrase: "initial acinar development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0243107:development [Physiologic Function]
   827   C0678723:Development [Organism Function]
   827   C1527148:Development [Functional Concept]
   755 E C0458003:Developmental [Qualitative Concept]

Phrase: "proceeds"

Phrase: "normally."
Processing 00000000.tx.59: However, in either context of CSF-1R hyperstimulation, structures fail to form lumen, become hyperproliferative, and progressively lose junctional stability and basement membrane integrity, culminating in the release of individual cells into the surrounding matrix. 

Phrase: "However,"

Phrase: "in either context"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449255:Context [Finding]
   861   C0542559:Context [Functional Concept]

Phrase: "of CSF-1R hyperstimulation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   717   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "lumen,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0524461:Lumen [Body Space or Junction]
  1000   C1282864:Lumen [Body Space or Junction]
  1000   C1301906:Lumen [Qualitative Concept]
  1000   C1551056:Lumen [Quantitative Concept]
   928 E C0524462:Luminal [Spatial Concept]

Phrase: "become"

Phrase: "hyperproliferative,"

Phrase: "and"

Phrase: "progressively"

Phrase: "lose"

Phrase: "junctional stability"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205360:Stability [Qualitative Concept]
   861   C2347098:Stability [Qualitative Concept]
   789 E C1547311:Stable [Intellectual Product]

Phrase: "and"

Phrase: "basement membrane integrity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205266:integrity [Qualitative Concept]
   827   C0872403:integrity [Individual Behavior]
   827   C1947912:Integrity [Qualitative Concept]
   734   C0004799:Basement membrane [Tissue]

Phrase: "culminating in the release of individual cells"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   748   C0007634:Cells [Cell]
   748   C0027361:Individual [Population Group]
   748   C0030685:Release [Health Care Activity]
   748   C0205260:Culminating [Qualitative Concept]
   748   C0237401:Individual [Human]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1963578:Release [Therapeutic or Preventive Procedure]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "into the surrounding matrix."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]
Processing 00000000.tx.60: While chronic CSF-1R activation does not alter steady-state levels or synthesis of the major epithelial cell adhesion molecule E-cadherin, immunofluorescence studies indicate that E-cadherin is lost from the plasma membrane and adopts a punctate localization. 

Phrase: "While"

Phrase: "chronic CSF-1R activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1516703:Colony Stimulating Factor Activation [Physiologic Function]
   827   C1514758:Receptor Activation [Cell Function]
   799   C1879547:Activation [Activity]
   734   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "steady-state levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0678587:steady state [Natural Phenomenon or Process]
   884   C0683927:state level [Spatial Concept]
   827   C0205361:Steady [Qualitative Concept]
   827   C0441889:Levels [Qualitative Concept]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "synthesis of the major epithelial cell adhesion molecule E-cadherin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0220781:synthesis [Biologic Function]
   739   C1883254:Synthesis [Activity]
   722   C2936320:Synthetic Cell [Manufactured Object]

Phrase: "immunofluorescence studies"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0016318:Immunofluorescence [Laboratory Procedure]
   861   C0079603:Immunofluorescence [Laboratory Procedure]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
   805 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   789 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "indicate"

Phrase: "that E-cadherin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0042172:E-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0694872:E-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413274:cadherin [Gene or Genome]

Phrase: "is"

Phrase: "lost from the plasma membrane"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0007603:Plasma membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0596901:Membrane [Cell Component]
   760   C0745777:Lost [Functional Concept]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "and"

Phrase: "adopts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:adopt [Finding]

Phrase: "a punctate localization."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]
Processing 00000000.tx.61: In addition, interaction of adherens junction complexes with the Triton-insoluble cytoskeleton is disrupted, impeding the ability of MCF-10A cells to achieve adhesive compaction. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "interaction of adherens junction complexes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "with the Triton-insoluble cytoskeleton"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0010853:Cytoskeleton [Cell Component]
   827   C1748451:Cytoskeleton [Cell Component]

Phrase: "is"

Phrase: "disrupted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:Disrupted [Qualitative Concept]

Phrase: ","

Phrase: "impeding"

Phrase: "the ability of MCF-10A cells to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0085732:Ability [Organism Attribute]

Phrase: "achieve"

Phrase: "adhesive compaction."
Processing 00000000.tx.62: Interfering with the activity of Src family kinases, either by pharmacological inhibition or by mutation of the Y561 docking site on CSF-1R, suppresses the adhesion phenotype. 

Phrase: "Interfering with the activity of Src family kinases,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C0282625:src-Family Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           src Kinases
   750   C0031727:Kinase Family [Amino Acid, Peptide, or Protein,Enzyme]
           Kinases
   750   C1150423:kinase activity [Molecular Function]
   744   C0015576:Family [Family Group]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C0521102:interfering [Qualitative Concept]
   744   C1561536:*Activity [Idea or Concept]
   744   C1704727:Family [Conceptual Entity]

Phrase: "either by pharmacological inhibition"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C0031330:Pharmacological [Biomedical Occupation or Discipline]
   770   C0205464:pharmacological [Functional Concept]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "or by mutation of the Y561 docking site"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   767   C2945843:Site of [Qualitative Concept]
   744   C0026882:Mutation [Genetic Function]
   744   C0205145:Site [Spatial Concept]
   744   C0442632:docking [Manufactured Object]
   744   C1515974:Site [Body Location or Region]
   744   C1522290:Docking [Molecular Function]
   744   C1705285:Mutation [Cell or Molecular Dysfunction]
   744   C2825164:Site [Spatial Concept]
   711 E C0330386:Dock [Plant]

Phrase: "on CSF-1R,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "the adhesion phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.63: These results suggest that CSF-1R activation, possibly by an autocrine mechanism, can profoundly disrupt the junctional integrity and architecture of mammary epithelial acini in vitro via activation of a Src-dependent pathway. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that CSF-1R activation,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   933   C1516703:Colony Stimulating Factor Activation [Physiologic Function]
   840   C1514758:Receptor Activation [Cell Function]
   804   C1879547:Activation [Activity]
   771   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   717   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "possibly by an autocrine mechanism,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441712:Mechanism [Functional Concept]
   760   C0596138:Autocrine [Organ or Tissue Function]
   760   C1706376:Mechanism [Manufactured Object]
   760   C2362652:Possibly [Qualitative Concept]

Phrase: "can"

Phrase: "profoundly"

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "the junctional integrity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205266:integrity [Qualitative Concept]
   861   C0872403:integrity [Individual Behavior]
   861   C1947912:Integrity [Qualitative Concept]

Phrase: "and"

Phrase: "architecture of mammary epithelial acini"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003737:Architecture [Occupation or Discipline]

Phrase: "in vitro via activation of a Src-dependent pathway."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0021135:In Vitro [Intellectual Product]
   764   C1533691:in vitro [Qualitative Concept]
           vitro
   764   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.64: These consequences distinguish hyperstimulation of CSF-1R from other RTKs examined in this model, and provide insight into the mechanisms whereby CSF-1 and its receptor could potentiate invasive activity in vivo.  

Phrase: "These consequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686907:consequences [Functional Concept]

Phrase: "distinguish"

Phrase: "hyperstimulation of CSF-1R"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   716   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "from other RTKs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0206364:Receptor Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   867   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "examined in this model,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332128:Examined [Finding]
   770   C3161035:Model [Intellectual Product]

Phrase: "and"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "insight into the mechanisms whereby CSF-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0233820:Insight [Mental Process]

Phrase: "and"

Phrase: "its receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "could"

Phrase: "potentiate"

Phrase: "invasive activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.65: Results Top Abstract Introduction Results Discussion Materials and methods References  CSF-1R activation supports EGF-independent proliferation and acinar development The proliferation and 3D morphogenesis of MCF-10A cells is dependent on the inclusion of EGF in the growth medium. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "CSF-1R activation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   933   C1516703:Colony Stimulating Factor Activation [Physiologic Function]
   840   C1514758:Receptor Activation [Cell Function]
   804   C1879547:Activation [Activity]
   771   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   717   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "EGF-independent proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0334094:Proliferation [Pathologic Function]
   827   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "acinar development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "The proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "3D morphogenesis of MCF-10A cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1156238:cell morphogenesis [Cell Function]
   753   C0026559:Morphogenesis [Organism Function]

Phrase: "is"

Phrase: "dependent on the inclusion of EGF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "in the growth medium."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Growth Medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C0439536:Medium [Quantitative Concept]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C1705217:Medium [Substance]
   861   C2911660:Growth [Activity]
   861   C3244283:medium [Intellectual Product]
Processing 00000000.tx.66: We initially sought to determine whether activation of CSF-1R could promote proliferation and acinar development in the absence of EGF. 

Phrase: "We initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "activation of CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   864   C1516703:Colony Stimulating Factor Activation [Physiologic Function]
   783   C1514758:Receptor Activation [Cell Function]
   753   C1879547:Activation [Activity]
   716   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "could"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "acinar development in the absence of EGF."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]
Processing 00000000.tx.67: Significant expression of CSF-1R in the mammary gland is observed only during late pregnancy and lactation; 

Phrase: "Significant expression of CSF-1R"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0597360:receptor expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the mammary gland"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0929301:Mammary gland [Body Part, Organ, or Organ Component]
           Mammary
  1000   C1521747:GLAND, MAMMARY [Tissue]
   861   C0006141:Mammary [Body Part, Organ, or Organ Component]
   861   C1285092:Gland [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "only during late pregnancy"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0878751:Late pregnancy [Pathologic Function]
   770   C0032961:Pregnancy [Organism Function]
   770   C0205087:Late [Temporal Concept]
   770   C0205171:Only [Quantitative Concept]
   770   C1720467:Only [Intellectual Product]
   770   C3484365:Pregnancy [Clinical Attribute]

Phrase: "and"

Phrase: "lactation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006147:Lactation [Organism Function]
  1000   C0022925:Lactation [Organ or Tissue Function]

Phrase: ";"
Processing 00000000.tx.68: MCF-10As were derived from the mammary tissue of a nonpregnant female, and do not express sufficient levels of CSF-1R to elicit a mitogenic response to CSF-1. 

Phrase: "MCF-10As"

Phrase: "were"

Phrase: "derived from the mammary tissue of a nonpregnant female,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   742   C0006141:Mammary [Body Part, Organ, or Organ Component]
   742   C0015780:Female [Finding]
   742   C0040300:Tissue [Tissue]
   742   C0043210:female [Population Group]
   742   C0086287:female [Population Group]
   742   C0929301:Mammary [Body Part, Organ, or Organ Component]
   742   C1441547:Derived [Qualitative Concept]
   742   C1547928:Tissue [Intellectual Product]
   742   C1705497:Female [Qualitative Concept]
   742   C1705498:Female [Qualitative Concept]
   742   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "express"

Phrase: "sufficient levels of CSF-1R to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "elicit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "a mitogenic response to CSF-1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]
Processing 00000000.tx.69: Therefore, to achieve higher receptor levels, we infected these cells with a retroviral vector encoding wild-type CSF-1R. 

Phrase: "Therefore,"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "achieve"

Phrase: "higher receptor levels,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0441889:Levels [Qualitative Concept]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "we"

Phrase: "infected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:Infected [Functional Concept]

Phrase: "these cells with a retroviral vector"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "wild-type CSF-1R."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.70: Receptor expression and CSF-1dependent activation were confirmed by immunoblotting (Fig. 1 A). 

Phrase: "Receptor expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597360:receptor expression [Genetic Function]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "CSF-1dependent activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]

Phrase: "were"

Phrase: "confirmed by immunoblotting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0750484:Confirmed [Idea or Concept]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "(Fig. 1 A"

Phrase: ")."
Processing 00000000.tx.71: Cells expressing wild-type CSF-1R cultured as monolayers in the presence of physiological levels of CSF-1 (10 ng/ml) proliferated at a similar rate as cells cultured in EGF and maintained a cobblestone phenotype (Fig. 1 B). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "wild-type CSF-1R"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "cultured as monolayers"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   824   C1510803:Monolayer culture [Laboratory Procedure]
   790   C0872351:monolayers [Clinical Drug]
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of physiological levels"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   861   C0205463:Physiological [Functional Concept]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
   789 E C0031842:Physiology [Biomedical Occupation or Discipline]
   789 E C0031843:physiology [Physiologic Function]

Phrase: "of CSF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "(10 ng/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439275:ng/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "proliferated at a similar rate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]
   760   C2348205:Similar [Qualitative Concept]

Phrase: "as cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "cultured in EGF"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: "a cobblestone phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "(Fig. 1 B"

Phrase: ")."
Processing 00000000.tx.72: In addition, treatment of these cells with CSF-1 promoted the formation of acini indistinguishable from those induced by EGF in 3D MatrigelTM culture (Fig. 1 C) (Debnath et al., 2002). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "treatment of these cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with CSF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "promoted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0033414:Promote [Activity]

Phrase: "the formation of acini"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "indistinguishable from those"

Phrase: "induced by EGF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205263:Induced [Functional Concept]

Phrase: "in 3D MatrigelTM culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "(Fig. 1 C) (Debnath et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.73: View larger version (43K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(43K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.74: Constitutive CSF-1R activation alters MCF-10As monolayer morphology and acinar morphogenesis. 

Phrase: "Constitutive CSF-1R activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1516703:Colony Stimulating Factor Activation [Physiologic Function]
   827   C1514758:Receptor Activation [Cell Function]
   799   C1879547:Activation [Activity]
   734   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "MCF-10As monolayer morphology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0332437:Morphology [Qualitative Concept]
   812   C0543482:morphology [Spatial Concept]
   812   C0700329:Morphology, NOS [Finding]
   812   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "acinar morphogenesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026559:Morphogenesis [Organism Function]
Processing 00000000.tx.75: (A) MCF-10A cells expressing wild-type or active CSF-1R were lysed in RIPA buffer and probed for receptor levels. 

Phrase: "(A) MCF-10A cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "active CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   937   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "were"

Phrase: "lysed in RIPA buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:lysed [Pathologic Function]
   770   C0034584:RIPA [Laboratory Procedure]

Phrase: "and"

Phrase: "probed for receptor levels."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0441889:Levels [Qualitative Concept]
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   737   C0182400:Probe [Medical Device]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737   C1704681:Probe [Gene or Genome]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737 E C2946261:Level [Pharmacologic Substance]
   737   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.76: Receptor activation was detected with a phospho-specific antibody to the Y723 autophosphorylation site. 

Phrase: "Receptor activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514758:Receptor Activation [Cell Function]
   861   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "detected with a phospho-specific antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0205369:Specific [Qualitative Concept]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1552740:specific [Intellectual Product]

Phrase: "to the Y723 autophosphorylation site."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
Processing 00000000.tx.77: Cells were starved overnight in assay media, and where noted were treated with 10 ng/ml CSF-1 for 5 min before lysis. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "starved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2348531:Starve [Activity]

Phrase: "overnight in assay media,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C0243073:assay [Qualitative Concept]
   770   C0439583:Overnight [Temporal Concept]
   770   C1254021:Media [Tissue]
   770   C1510438:Assay [Laboratory Procedure]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "where"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "were"

Phrase: "treated with 10 ng/ml CSF-1"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   778   C0439275:ng/mL [Quantitative Concept]
   778   C1150625:CSF-1 [Molecular Function]
   774   C0964553:NG.1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C1334110:NG.1 [Gene or Genome]
   748   C0439526:/mL [Quantitative Concept]
   748   C1522326:Treated [Functional Concept]
   748   C3540512:CSF [Therapeutic or Preventive Procedure]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "before lysis."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0024348:Lysis [Pathologic Function]
  1000   C1536403:lysis [Cell Function]
   928 E C0439680:Lytic [Qualitative Concept]
Processing 00000000.tx.78: (B) Phase-contrast images of MCF-10A cells expressing wild-type or active CSF-1R cultured to confluence in assay media with growth factors noted in parentheses. 

Phrase: "(B) Phase-contrast images of MCF-10A cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C1704254:Image [Intellectual Product]
   711   C1704922:Image [Entity]
   711   C3542466:Image [Intellectual Product]

Phrase: "expressing"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "active CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   937   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "cultured to confluence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]
   718   C0205200:Confluent [Qualitative Concept]

Phrase: "in assay media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "with growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "noted in parentheses."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1316572:Note [Clinical Attribute]
   756   C1317574:Note [Intellectual Product]
   756   C1369612:Note [Clinical Attribute]
Processing 00000000.tx.79: (C) MCF-10A cells expressing wild-type or active CSF-1R were cultured in MatrigelTM, and assay media with growth factors was replaced every 4 d. 

Phrase: "(C) MCF-10A cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   886   C0229579:C-Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "active CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   937   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "were"

Phrase: "cultured in MatrigelTM,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "assay media with growth factors"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   797   C0010454:growth media [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Media [Intellectual Product]
   760   C0162867:Media [Tissue]
   760   C1254021:Media [Tissue]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "replaced"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0559956:Replaced [Functional Concept]
  1000   C1299987:replaced [Functional Concept]
   966 E C1554078:Replace [Idea or Concept]

Phrase: "every 4 d."
Processing 00000000.tx.80: Brightfield images of day 5 and day 15 acini are shown. 

Phrase: "Brightfield images of day 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1704254:Image [Intellectual Product]
   726   C1704922:Image [Entity]
   726   C3542466:Image [Intellectual Product]

Phrase: "and"

Phrase: "day 15 acini"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C0935597:Acinus [Body Part, Organ, or Organ Component]
   793   C1442495:ACINUS [Gene or Genome]
   743 E C0332207:Acinar [Spatial Concept]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.81: (D) The average size of MCF-10A acini was determined by microscopic area measurements using MetaMorph software (n = 30).  

Phrase: "("

Phrase: "D)"

Phrase: "The average size of MCF-10A acini"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0456389:size [Spatial Concept]

Phrase: "was"

Phrase: "determined by microscopic area measurements"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017446:Area [Geographic Area]
   760   C0205146:Area [Spatial Concept]
   760   C0205288:Microscopic [Qualitative Concept]
   760   C0242485:measurements [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "MetaMorph software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(n = 30"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0632490:N 30 [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.82: Constitutive activation of CSF-1R disrupts MCF-10A acinar architecture Previous studies have shown that constitutively active CSF-1R has potent transforming activity in fibroblasts (Roussel et al., 1987). 

Phrase: "Constitutive activation of CSF-1R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1516703:Colony Stimulating Factor Activation [Physiologic Function]
   774   C1514758:Receptor Activation [Cell Function]
   748   C1879547:Activation [Activity]

Phrase: "disrupts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "MCF-10A acinar architecture Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0947630:studies [Laboratory Procedure]
   766 E C0557651:Study [Manufactured Object]
   766 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that constitutively active CSF-1R"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "has"

Phrase: "potent transforming activity in fibroblasts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "(Roussel et al.,"

Phrase: "1987"

Phrase: ")."
Processing 00000000.tx.83: To investigate whether deregulated CSF-1R signaling could similarly perturb the behavior of MCF-10As, we expressed an active variant of the receptor bearing two point mutations essential for the transforming capacity of the viral oncogene (v-fms). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "deregulated CSF-1R signaling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1514762:Receptor Signaling [Molecular Function]
   799   C0037083:Signaling [Cell Function]
   799   C3537152:signaling [Biologic Function]
   734   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "could"

Phrase: "similarly"

Phrase: "perturb"

Phrase: "the behavior of MCF-10As,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0004927:Behavior [Individual Behavior]
   760   C2707008:Behavior [Clinical Attribute]

Phrase: "we"

Phrase: "expressed"

Phrase: "an active variant of the receptor bearing two point mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205419:Variant [Qualitative Concept]

Phrase: "essential for the transforming capacity of the viral oncogene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205224:Essential [Qualitative Concept]

Phrase: "(v-fms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080282:v fms [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.84: The mutation L301S in the extracellular domain permits ligand-independent receptor activation, and Y969F relieves an autoinhibitory regulatory mechanism that may involve down-regulation of the receptor via recruitment of Cbl (Roussel et al., 1988; Wilhelmsen et al., 2002). 

Phrase: "The mutation L301S in the extracellular domain"

Phrase: "permits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023636:Permit [Regulation or Law]
  1000   C0329040:Permit [Fish]

Phrase: "ligand-independent receptor activation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514758:Receptor Activation [Cell Function]
   812   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "Y969F"

Phrase: "relieves"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1301676:Relieves [Functional Concept]
   916 E C0332303:relieving [Functional Concept]
   916 E C1301771:Relieved [Qualitative Concept]

Phrase: "an autoinhibitory regulatory mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "may"

Phrase: "involve"

Phrase: "down-regulation of the receptor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   844   C0949469:Receptor Down-Regulation [Molecular Function]
   806   C0013081:Down-Regulation [Cell Function,Molecular Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]
   704   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   704   C2626739:Lanugo [Eukaryote]

Phrase: "via recruitment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2949735:Recruitment [Activity]

Phrase: "of Cbl (Roussel et al.,"

Phrase: "1988"

Phrase: "; Wilhelmsen et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.85: Monolayers of MCF-10As expressing active CSF-1R proliferated in the absence of ligand, adopted a more refractile appearance, and displayed reduced contact inhibition (Fig. 1 B). 

Phrase: "Monolayers of MCF-10As"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0872351:monolayers [Clinical Drug]

Phrase: "expressing"

Phrase: "active CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   937   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "proliferated in the absence of ligand,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0023688:Ligand [Chemical]
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "adopted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:Adopted [Finding]

Phrase: "a more refractile appearance,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0233426:Appearance [Organism Attribute]
   827   C0700364:Appearance [Qualitative Concept]

Phrase: "and"

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "reduced contact inhibition"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0009835:Contact Inhibition [Cell Function]
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C0332158:contact [Functional Concept]
   827   C0337611:Contact [Population Group]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C1705415:Contact [Idea or Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]

Phrase: "(Fig. 1 B"

Phrase: ")."
Processing 00000000.tx.86: In 3D culture, the cells initiated morphogenesis in the absence of exogenous growth factors and initially formed spherical clusters with well-defined borders. 

Phrase: "In 3D culture,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "initiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1548602:Initiate [Idea or Concept]
   966   C1704686:Initiate [Functional Concept]

Phrase: "morphogenesis in the absence of exogenous growth factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0026559:Morphogenesis [Organism Function]

Phrase: "and"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "spherical clusters with well-defined borders."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1555715:Cluster [Idea or Concept]
   719   C1704332:Cluster [Quantitative Concept]
Processing 00000000.tx.87: However, as morphogenesis progressed, these structures exhibited enhanced proliferation and significantly increased size relative to wild-type controls (Fig. 1 D). 

Phrase: "However,"

Phrase: "as"

Phrase: "morphogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026559:Morphogenesis [Organism Function]

Phrase: "progressed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1272688:progressed [Functional Concept]
   966 E C1280477:Progress [Functional Concept]

Phrase: ","

Phrase: "these structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "enhanced proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "significantly increased size"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0332509:Increased size [Finding]
   827   C0456389:size [Spatial Concept]

Phrase: "relative to wild-type controls"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: "(Fig. 1 D"

Phrase: ")."
Processing 00000000.tx.88: Furthermore, after 89 d in culture, acini exhibited a progressive loss of structural integrity. 

Phrase: "Furthermore,"

Phrase: "after"

Phrase: "89 d in culture,"

Phrase: "acini"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C0935597:Acinus [Body Part, Organ, or Organ Component]
   966   C1442495:ACINUS [Gene or Genome]
   916 E C0332207:Acinar [Spatial Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a progressive loss of structural integrity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]
Processing 00000000.tx.89: The structures maintained a high proliferative rate, became visibly discohesive, and individual cells dissociated from the acini (Fig. 1 B). 

Phrase: "The structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: "a high proliferative rate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "became"

Phrase: "visibly discohesive,"

Phrase: "and"

Phrase: "individual cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "dissociated from the acini"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0935597:Acinus [Body Part, Organ, or Organ Component]
   737   C1442495:ACINUS [Gene or Genome]

Phrase: "(Fig. 1 B"

Phrase: ")."
Processing 00000000.tx.90: This phenotype is distinct from that induced by activation of ErbB2, which promotes the formation of filled, multiacinar structures but does not impact the integrity of the outer cell layer (Muthuswamy et al., 2001). 

Phrase: "This phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]

Phrase: "is"

Phrase: "distinct from that"

Phrase: "induced by activation of ErbB2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induced [Functional Concept]
   760   C1879547:Activation [Activity]

Phrase: "which"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the formation of filled, multiacinar structures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "but"

Phrase: "does"

Phrase: "not impact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1825598:IMPACT [Gene or Genome]

Phrase: "the integrity of the outer cell layer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205266:integrity [Qualitative Concept]
   748   C0872403:integrity [Individual Behavior]
   748   C1947912:Integrity [Qualitative Concept]

Phrase: "(Muthuswamy et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.91: Autocrine or chronic stimulation of CSF-1R mimics the effects of constitutive activity on acinar integrity While the presence of activating CSF-1R mutations in epithelial tumors has not been confirmed, coexpression of CSF-1R and CSF-1 is frequently observed in the epithelium of invasive mammary carcinomas (Kacinski et al., 1991). 

Phrase: "Autocrine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596138:Autocrine [Organ or Tissue Function]

Phrase: "or"

Phrase: "chronic stimulation of CSF-1R"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "mimics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0393040:mimics [Therapeutic or Preventive Procedure]
  1000   C1176299:mimics [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "the effects of constitutive activity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on acinar integrity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205266:integrity [Qualitative Concept]
   861   C0872403:integrity [Individual Behavior]
   861   C1947912:Integrity [Qualitative Concept]

Phrase: "While"

Phrase: "the presence of activating CSF-1R mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in epithelial tumors"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1368683:epithelial tumors [Neoplastic Process]
   861   C0027651:Tumors [Neoplastic Process]
   861   C0221908:Epithelial [Qualitative Concept]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: ","

Phrase: "coexpression of CSF-1R"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   716   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "and"

Phrase: "CSF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "frequently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Frequently [Temporal Concept]

Phrase: "observed in the epithelium of invasive mammary carcinomas"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   767   C0596882:Mammary Epithelium [Body Part, Organ, or Organ Component]
   750   C1334274:Invasive Carcinoma [Neoplastic Process]
   744   C0006141:Mammary [Body Part, Organ, or Organ Component]
   744   C0007097:Carcinomas [Neoplastic Process]
           Epithelial Carcinoma
   744   C0014609:Epithelium [Tissue]
   744   C0205281:Invasive [Qualitative Concept]
   744   C0929301:Mammary [Body Part, Organ, or Organ Component]
   744   C1441672:Observed [Functional Concept]
   737   C0678222:Mammary Carcinoma [Neoplastic Process]

Phrase: "(Kacinski et al.,"

Phrase: "1991"

Phrase: ")."
Processing 00000000.tx.92: This suggests that autocrine CSF-1R activation may be sufficient to promote tumor progression. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that autocrine CSF-1R activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1516703:Colony Stimulating Factor Activation [Physiologic Function]
   827   C1514758:Receptor Activation [Cell Function]
   799   C1879547:Activation [Activity]
   734   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "may"

Phrase: "be"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "tumor progression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178874:Tumor Progression [Neoplastic Process]
   861   C0242656:progression [Pathologic Function]
   861   C0449258:Progression [Functional Concept]
Processing 00000000.tx.93: To determine whether autocrine signaling could disrupt acinar structure, we generated MCF-10As coexpressing CSF-1 and wild-type CSF-1R. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "autocrine signaling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0525010:Autocrine Signaling [Cell Function]
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "could"

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "acinar structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "we"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "MCF-10As"

Phrase: "coexpressing"

Phrase: "CSF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "wild-type CSF-1R."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.94: Ligand expression was confirmed by ELISA (unpublished data). 

Phrase: "Ligand expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "confirmed by ELISA (unpublished data"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   760   C0014441:ELISA [Laboratory Procedure]
   760   C0750484:Confirmed [Idea or Concept]
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]
   726 E C1456348:Confirm [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.95: Monolayers of cells expressing both ligand and receptor exhibited a similar phenotype to those expressing constitutively active receptor (unpublished data). 

Phrase: "Monolayers of cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0872351:monolayers [Clinical Drug]

Phrase: "expressing"

Phrase: "both ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligand [Chemical]

Phrase: "and"

Phrase: "receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a similar phenotype to those expressing constitutively active receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0031437:Phenotype [Organism Attribute]
   742   C1285572:Phenotype [Laboratory Procedure]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.96: Furthermore, in 3D culture, these cells initiated morphogenesis normally, but were hyperproliferative; 

Phrase: "Furthermore,"

Phrase: "in 3D culture,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "initiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1548602:Initiate [Idea or Concept]
   966   C1704686:Initiate [Functional Concept]

Phrase: "morphogenesis normally,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026559:Morphogenesis [Organism Function]

Phrase: "but"

Phrase: "were"

Phrase: "hyperproliferative"

Phrase: ";"
Processing 00000000.tx.97: as a result, acini expanded greatly in size and failed to undergo growth arrest. 

Phrase: "as a result,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "acini"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C0935597:Acinus [Body Part, Organ, or Organ Component]
   966   C1442495:ACINUS [Gene or Genome]
   916 E C0332207:Acinar [Spatial Concept]

Phrase: "expanded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205229:expanded [Spatial Concept]

Phrase: "greatly in size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0456389:size [Spatial Concept]

Phrase: "and"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "undergo"

Phrase: "growth arrest."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0333951:Growth arrest [Pathologic Function]
   861   C0237477:Arrest [Temporal Concept]
   861   C0392351:arrest [Governmental or Regulatory Activity]
Processing 00000000.tx.98: Similar to those expressing active receptor, these acini also exhibited a progressive architectural disruption after 89 d, such that the integrity of the luminal cell layer was compromised and single cells were released into the matrix (Fig. 

Phrase: "Similar to those expressing active receptor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "these acini also"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0935597:Acinus [Body Part, Organ, or Organ Component]
   827   C1442495:ACINUS [Gene or Genome]
   777 E C0332207:Acinar [Spatial Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a progressive architectural disruption after 89 d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332453:Disruption [Functional Concept]

Phrase: "such"

Phrase: "that"

Phrase: "the integrity of the luminal cell layer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205266:integrity [Qualitative Concept]
   748   C0872403:integrity [Individual Behavior]
   748   C1947912:Integrity [Qualitative Concept]

Phrase: "was"

Phrase: "compromised"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2945640:compromise [Finding]

Phrase: "and"

Phrase: "single cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "released into the matrix"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   770   C1704640:Matrix [Spatial Concept]
   770   C1706515:Matrix [Body Substance]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.99: 2 A; 

Phrase: "2 A"

Phrase: ";"
Processing 00000000.tx.100: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.101: S1, available at http://www.jcb.org/cgi/content/full/jcb.200309102/DC1). 

Phrase: "S1,"

Phrase: "available at http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: ":"

Phrase: "//www.jcb.org/cgi/content/full/jcb.200309102/DC1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C1415570:DC1 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.102: These results indicate that activation of CSF-1R in an autocrine fashion can have profound effects on in vitro acinar morphogenesis. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that activation of CSF-1R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1516703:Colony Stimulating Factor Activation [Physiologic Function]
   774   C1514758:Receptor Activation [Cell Function]
   748   C1879547:Activation [Activity]

Phrase: "in an autocrine fashion"

Phrase: "can"

Phrase: "have"

Phrase: "profound effects on in vitro acinar morphogenesis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.103: View larger version (47K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(47K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.104: Autocrine or chronic activation can mimic the active CSF-1R phenotype. 

Phrase: "Autocrine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596138:Autocrine [Organ or Tissue Function]

Phrase: "or"

Phrase: "chronic activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "can"

Phrase: "mimic"

Phrase: "the active CSF-1R phenotype."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0031437:Phenotype [Organism Attribute]
   799   C1285572:Phenotype [Laboratory Procedure]
   734   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
Processing 00000000.tx.105: (A) MCF-10As expressing CSF-1R and CSF-1 were cultured in MatrigelTM in assay media. 

Phrase: "(A) MCF-10As"

Phrase: "expressing"

Phrase: "CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "CSF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "cultured in MatrigelTM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "in assay media."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.106: Brightfield images of day 5 and day 19 acini are shown. 

Phrase: "Brightfield images of day 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1704254:Image [Intellectual Product]
   726   C1704922:Image [Entity]
   726   C3542466:Image [Intellectual Product]

Phrase: "and"

Phrase: "day 19 acini"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C0935597:Acinus [Body Part, Organ, or Organ Component]
   793   C1442495:ACINUS [Gene or Genome]
   743 E C0332207:Acinar [Spatial Concept]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.107: (B) 3D cultures of cells expressing CSF-1R were stimulated daily with 10 ng/ml CSF-1. 

Phrase: "(B) 3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450363:3D [Spatial Concept]
   861   C2986797:3D [Functional Concept]

Phrase: "cultures of cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   858   C0007585:cells culture [Laboratory Procedure]
   790   C0007634:Cells [Cell]
   790   C0010453:Culture [Idea or Concept]
   790   C0220814:culture [Functional Concept]
   790   C0430400:Culture [Laboratory Procedure]
   790   C2242979:Culture [Laboratory Procedure]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "were"

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "daily with 10 ng/ml CSF-1."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   778   C0439275:ng/mL [Quantitative Concept]
   778   C1150625:CSF-1 [Molecular Function]
   774   C0964553:NG.1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C1334110:NG.1 [Gene or Genome]
   748   C0332173:Daily [Temporal Concept]
   748   C0439526:/mL [Quantitative Concept]
   748   C3540512:CSF [Therapeutic or Preventive Procedure]
Processing 00000000.tx.108: Phase-contrast images of day 5 and day 13 acini are shown.  

Phrase: "Phase-contrast images of day 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1704254:Image [Intellectual Product]
   719   C1704922:Image [Entity]
   719   C3542466:Image [Intellectual Product]

Phrase: "and"

Phrase: "day 13 acini"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C0935597:Acinus [Body Part, Organ, or Organ Component]
   793   C1442495:ACINUS [Gene or Genome]
   743 E C0332207:Acinar [Spatial Concept]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.109: The development of discohesive structures upon CSF-1R hyperstimulation suggested that constitutive receptor signaling might impact molecules involved in cellcell adhesion. 

Phrase: "The development of discohesive structures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "upon CSF-1R hyperstimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   717   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that constitutive receptor signaling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1514762:Receptor Signaling [Molecular Function]
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]

Phrase: "might"

Phrase: "impact molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "involved in cellcell adhesion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0001511:Adhesion [Pathologic Function]
   770   C0175633:Adhesion [Natural Phenomenon or Process]
   770   C1314939:Involved [Functional Concept]
Processing 00000000.tx.110: Consequently, we analyzed the localization of the adherens junction proteins during morphogenesis. 

Phrase: "Consequently,"

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the localization of the adherens junction proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0597704:protein localisation [Cell Function]
   757   C1159772:Protein Localization [Cell Function]
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "during morphogenesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026559:Morphogenesis [Organism Function]
Processing 00000000.tx.111: Acini formed in response to exogenous CSF-1 exhibited well-defined cellcell junctions, illustrated by membrane localization of E-cadherin, concentrated toward the basal pole of the lateral membrane (Fig. 3 A). 

Phrase: "Acini"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C0935597:Acinus [Body Part, Organ, or Organ Component]
   966   C1442495:ACINUS [Gene or Genome]
   916 E C0332207:Acinar [Spatial Concept]

Phrase: "formed in response"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0205431:Formed [Functional Concept]
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]
   756 E C0348078:Form [Qualitative Concept]
   756 E C0376315:Form [Manufactured Object]
   756 E C1522492:Form [Functional Concept]

Phrase: "to exogenous CSF-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C1150625:CSF-1 [Molecular Function]
   827   C0205101:Exogenous [Spatial Concept]
   827   C0205228:Exogenous [Functional Concept]
   827   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "well-defined cellcell junctions,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0205144:Junction [Spatial Concept]
   779   C1706311:Junction [Medical Device]

Phrase: "illustrated by membrane localization of E-cadherin,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0025255:Membrane [Tissue]
   748   C0475264:Localisation [Functional Concept]
   748   C0596901:Membrane [Cell Component]
   748   C1413274:cadherin [Gene or Genome]
   748   C1706182:Membrane [Manufactured Object]
   748   C1744691:localisation [Biologic Function]

Phrase: "concentrated toward the basal pole of the lateral membrane"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   742   C0025255:Membrane [Tissue]
   742   C0205093:Lateral [Spatial Concept]
   742   C0205112:Basal [Spatial Concept]
   742   C0596901:Membrane [Cell Component]
   742   C0935623:Pole [Body Location or Region]
   742   C1418729:POLE [Gene or Genome]
   742   C1706182:Membrane [Manufactured Object]
   742   C1880165:Concentrated [Biomedical or Dental Material]
   712   C0598101:membrane polarity [Spatial Concept]
   708 E C1880310:Concentrate [Manufactured Object]
   708 E C2003864:Concentrate [Substance]

Phrase: "(Fig. 3 A"

Phrase: ")."
Processing 00000000.tx.112: Furthermore, acini formed lumen and displayed aspects of polarity, basally deposited the ECM protein laminin 5, and underwent proliferative arrest over a similar time course as with acini grown in the presence of EGF (Fig. 3, A and B) (Debnath et al., 2002). 

Phrase: "Furthermore,"

Phrase: "acini"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C0935597:Acinus [Body Part, Organ, or Organ Component]
   966   C1442495:ACINUS [Gene or Genome]
   916 E C0332207:Acinar [Spatial Concept]

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "lumen"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0524461:Lumen [Body Space or Junction]
  1000   C1282864:Lumen [Body Space or Junction]
  1000   C1301906:Lumen [Qualitative Concept]
  1000   C1551056:Lumen [Quantitative Concept]
   928 E C0524462:Luminal [Spatial Concept]

Phrase: "and"

Phrase: "displayed aspects of polarity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1547011:Aspect [Quantitative Concept]
   737   C1879746:Aspect [Qualitative Concept]

Phrase: "basally"

Phrase: "deposited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:deposited [Functional Concept]

Phrase: "the ECM protein laminin 5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0171955:laminin-5 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0015350:ECM [Tissue]
   812   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1417215:ECM [Gene or Genome]

Phrase: "and"

Phrase: "underwent"

Phrase: "proliferative arrest over a similar time course"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237477:Arrest [Temporal Concept]
   748   C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "as with acini"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C0935597:Acinus [Body Part, Organ, or Organ Component]
   756   C1442495:ACINUS [Gene or Genome]
   706 E C0332207:Acinar [Spatial Concept]

Phrase: "grown in the presence of EGF (Fig. 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0349966:Fig [Food]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B) (Debnath et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.113: View larger version (29K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.114: CSF-1 coexpression causes hyperproliferation and architectural disruption. 

Phrase: "CSF-1 coexpression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   734   C1150625:CSF-1 [Molecular Function]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "hyperproliferation"

Phrase: "and"

Phrase: "architectural disruption."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332453:Disruption [Functional Concept]
Processing 00000000.tx.115: MCF-10A cells expressing CSF-1R and vector control (CSF-1R/Vector) or CSF-1 (CSF-1R/CSF-1) were cultured in MatrigelTM in assay media with 10 ng/ml CSF-1 where noted (CSF-1). 

Phrase: "MCF-10A cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "vector control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0031249:vector control [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243148:control [Qualitative Concept]
   861   C0442335:Vector [Spatial Concept]
   861   C1550141:Control [Substance]
   861   C1705099:Vector [Idea or Concept]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(CSF-1R/Vector"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0442335:Vector [Spatial Concept]
   804   C1705099:Vector [Idea or Concept]
   771   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   717   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: "or"

Phrase: "CSF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "(CSF-1R/CSF-1"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   919   C0079784:Colony-Stimulating Factor 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
           CSF-1
   919   C1332789:COLONY-STIMULATING FACTOR 1 [Gene or Genome]
   901   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   861   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1150625:CSF-1 [Molecular Function]
   799   C0439158:colony [Quantitative Concept]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C1521761:Factor [Functional Concept]
   799   C1947989:Colony [Cell]
   799   C1948023:Stimulating [Natural Phenomenon or Process]
   799   C2827422:Factor [Conceptual Entity]
   799   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "were"

Phrase: "cultured in MatrigelTM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "in assay media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "with 10 ng/ml CSF-1 where"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   858   C0964553:NG.1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858   C1334110:NG.1 [Gene or Genome]
   827   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439275:ng/mL [Quantitative Concept]
   827   C1150625:CSF-1 [Molecular Function]
   799   C0439526:/mL [Quantitative Concept]
   799   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "(CSF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: ")."
Processing 00000000.tx.116: Confocal images of day 6 and day 17 acinar cultures are shown. 

Phrase: "Confocal images of day 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1704254:Image [Intellectual Product]
   726   C1704922:Image [Entity]
   726   C3542466:Image [Intellectual Product]

Phrase: "and"

Phrase: "day 17 acinar cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0010453:Cultures [Idea or Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.117: Structures were stained with DAPI (blue) along with Ki67 (green) and E-cadherin (red) (A and C) or cleaved caspase-3 (green) and laminin 5 (red) (B and D).  

Phrase: "Structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "were"

Phrase: "stained with DAPI (blue"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0057142:DAPI [Organic Chemical,Pharmacologic Substance]
   770   C1260957:Blue [Qualitative Concept]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: ")"

Phrase: "along with Ki67"

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "E-cadherin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0042172:E-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0694872:E-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413274:cadherin [Gene or Genome]

Phrase: "(red) (A"

Phrase: "and"

Phrase: "C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "or"

Phrase: "cleaved caspase-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "laminin 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0171955:laminin-5 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(red) (B"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.118: Although E-cadherin initially exhibited a similar membrane localization in acini coexpressing CSF-1R and CSF-1, subsequently, it became diffusely localized, and immunostaining was diminished (Fig. 3 C). 

Phrase: "Although"

Phrase: "E-cadherin initially"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0042172:E-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0694872:E-CADHERIN [Gene or Genome]
   827   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1413274:cadherin [Gene or Genome]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a similar membrane localization in acini"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "coexpressing"

Phrase: "CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "CSF-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "subsequently,"

Phrase: "it"

Phrase: "became"

Phrase: "diffusely"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: ","

Phrase: "and"

Phrase: "immunostaining"

Phrase: "was"

Phrase: "diminished"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:Diminished [Quantitative Concept]

Phrase: "(Fig. 3 C)."
Processing 00000000.tx.119: Loss of membrane staining correlated with the degree of architectural disruption. 

Phrase: "Loss of membrane staining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "correlated with the degree of architectural disruption."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0332453:Disruption [Functional Concept]
   748   C0441889:Degree [Qualitative Concept]
   748   C0449286:Degree [Quantitative Concept]
   748   C0542560:Degree [Intellectual Product]
   748   C1561545:degree [Quantitative Concept]
   748   C1707520:Correlated [Qualitative Concept]
   748   C2348088:Degree [Quantitative Concept]
Processing 00000000.tx.120: Concomitant with the relocalization of junctional components, we observed disruption of the integrity of the basal basement membrane and disordered deposition of laminin 5 in these structures (Fig. 3 D). 

Phrase: "Concomitant with the relocalization of junctional components,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0521115:Concomitant [Temporal Concept]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "disruption of the integrity of the basal basement membrane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0332453:Disruption [Functional Concept]

Phrase: "and"

Phrase: "disordered deposition of laminin 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333562:Deposition [Functional Concept]

Phrase: "in these structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "(Fig. 3 D"

Phrase: ")."
Processing 00000000.tx.121: Furthermore, the expansion in size of the autocrine structures correlated with significantly increased proliferation (Fig. 3 C). 

Phrase: "Furthermore,"

Phrase: "the expansion in size of the autocrine structures"

Phrase: "correlated with significantly increased proliferation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205217:Increased [Quantitative Concept]
   760   C0334094:Proliferation [Pathologic Function]
   760   C0442805:Increased [Functional Concept]
   760   C1514485:Proliferation [Functional Concept]
   760   C1707520:Correlated [Qualitative Concept]

Phrase: "(Fig. 3 C)."
Processing 00000000.tx.122: While activation of ErbB2 was shown to have similar effects on cell proliferation and lumen formation, it had no such impact on the distribution of cell adhesion molecules (Muthuswamy et al., 2001), suggesting that this may represent a distinct capacity of autocrine CSF-1R signaling. 

Phrase: "While"

Phrase: "activation of ErbB2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "similar effects on cell proliferation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "lumen formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "it"

Phrase: "had"

Phrase: "no such impact on the distribution of cell adhesion molecules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1825598:IMPACT [Gene or Genome]

Phrase: "(Muthuswamy et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this"

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a distinct capacity of autocrine CSF-1R signaling."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1516240:Capacity [Quantitative Concept]
Processing 00000000.tx.123: These effects could reflect a unique capability of autocrine engagement of CSF-1R, such as activation of an internal pool of newly synthesized molecules during trafficking to the plasma membrane. 

Phrase: "These effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "could"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "a unique capability of autocrine engagement of CSF-1R,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C2698977:Capability [Qualitative Concept]

Phrase: "such as activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of an internal pool"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0337051:Pool [Geographic Area]
   861   C1509144:pool [Clinical Attribute]
   861   C2349200:Pool [Functional Concept]

Phrase: "of newly synthesized molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "during"

Phrase: "trafficking to the plasma membrane."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0007603:Plasma membrane [Cell Component]
   781   C1513112:Membrane Traffic [Molecular Function]
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0596901:Membrane [Cell Component]
   760   C0599896:trafficking [Cell Function]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.124: Alternatively, the disruptive effects of ligand coexpression could simply be a consequence of chronic receptor stimulation. 

Phrase: "Alternatively,"

Phrase: "the disruptive effects of ligand coexpression"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "could"

Phrase: "simply"

Phrase: "be"

Phrase: "a consequence of chronic receptor stimulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0686907:Consequence of [Functional Concept]
           Consequence
Processing 00000000.tx.125: We addressed the latter possibility by modifying the feeding schedule of 3D cultures, which typically involves replenishment with fresh medium every 4 d. 

Phrase: "We"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "the latter possibility by modifying"

Phrase: "the feeding schedule of 3D cultures,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0920763:feeding schedule [Finding]
   753   C0086960:Schedule [Intellectual Product]

Phrase: "which typically"

Phrase: "involves"

Phrase: "replenishment with fresh medium"

Phrase: "every 4 d."
Processing 00000000.tx.126: When cultures were instead supplemented with CSF-1 daily, structural disruption was perceptible by day 13 (Fig. 2 B). 

Phrase: "When"

Phrase: "cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "instead"

Phrase: "supplemented with CSF-1 daily,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   806   C1150625:CSF-1 [Molecular Function]
   760   C0332173:Daily [Temporal Concept]
   760   C3540512:CSF [Therapeutic or Preventive Procedure]
   726   C0242295:Supplement [Food]
   726   C1947943:Supplement [Intellectual Product]
   726   C2348609:Supplement [Functional Concept]

Phrase: "structural disruption"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332453:Disruption [Functional Concept]

Phrase: "was"

Phrase: "perceptible by day 13"

Phrase: "(Fig. 2 B"

Phrase: ")."
Processing 00000000.tx.127: In contrast, daily treatment of parental MCF-10As with EGF did not elicit a discohesive phenotype (Fig. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "daily treatment of parental MCF-10As"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "with EGF"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "elicit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "a discohesive phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.128: S2, available at http://www.jcb.org/cgi/content/full/jcb.200309102/DC1). 

Phrase: "S2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1179705:S2 [Body Location or Region]
  1000   C1419032:S2 [Gene or Genome]
  1000   C1419718:S2 [Gene or Genome]

Phrase: "available at http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: ":"

Phrase: "//www.jcb.org/cgi/content/full/jcb.200309102/DC1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C1415570:DC1 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.129: This suggests that while intracellular activation of CSF-1R may occur in the autocrine context, it is not necessary to produce the observed phenotype. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "while"

Phrase: "intracellular activation of CSF-1R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1516703:Colony Stimulating Factor Activation [Physiologic Function]
   774   C1514758:Receptor Activation [Cell Function]
   748   C1879547:Activation [Activity]

Phrase: "may"

Phrase: "occur in the autocrine context,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0449255:Context [Finding]
   760   C0542559:Context [Functional Concept]
   760   C0596138:Autocrine [Organ or Tissue Function]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "it"

Phrase: "is"

Phrase: "not necessary to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1518422:Not [Functional Concept]

Phrase: "produce"

Phrase: "the observed phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.130: Rather, chronic exposure to ligand is sufficient to promote disruption of acinar architecture, whether provided exogenously or in an autocrine fashion. 

Phrase: "Rather,"

Phrase: "chronic exposure to ligand"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0332157:Exposure to [Clinical Attribute]
           Exposure
   770   C0205191:chronic [Temporal Concept]
   770   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "is"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "disruption of acinar architecture,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332453:Disruption [Functional Concept]

Phrase: "whether"

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "exogenously"

Phrase: "or in an autocrine fashion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596138:Autocrine [Organ or Tissue Function]
Processing 00000000.tx.131: Autocrine CSF-1R activation alters the motility of MCF-10A monolayers Perturbation of cadherin-mediated adhesion has been shown to influence the movement of epithelial monolayers (Owens et al., 2000). 

Phrase: "Autocrine CSF-1R activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1516703:Colony Stimulating Factor Activation [Physiologic Function]
   827   C1514758:Receptor Activation [Cell Function]
   799   C1879547:Activation [Activity]
   734   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the motility of MCF-10A monolayers Perturbation of cadherin-mediated adhesion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0007608:Motility [Cell Function]
   738   C0678835:Motility [Laboratory or Test Result]
   738   C1510470:Motility [Organism Function]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "influence"

Phrase: "the movement of epithelial monolayers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0026649:Movement [Organism Function]

Phrase: "(Owens et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.132: To determine whether CSF-1R activation altered the motility of MCF-10A cells, we assessed the dynamics of wound healing in response to exogenous or coexpressed CSF-1. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "CSF-1R activation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   933   C1516703:Colony Stimulating Factor Activation [Physiologic Function]
   840   C1514758:Receptor Activation [Cell Function]
   804   C1879547:Activation [Activity]
   771   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   717   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "the motility of MCF-10A cells,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0007608:cell motility [Cell Function]
           Motility
   753   C0678835:Motility [Laboratory or Test Result]
   753   C1510470:Motility [Organism Function]

Phrase: "we"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "the dynamics of wound healing"

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to exogenous"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205101:Exogenous [Spatial Concept]
  1000   C0205228:Exogenous [Functional Concept]

Phrase: "or"

Phrase: "coexpressed"

Phrase: "CSF-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]
Processing 00000000.tx.133: Assays were performed in the presence of mitomycin C to eliminate the contribution of proliferation to wound closure. 

Phrase: "Assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed in the presence of mitomycin C to"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0002475:Mitomycin C [Antibiotic,Organic Chemical]
           Mitomycin
   744   C0026254:mitomycin [Organic Chemical,Pharmacologic Substance]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0884358:Performed [Functional Concept]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "eliminate"

Phrase: "the contribution of proliferation to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880177:Contribution [Activity]

Phrase: "wound"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0043250:Wound [Injury or Poisoning]
   966 E C0016204:Wind NOS [Sign or Symptom]
   966 E C0043187:Wind [Natural Phenomenon or Process]
   916 E C0021501:wounds [Qualitative Concept]
   916 E C0332797:Wounded [Functional Concept]

Phrase: "closure."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0185003:Closure [Therapeutic or Preventive Procedure]
  1000   C1521802:Closure [Research Activity]
   944 E C0447303:Occlusal [Body Location or Region]
   944 E C0591895:occlusal [Organic Chemical,Pharmacologic Substance]
   944 E C1947917:Occlusal [Functional Concept]
Processing 00000000.tx.134: Receptor-expressing cells treated with 10 ng/ml CSF-1 began to migrate into the wound space as an intact sheet from 68 h after wounding, and required a period of >48 h to completely seal the wound. 

Phrase: "Receptor-expressing cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   896   C1514760:Receptor Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "treated with 10 ng/ml CSF-1"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   778   C0439275:ng/mL [Quantitative Concept]
   778   C1150625:CSF-1 [Molecular Function]
   774   C0964553:NG.1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C1334110:NG.1 [Gene or Genome]
   748   C0439526:/mL [Quantitative Concept]
   748   C1522326:Treated [Functional Concept]
   748   C3540512:CSF [Therapeutic or Preventive Procedure]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "began"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "migrate into the wound space"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0043250:Wound [Injury or Poisoning]
   760   C0232902:migrate [Functional Concept]
   760   C1883067:Space [Spatial Concept]

Phrase: "as an intact sheet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349187:Sheet [Quantitative Concept]

Phrase: "from 68 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "after wounding,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   966   C0043250:Wound [Injury or Poisoning]
   907 E C0021501:wounds [Qualitative Concept]
   907 E C0332797:Wounded [Functional Concept]

Phrase: "and"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "a period of >48 h to completely"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441932:H+ [Classification]
   748   C0564385:/h [Quantitative Concept]

Phrase: "seal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036492:Seal [Mammal]
  1000   C0325125:seal [Mammal]
  1000   C1704637:Seal [Manufactured Object]

Phrase: "the wound."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043250:Wound [Injury or Poisoning]
Processing 00000000.tx.135: In contrast, cells coexpressing CSF-1 rapidly broke away from the wound margin and migrated into the wound space as individual cells within 4 h after wounding. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "coexpressing"

Phrase: "CSF-1 rapidly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C1150625:CSF-1 [Molecular Function]
   827   C1637379:Rapidly [Qualitative Concept]
   827   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "broke away from the wound margin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1545981:Wound margin [Finding]
   753   C0043250:Wound [Injury or Poisoning]
   753   C0205284:Margin [Spatial Concept]
   753   C0229985:margin [Body Part, Organ, or Organ Component]
   753   C1269830:Margin [Finding]
   719   C1881704:BREAK [Phenomenon or Process]

Phrase: "and"

Phrase: "migrated into the wound space"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0043250:Wound [Injury or Poisoning]
   760   C0232902:Migrated [Functional Concept]
   760   C1883067:Space [Spatial Concept]

Phrase: "as individual cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "within 4 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "after wounding."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   966   C0043250:Wound [Injury or Poisoning]
   907 E C0021501:wounds [Qualitative Concept]
   907 E C0332797:Wounded [Functional Concept]
Processing 00000000.tx.136: Complete closure was achieved in <24 h (Fig. 4). 

Phrase: "Complete closure"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0185003:Closure [Therapeutic or Preventive Procedure]
   861   C1521802:Closure [Research Activity]
   805 E C0447303:Occlusal [Body Location or Region]
   805 E C0591895:occlusal [Organic Chemical,Pharmacologic Substance]
   805 E C1947917:Occlusal [Functional Concept]

Phrase: "was"

Phrase: "achieved"

Phrase: "in <24 h (Fig. 4"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0033727:H+ [Element, Ion, or Isotope]
   804   C0150312:In [Quantitative Concept]
   804   C0332285:In [Spatial Concept]
   804   C0349966:Fig [Food]
   804   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441932:H+ [Classification]
   804   C0564385:/h [Quantitative Concept]
   804   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.137: View larger version (52K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(52K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.138: Autocrine CSF-1R activation alters wound healing dynamics in MCF-10As. 

Phrase: "Autocrine CSF-1R activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1516703:Colony Stimulating Factor Activation [Physiologic Function]
   827   C1514758:Receptor Activation [Cell Function]
   799   C1879547:Activation [Activity]
   734   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "wound healing dynamics in MCF-10As."
Processing 00000000.tx.139: Confluent monolayers of MCF-10As expressing CSF-1R and vector control (CSF-1R/Vector) or CSF-1 (CSF-1R/CSF-1) were starved overnight in assay media. 

Phrase: "Confluent monolayers of MCF-10As"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0872351:monolayers [Clinical Drug]

Phrase: "expressing"

Phrase: "CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "vector control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0031249:vector control [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243148:control [Qualitative Concept]
   861   C0442335:Vector [Spatial Concept]
   861   C1550141:Control [Substance]
   861   C1705099:Vector [Idea or Concept]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(CSF-1R/Vector"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0442335:Vector [Spatial Concept]
   804   C1705099:Vector [Idea or Concept]
   771   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   717   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: "or"

Phrase: "CSF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "(CSF-1R/CSF-1"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   919   C0079784:Colony-Stimulating Factor 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
           CSF-1
   919   C1332789:COLONY-STIMULATING FACTOR 1 [Gene or Genome]
   901   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   861   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1150625:CSF-1 [Molecular Function]
   799   C0439158:colony [Quantitative Concept]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C1521761:Factor [Functional Concept]
   799   C1947989:Colony [Cell]
   799   C1948023:Stimulating [Natural Phenomenon or Process]
   799   C2827422:Factor [Conceptual Entity]
   799   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "were"

Phrase: "starved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2348531:Starve [Activity]

Phrase: "overnight in assay media."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C0243073:assay [Qualitative Concept]
   770   C0439583:Overnight [Temporal Concept]
   770   C1254021:Media [Tissue]
   770   C1510438:Assay [Laboratory Procedure]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.140: A wound was introduced into each monolayer with a pipette tip, and cells were incubated in assay media with 10 ng/ml CSF-1 where noted (CSF-1) for 48 h. 

Phrase: "A wound"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043250:Wound [Injury or Poisoning]

Phrase: "was"

Phrase: "introduced into each monolayer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0872351:monolayer [Clinical Drug]
   737   C1292748:introduce [Functional Concept]

Phrase: "with a pipette tip,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1710425:Tip [Medical Device]
   861   C3282898:Tip [Qualitative Concept]

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated in assay media"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C0243073:assay [Qualitative Concept]
   770   C1254021:Media [Tissue]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1510438:Assay [Laboratory Procedure]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "with 10 ng/ml CSF-1 where"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   858   C0964553:NG.1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858   C1334110:NG.1 [Gene or Genome]
   827   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439275:ng/mL [Quantitative Concept]
   827   C1150625:CSF-1 [Molecular Function]
   799   C0439526:/mL [Quantitative Concept]
   799   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "(CSF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "for 48 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.141: Phase-contrast images of wound clo-sure are representative of four separate experiments.  

Phrase: "Phase-contrast images of wound clo-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1704254:Image [Intellectual Product]
   719   C1704922:Image [Entity]
   719   C3542466:Image [Intellectual Product]

Phrase: "sure"

Phrase: "are"

Phrase: "representative of four separate experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.142: CSF-1R promotes cadherin internalization and dissociation from the actin cytoskeleton We then examined whether the altered cellcell adhesion and increased motility mediated by autocrine CSF-1R activation involved modulation of junctional complexes. 

Phrase: "CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cadherin internalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0871786:internalization [Mental Process]

Phrase: "and"

Phrase: "dissociation from the actin cytoskeleton"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "the altered cellcell adhesion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001511:Adhesion [Pathologic Function]
   827   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "increased motility"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0007608:Motility [Cell Function]
   861   C0678835:Motility [Laboratory or Test Result]
   861   C1510470:Motility [Organism Function]
   789 E C1979933:Motile [Finding]

Phrase: "mediated by autocrine CSF-1R activation"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   833   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   822   C1516703:Colony Stimulating Factor Activation [Physiologic Function]
   800   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1514758:Receptor Activation [Cell Function]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0439158:colony [Quantitative Concept]
   744   C0596138:Autocrine [Organ or Tissue Function]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1521761:Factor [Functional Concept]
   744   C1879547:Activation [Activity]
   744   C1947989:Colony [Cell]
   744   C1948023:Stimulating [Natural Phenomenon or Process]
   744   C2827422:Factor [Conceptual Entity]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "modulation of junctional complexes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0443264:Modulation [Spatial Concept]
Processing 00000000.tx.143: Assessment of E-cadherin localization at the wound margin revealed that while discrete lateral staining was maintained in cells expressing CSF-1R alone, it accumulated in intracellular vesicles in cells coexpressing receptor and ligand (Fig. 5 A). 

Phrase: "Assessment of E-cadherin localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1261322:Assessment [Health Care Activity]
   760   C1516048:Assessment [Activity]

Phrase: "at the wound margin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1545981:Wound margin [Finding]
   861   C0205284:Margin [Spatial Concept]
   861   C0229985:margin [Body Part, Organ, or Organ Component]
   861   C1269830:Margin [Finding]
   789 E C1550517:marginal [Idea or Concept]
   789 E C1947914:Marginal [Qualitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "while"

Phrase: "discrete lateral staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "maintained in cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1314677:Maintained [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C0024501:Maintain [Activity]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "it"

Phrase: "accumulated in intracellular vesicles"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0175996:intracellular [Cell Component]
   770   C0178719:Intracellular [Spatial Concept]
   770   C0333262:VESICLES [Acquired Abnormality]
   737 E C1622418:vesicle [Cell Component]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "coexpressing"

Phrase: "receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligand [Chemical]

Phrase: "(Fig. 5 A"

Phrase: ")."
Processing 00000000.tx.144: Similarly punctate E-cadherin staining was detected in discohesive acini viewed at high magnification (Fig. 5 B). 

Phrase: "Similarly punctate E-cadherin staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0487602:Staining [Laboratory Procedure]
   804   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "detected in discohesive acini"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   737   C0935597:Acinus [Body Part, Organ, or Organ Component]
   737   C1442495:ACINUS [Gene or Genome]

Phrase: "viewed at high magnification"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   802   C1508435:View magnification [Spatial Concept]
   770   C0205250:High [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]
   737   C0449911:View [Spatial Concept]

Phrase: "(Fig. 5 B"

Phrase: ")."
Processing 00000000.tx.145: Although internalization of E-cadherin may promote its degradation, we did not observe a reduction in total E-cadherin in lysates from cells coexpressing CSF-1R and CSF-1 (Fig. 5 C), and no degradation products were detected (Fujita et al., 2002). 

Phrase: "Although"

Phrase: "internalization of E-cadherin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0871786:internalization [Mental Process]

Phrase: "may"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "its degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observe"

Phrase: "a reduction in total E-cadherin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "from cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "coexpressing"

Phrase: "CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "CSF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 5 C),"

Phrase: "and"

Phrase: "no degradation products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Fujita et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.146: In addition, both cell types exhibited a similar recovery of E-cadherin after trypsin treatment, suggesting that the adhesive defect is not a consequence of a decline in cadherin synthesis (Fig. 5 D). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "both cell types"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a similar recovery of E-cadherin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0237820:Recovery [Activity]
   753   C1555688:recovery [Idea or Concept]
   753   C2004454:Recovery [Organism Function]

Phrase: "after trypsin treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the adhesive defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1457869:Defect [Functional Concept]
   861   C1861101:DEFECT [Disease or Syndrome]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a consequence of a decline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "in cadherin synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "D)."
Processing 00000000.tx.147: Rather the disappearance of E-cadherin from the membrane may be due to an increased rate of endocytosis or a defect in the recycling of internalized molecules (Le et al., 1999). 

Phrase: "Rather"

Phrase: "the disappearance of E-cadherin"

Phrase: "from the membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "may"

Phrase: "be due to an increased rate of endocytosis"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0678226:Due to [Functional Concept]
           due
   767   C1372294:Increased Endocytosis [Cell Function]
   744   C0014139:Endocytosis [Cell Function]
   744   C0205217:Increased [Quantitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]
   744   C2984285:Endocytosis [Functional Concept]
   744   C2987476:Be [Conceptual Entity]
   744   C3146286:Due [Idea or Concept]

Phrase: "or"

Phrase: "a defect in the recycling of internalized molecules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1457869:Defect [Functional Concept]
   744   C1861101:DEFECT [Disease or Syndrome]

Phrase: "(Le et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.148: View larger version (56K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(56K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.149: Coexpression of CSF-1 with CSF-1R elicits relocalization of E-cadherin from the membrane to intracellular vesicles. 

Phrase: "Coexpression of CSF-1"

Phrase: "with CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "elicits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "relocalization of E-cadherin"

Phrase: "from the membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "to intracellular vesicles."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]
Processing 00000000.tx.150: (A) MCF-10As expressing CSF-1R and vector control (CSF-1R/Vector) or CSF-1 (CSF-1R/CSF-1) were fixed for E-cadherin immunofluorescence 8 h after wounding. 

Phrase: "(A) MCF-10As"

Phrase: "expressing"

Phrase: "CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "vector control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0031249:vector control [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243148:control [Qualitative Concept]
   861   C0442335:Vector [Spatial Concept]
   861   C1550141:Control [Substance]
   861   C1705099:Vector [Idea or Concept]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(CSF-1R/Vector"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0442335:Vector [Spatial Concept]
   804   C1705099:Vector [Idea or Concept]
   771   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   717   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: "or"

Phrase: "CSF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "(CSF-1R/CSF-1"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   919   C0079784:Colony-Stimulating Factor 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
           CSF-1
   919   C1332789:COLONY-STIMULATING FACTOR 1 [Gene or Genome]
   901   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   861   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1150625:CSF-1 [Molecular Function]
   799   C0439158:colony [Quantitative Concept]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C1521761:Factor [Functional Concept]
   799   C1947989:Colony [Cell]
   799   C1948023:Stimulating [Natural Phenomenon or Process]
   799   C2827422:Factor [Conceptual Entity]
   799   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "were"

Phrase: "fixed for E-cadherin immunofluorescence 8 h"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   774   C0390690:H-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1332728:H-CADHERIN [Gene or Genome]
   774   C1413282:CADHERIN 8 [Gene or Genome]
   774   C1570804:H-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0016318:Immunofluorescence [Laboratory Procedure]
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0079603:Immunofluorescence [Laboratory Procedure]
   748   C0231441:Fixed [Finding]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441932:H+ [Classification]
   748   C0443218:Fixed [Qualitative Concept]
   748   C0564385:/h [Quantitative Concept]
   748   C1413274:cadherin [Gene or Genome]
   748   C2827483:Fixed [Body Substance]

Phrase: "after wounding."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   966   C0043250:Wound [Injury or Poisoning]
   907 E C0021501:wounds [Qualitative Concept]
   907 E C0332797:Wounded [Functional Concept]
Processing 00000000.tx.151: (B) Confocal images of day 21 acini expressing wild-type or active CSF-1R, stained with DAPI (blue) and E-cadherin (green). 

Phrase: "(B) Confocal images of day 21 acini"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1704254:Image [Intellectual Product]
   714   C1704922:Image [Entity]
   714   C3542466:Image [Intellectual Product]

Phrase: "expressing"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "active CSF-1R,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   937   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "stained with DAPI (blue"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0057142:DAPI [Organic Chemical,Pharmacologic Substance]
   770   C1260957:Blue [Qualitative Concept]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: ")"

Phrase: "and"

Phrase: "E-cadherin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0042172:E-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0694872:E-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413274:cadherin [Gene or Genome]

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.152: (C) Total levels of E-cadherin from RIPA lysates of MCF-10As expressing CSF-1R and vector control (Vector) or CSF-1 (CSF-1). 

Phrase: "(C) Total levels of E-cadherin"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "from RIPA lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "of MCF-10As"

Phrase: "expressing"

Phrase: "CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "vector control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0031249:vector control [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243148:control [Qualitative Concept]
   861   C0442335:Vector [Spatial Concept]
   861   C1550141:Control [Substance]
   861   C1705099:Vector [Idea or Concept]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: "or"

Phrase: "CSF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "(CSF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: ")."
Processing 00000000.tx.153: (D) MCF-10As expressing CSF-1R and vector control (lanes 1, 3, 5, and 7) or CSF-1 (lanes 2, 4, 6, and 8) were harvested by treatment with EDTA (12 and 56) or trypsin (34 and 78) and placed in suspension for 6 h before lysis in RIPA buffer and E-cadherin immunoblotting.  

Phrase: "("

Phrase: "D)"

Phrase: "MCF-10As"

Phrase: "expressing"

Phrase: "CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "vector control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0031249:vector control [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243148:control [Qualitative Concept]
   861   C0442335:Vector [Spatial Concept]
   861   C1550141:Control [Substance]
   861   C1705099:Vector [Idea or Concept]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(lanes 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "7"

Phrase: ")"

Phrase: "or"

Phrase: "CSF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "(lanes 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "4,"

Phrase: "6,"

Phrase: "and"

Phrase: "8"

Phrase: ")"

Phrase: "were"

Phrase: "harvested by treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   756   C1512335:Harvest [Health Care Activity]

Phrase: "with EDTA (12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "56"

Phrase: ")"

Phrase: "or"

Phrase: "trypsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(34"

Phrase: "and"

Phrase: "78"

Phrase: ")"

Phrase: "and"

Phrase: "placed in suspension"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0038960:Suspension [Biomedical or Dental Material]
   790   C1382107:Suspension [Substance]
   790   C1705537:Suspension [Functional Concept]
   756   C0442504:Place [Spatial Concept]
   756   C1704765:Place [Functional Concept]
   756   C1882509:Place [Activity]
   756   C3496241:place [Disease or Syndrome]

Phrase: "for 6 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "before lysis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0024348:Lysis [Pathologic Function]
  1000   C1536403:lysis [Cell Function]
   928 E C0439680:Lytic [Qualitative Concept]

Phrase: "in RIPA buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "E-cadherin immunoblotting."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0020985:Immunoblotting [Laboratory Procedure]
   734   C0042172:E-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0694872:E-CADHERIN [Gene or Genome]
Processing 00000000.tx.154: The finding that E-cadherin levels are not altered by autocrine CSF-1R activation raised the question as to which stage in the formation and maturation of cell junctions is affected. 

Phrase: "The finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that E-cadherin levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C0042172:E-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0694872:E-CADHERIN [Gene or Genome]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "altered by autocrine CSF-1R activation"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   822   C1516703:Colony Stimulating Factor Activation [Physiologic Function]
   800   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1514758:Receptor Activation [Cell Function]
   744   C0392747:Altered [Functional Concept]
   744   C0439158:colony [Quantitative Concept]
   744   C0596138:Autocrine [Organ or Tissue Function]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1521761:Factor [Functional Concept]
   744   C1879547:Activation [Activity]
   744   C1947989:Colony [Cell]
   744   C1948023:Stimulating [Natural Phenomenon or Process]
   744   C2827422:Factor [Conceptual Entity]

Phrase: "raised"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442818:Raised [Quantitative Concept]

Phrase: "the question as to which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1522634:Question [Intellectual Product]

Phrase: "stage in the formation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205390:Stage [Temporal Concept]
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1300072:Stage [Clinical Attribute]
   770   C1306673:Stage [Qualitative Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "maturation of cell junctions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1516349:Cell Maturation [Cell Function]
   770   C0678723:Maturation [Organism Function]
   770   C0870861:maturation [Phenomenon or Process]
   770   C1254042:Maturation [Physiologic Function]

Phrase: "is"

Phrase: "affected."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]
Processing 00000000.tx.155: Adhesion is initiated by homophilic cadherin contact, which then consecutively triggers catenin binding, cadherin clustering, and recruitment of the actin cytoskeleton. 

Phrase: "Adhesion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001511:Adhesion [Pathologic Function]
  1000   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "initiated by homophilic cadherin contact,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332158:contact [Functional Concept]
   760   C0337611:Contact [Population Group]
   760   C1413274:cadherin [Gene or Genome]
   760   C1705415:Contact [Idea or Concept]
   726   C1548602:Initiate [Idea or Concept]
   726   C1704686:Initiate [Functional Concept]

Phrase: "which then consecutively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883708:Then [Temporal Concept]

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "catenin binding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "cadherin clustering,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009085:Clustering [Research Activity]

Phrase: "and"

Phrase: "recruitment of the actin cytoskeleton."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2949735:Recruitment [Activity]
Processing 00000000.tx.156: Cytoskeletal association corresponds with a progression from relatively weak adhesion to the generation of strong adhesive forces and initiation of cellcell compaction (Adams et al., 1998). 

Phrase: "Cytoskeletal association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "corresponds with a progression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]

Phrase: "from relatively weak adhesion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001511:Adhesion [Pathologic Function]
   827   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "to the generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0079411:Generation [Temporal Concept]
  1000   C3146294:Generation [Activity]
   907 E C1414672:Genesis [Gene or Genome]
   907 E C2984892:Genesis [Gene or Genome]

Phrase: "of strong adhesive forces"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0441722:forces [Phenomenon or Process]
   793 E C0563538:Force [Phenomenon or Process]
   755 E C0729333:Dynamic [Functional Concept]

Phrase: "and"

Phrase: "initiation of cellcell compaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0589507:Initiation [Mental Process]
   770   C1158830:Initiation [Genetic Function]
   770   C1704686:Initiation [Functional Concept]

Phrase: "(Adams et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.157: This transition can be observed when epithelial cells are allowed to cluster in suspension. 

Phrase: "This transition"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0599156:Transition [Cell or Molecular Dysfunction]
  1000   C2700061:Transition [Activity]
   928 E C1182674:Transitional [Spatial Concept]
   928 E C1548597:Transitional [Idea or Concept]

Phrase: "can"

Phrase: "be"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "epithelial cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0014597:Epithelial Cells [Cell]
  1000   C1273342:Epithelial Cells [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C0221908:Epithelial [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cluster in suspension."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0038960:Suspension [Biomedical or Dental Material]
   790   C1382107:Suspension [Substance]
   790   C1555715:Cluster [Idea or Concept]
   790   C1704332:Cluster [Quantitative Concept]
   790   C1705537:Suspension [Functional Concept]
Processing 00000000.tx.158: Initially, cells form loose chains in which the membranes of contacting cells remain distinct. 

Phrase: "Initially,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "loose chains in which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0337112:chains [Manufactured Object]
   770   C1524075:Chains [Idea or Concept]

Phrase: "the membranes of contacting cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C0007603:Cell membranes [Cell Component]
   764 E C3161472:Cell Membrane [Cell Component]
   760   C0025255:Membranes [Tissue]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "remain"

Phrase: "distinct."
Processing 00000000.tx.159: After several hours, compaction occurs between adjacent cells such that individual cell borders are no longer discernible. 

Phrase: "After several hours,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "compaction"

Phrase: "occurs between adjacent cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0007634:Cells [Cell]
   770   C0205117:Adjacent [Spatial Concept]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "such"

Phrase: "that individual cell borders"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205284:Border [Spatial Concept]
   827   C1522411:Border [Body Location or Region]
   827   C2828371:Border [Classification]

Phrase: "are"

Phrase: "no longer discernible."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205396:Discernible [Qualitative Concept]
Processing 00000000.tx.160: Compaction of MCF-10As expressing wild-type CSF-1R was detected within 4 h in suspension in the presence of CSF-1, and by 8 h, few loosely associated clusters remained. 

Phrase: "Compaction of MCF-10As"

Phrase: "expressing"

Phrase: "wild-type CSF-1R"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "was"

Phrase: "detected within 4 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0442726:Detected [Finding]
   770   C0564385:/h [Quantitative Concept]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "in suspension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038960:Suspension [Biomedical or Dental Material]
  1000   C1382107:Suspension [Substance]
  1000   C1705537:Suspension [Functional Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of CSF-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "and by 8 h,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1515981:And [Idea or Concept]

Phrase: "few loosely associated clusters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1555715:Cluster [Idea or Concept]
   793   C1704332:Cluster [Quantitative Concept]

Phrase: "remained."
Processing 00000000.tx.161: In contrast, cells coexpressing CSF-1R and CSF-1 formed weak associations in suspension, but displayed limited progression to the compaction stage (Fig. 6). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "coexpressing"

Phrase: "CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "CSF-1 formed weak associations in suspension,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0004083:Associations [Mental Process]
   714 E C0439849:Association [Qualitative Concept]
   714 E C0596306:Association [Phenomenon or Process]
   714 E C0699792:association [Social Behavior]

Phrase: "but"

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "limited progression to the compaction stage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0242656:progression [Pathologic Function]
   753   C0449258:Progression [Functional Concept]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.162: This suggests that these cells retain adequate transmembrane cadherin to initiate adhesive contacts; 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "retain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "adequate transmembrane cadherin to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1413274:cadherin [Gene or Genome]

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "adhesive contacts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332158:contact [Functional Concept]
   827   C0337611:Contact [Population Group]
   827   C1705415:Contact [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.163: however, surface levels may nonetheless be insufficient to initiate clustering and promote cytoskeletal linkage. 

Phrase: "however,"

Phrase: "surface levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "may"

Phrase: "nonetheless"

Phrase: "be"

Phrase: "insufficient to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205412:Insufficient [Qualitative Concept]
   861   C0231180:Insufficient [Qualitative Concept]
   789 E C0231179:Insufficiency [Functional Concept]

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "clustering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009085:Clustering [Research Activity]

Phrase: "and"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cytoskeletal linkage."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023745:linkage [Molecular Function]
Processing 00000000.tx.164: This contrasts with the effect of Ca2+ sequestration, which prevents productive homophilic cadherin interaction; 

Phrase: "This contrasts with the effect of Ca2+ sequestration,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1979874:Contrast [Qualitative Concept]

Phrase: "which"

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "productive homophilic cadherin interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704675:Interaction [Functional Concept]

Phrase: ";"
Processing 00000000.tx.165: MCF-10As placed in suspension in the presence of EGTA remained as single cells (unpublished data). 

Phrase: "MCF-10As"

Phrase: "placed in suspension"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0038960:Suspension [Biomedical or Dental Material]
   790   C1382107:Suspension [Substance]
   790   C1705537:Suspension [Functional Concept]
   756   C0442504:Place [Spatial Concept]
   756   C1704765:Place [Functional Concept]
   756   C1882509:Place [Activity]
   756   C3496241:place [Disease or Syndrome]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "remained as single cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0007634:Cells [Cell]
   770   C0037179:Single [Population Group]
   770   C0087136:single [Finding]
   770   C0205171:Single [Quantitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.166: View larger version (26K): [in this window] [in a new window]  Figure 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.167: Autocrine CSF-1R activation prevents adhesive compaction. 

Phrase: "Autocrine CSF-1R activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1516703:Colony Stimulating Factor Activation [Physiologic Function]
   827   C1514758:Receptor Activation [Cell Function]
   799   C1879547:Activation [Activity]
   734   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "adhesive compaction."
Processing 00000000.tx.168: MCF-10As expressing CSF-1R and vector control (CSF-1R/Vector) or CSF-1 (CSF-1R/CSF-1) were placed in suspension in assay media with 10 ng/ml CSF-1 where noted (CSF-1) for 6 h before harvest. 

Phrase: "MCF-10As"

Phrase: "expressing"

Phrase: "CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "vector control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0031249:vector control [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243148:control [Qualitative Concept]
   861   C0442335:Vector [Spatial Concept]
   861   C1550141:Control [Substance]
   861   C1705099:Vector [Idea or Concept]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(CSF-1R/Vector"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0442335:Vector [Spatial Concept]
   804   C1705099:Vector [Idea or Concept]
   771   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   717   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: "or"

Phrase: "CSF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "(CSF-1R/CSF-1"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   919   C0079784:Colony-Stimulating Factor 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
           CSF-1
   919   C1332789:COLONY-STIMULATING FACTOR 1 [Gene or Genome]
   901   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   861   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1150625:CSF-1 [Molecular Function]
   799   C0439158:colony [Quantitative Concept]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C1521761:Factor [Functional Concept]
   799   C1947989:Colony [Cell]
   799   C1948023:Stimulating [Natural Phenomenon or Process]
   799   C2827422:Factor [Conceptual Entity]
   799   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "were"

Phrase: "placed in suspension"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0038960:Suspension [Biomedical or Dental Material]
   790   C1382107:Suspension [Substance]
   790   C1705537:Suspension [Functional Concept]
   756   C0442504:Place [Spatial Concept]
   756   C1704765:Place [Functional Concept]
   756   C1882509:Place [Activity]
   756   C3496241:place [Disease or Syndrome]

Phrase: "in assay media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "with 10 ng/ml CSF-1 where"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   858   C0964553:NG.1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858   C1334110:NG.1 [Gene or Genome]
   827   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0439275:ng/mL [Quantitative Concept]
   827   C1150625:CSF-1 [Molecular Function]
   799   C0439526:/mL [Quantitative Concept]
   799   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "(CSF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "for 6 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "before harvest."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512335:Harvest [Health Care Activity]
Processing 00000000.tx.169: Cells were resuspended in 0.5% agarose and spotted onto glass slides for DIC imaging.  

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "resuspended in 0.5% agarose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0444499:0/5 [Quantitative Concept]
   760   C0036681:Agarose [Carbohydrate]

Phrase: "and"

Phrase: "spotted onto glass"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0017596:Glass [Manufactured Object]
   790   C1947936:Glass [Medical Device]
   756   C0329155:Spot [Fish]
   756   C1427618:SPOT [Gene or Genome]
   756   C1705203:Spot [Conceptual Entity]
   718 E C0074759:Glassy [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   718 E C0522500:Glassy [Qualitative Concept]

Phrase: "slides for DIC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444330:Slide [Research Device]
   790   C1705201:Slide [Manufactured Object]

Phrase: "imaging."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.170: Since autocrine CSF-1R activation does not result in cadherin loss, we evaluated whether it could compromise cell adhesion by modulating the composition of adherens junction complexes. 

Phrase: "Since"

Phrase: "autocrine CSF-1R activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1516703:Colony Stimulating Factor Activation [Physiologic Function]
   827   C1514758:Receptor Activation [Cell Function]
   799   C1879547:Activation [Activity]
   734   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "result in cadherin loss,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1274040:Result [Functional Concept]
   770   C1413274:cadherin [Gene or Genome]
   770   C1517945:Loss [Quantitative Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "whether"

Phrase: "it"

Phrase: "could"

Phrase: "compromise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945640:compromise [Finding]

Phrase: "cell adhesion by modulating"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0007577:Cell Adhesion [Cell Function]
   770   C0001511:Adhesion [Pathologic Function]
   770   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "the composition of adherens junction complexes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0486616:Composition [Clinical Attribute]
   753   C1555710:composition [Idea or Concept]
Processing 00000000.tx.171: Various members of the catenin family associate directly or indirectly with E-cadherin, and impact its adhesive capacity and association with the cytoskeleton (Herrenknecht et al., 1991; McCrea et al., 1991; Reynolds et al., 1994). 

Phrase: "Various members of the catenin family"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   783   C0086282:Family Members [Family Group]
   767 E C1611821:Family Member [Intellectual Product]
   753   C0680022:members [Population Group]
   719 E C2698041:Member [Professional or Occupational Group]

Phrase: "associate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750490:Associate [Idea or Concept]
  1000   C1706221:Associate [Professional or Occupational Group]

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "or"

Phrase: "indirectly with E-cadherin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1413274:cadherin [Gene or Genome]

Phrase: "and"

Phrase: "impact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1825598:IMPACT [Gene or Genome]

Phrase: "its adhesive capacity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]

Phrase: "and"

Phrase: "association with the cytoskeleton"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "(Herrenknecht et al.,"

Phrase: "1991"

Phrase: "; McCrea et al.,"

Phrase: "1991"

Phrase: "; Reynolds et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.172: However, autocrine cells did not exhibit changes in total levels of -catenin, p120 catenin, or -catenin (Fig. 7 A). 

Phrase: "However,"

Phrase: "autocrine cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "changes in total levels of -catenin,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "p120 catenin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2699128:p120-catenin [Amino Acid, Peptide, or Protein]

Phrase: "or -catenin"

Phrase: "(Fig. 7 A"

Phrase: ")."
Processing 00000000.tx.173: Furthermore, when E-cadherin was immunoprecipitated from these cells, the levels of associated catenins were likewise unaltered (Fig. 7 B). 

Phrase: "Furthermore,"

Phrase: "when"

Phrase: "E-cadherin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0042172:E-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0694872:E-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413274:cadherin [Gene or Genome]

Phrase: "was"

Phrase: "immunoprecipitated from these cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737   C0301871:Immunoprecipitate [Immunologic Factor]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "the levels of associated catenins"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "likewise unaltered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709843:Unaltered [Qualitative Concept]

Phrase: "(Fig. 7 B"

Phrase: ")."
Processing 00000000.tx.174: This is consistent with previous data showing that adherens junction plaques are internalized as intact complexes (Boterberg et al., 2000). 

Phrase: "This"

Phrase: "is"

Phrase: "consistent with previous data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that adherens junction plaques"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0333463:plaques [Acquired Abnormality]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]
   734   C0230613:Adherens Junction [Cell Component]
   734   C0887872:Adherens Junction [Cell Component]
   734   C2984274:Adherens junction [Functional Concept]

Phrase: "are"

Phrase: "internalized as intact complexes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205266:Intact [Qualitative Concept]
   770   C1554187:Intact [Idea or Concept]
   770   C1704241:Complexes [Chemical Viewed Structurally]
   737 E C0439855:Complex [Qualitative Concept]

Phrase: "(Boterberg et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.175: Following complex formation, interaction of -catenin with the actin cytoskeleton is required for stabilization of adhesion and cellular compaction (Adams and Nelson, 1998). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "complex formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "interaction of -catenin with the actin cytoskeleton"

Phrase: "is"

Phrase: "required for stabilization of adhesion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0001511:Adhesion [Pathologic Function]
   760   C0175633:Adhesion [Natural Phenomenon or Process]
   760   C1293130:Stabilisation [Therapeutic or Preventive Procedure]
   760   C1514873:Required [Functional Concept]

Phrase: "and"

Phrase: "cellular compaction"

Phrase: "(Adams"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331762:Adams [Health Care Related Organization]

Phrase: "and"

Phrase: "Nelson,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.176: To determine if the proportion of E-cadherin associated with the cytoskeletal fraction was reduced in autocrine CSF-1R cells, solubility in the presence of a nonionic detergent was assessed. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "if"

Phrase: "the proportion of E-cadherin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709707:Proportion [Quantitative Concept]

Phrase: "associated with the cytoskeletal fraction"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0010853:Cytoskeletal [Cell Component]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "was"

Phrase: "reduced in autocrine CSF-1R cells,"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   833   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   800   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C1514760:Receptor Cell [Cell]
   744   C0007634:Cells [Cell]
   744   C0392756:Reduced [Qualitative Concept]
   744   C0439158:colony [Quantitative Concept]
   744   C0596138:Autocrine [Organ or Tissue Function]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1521761:Factor [Functional Concept]
   744   C1947989:Colony [Cell]
   744   C1948023:Stimulating [Natural Phenomenon or Process]
   744   C2827422:Factor [Conceptual Entity]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "solubility in the presence of a nonionic detergent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0037628:Solubility [Qualitative Concept]

Phrase: "was"

Phrase: "assessed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]
Processing 00000000.tx.177: A significant decrease in E-cadherin in Triton-insoluble lysate fractions was observed in cells coexpressing CSF-1 (Fig. 7 C). 

Phrase: "A significant decrease in E-cadherin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "in Triton-insoluble lysate fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1264633:Fractions [Quantitative Concept]
   779 E C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "observed in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1441672:Observed [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "coexpressing"

Phrase: "CSF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 7 C)."
Processing 00000000.tx.178: This suggests that chronic CSF-1R signaling is capable of thwarting the progression from initial cell contact to strong adhesion, and provides a potential explanation for its ability to disrupt 3D architecture. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that chronic CSF-1R signaling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1514762:Receptor Signaling [Molecular Function]
   799   C0037083:Signaling [Cell Function]
   799   C3537152:signaling [Biologic Function]
   734   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "is"

Phrase: "capable of thwarting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C2698977:Capability [Qualitative Concept]

Phrase: "the progression from initial cell contact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0242656:progression [Pathologic Function]
   753   C0449258:Progression [Functional Concept]

Phrase: "to strong adhesion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001511:Adhesion [Pathologic Function]
   861   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a potential explanation for its ability to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0681841:Explanation [Intellectual Product]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "3D architecture."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003737:Architecture [Occupation or Discipline]
Processing 00000000.tx.179: View larger version (26K): [in this window] [in a new window]  Figure 7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 7."
Processing 00000000.tx.180: Assembly of the cadherincatenin complex is unaltered in CSF-1 coexpressing cells, but association with the cytoskeleton is disrupted. 

Phrase: "Assembly of the cadherincatenin complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1706853:Assembly [Activity]
   760   C1879748:Assembly [Manufactured Object]

Phrase: "is"

Phrase: "unaltered in CSF-1 coexpressing cells,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709843:Unaltered [Qualitative Concept]

Phrase: "but"

Phrase: "association with the cytoskeleton"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "is"

Phrase: "disrupted."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:Disrupted [Qualitative Concept]
Processing 00000000.tx.181: Parental MCF-10As and cells expressing CSF-1R and vector control (CSF-1R/Vector) or CSF-1 (CSF-1R/CSF-1) were grown to confluence in assay media before lysis. 

Phrase: "Parental MCF-10As"

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "vector control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0031249:vector control [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243148:control [Qualitative Concept]
   861   C0442335:Vector [Spatial Concept]
   861   C1550141:Control [Substance]
   861   C1705099:Vector [Idea or Concept]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(CSF-1R/Vector"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0442335:Vector [Spatial Concept]
   804   C1705099:Vector [Idea or Concept]
   771   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   717   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: "or"

Phrase: "CSF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "(CSF-1R/CSF-1"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   919   C0079784:Colony-Stimulating Factor 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
           CSF-1
   919   C1332789:COLONY-STIMULATING FACTOR 1 [Gene or Genome]
   901   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   861   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1150625:CSF-1 [Molecular Function]
   799   C0439158:colony [Quantitative Concept]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C1521761:Factor [Functional Concept]
   799   C1947989:Colony [Cell]
   799   C1948023:Stimulating [Natural Phenomenon or Process]
   799   C2827422:Factor [Conceptual Entity]
   799   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "were"

Phrase: "grown to confluence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0205200:Confluent [Qualitative Concept]

Phrase: "in assay media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "before lysis."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0024348:Lysis [Pathologic Function]
  1000   C1536403:lysis [Cell Function]
   928 E C0439680:Lytic [Qualitative Concept]
Processing 00000000.tx.182: Media was supplemented with 5 ng/ml EGF for parental cells and 10 ng/ml CSF-1 for CSF-1R/Vector cells. 

Phrase: "Media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "supplemented with 5 ng/ml EGF"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0439275:ng/mL [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "for parental cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "10 ng/ml CSF-1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   875   C0964553:NG.1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C1334110:NG.1 [Gene or Genome]
   840   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C0439275:ng/mL [Quantitative Concept]
   840   C1150625:CSF-1 [Molecular Function]
   804   C0439526:/mL [Quantitative Concept]
   804   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "for CSF-1R/Vector cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   822   C1514760:Receptor Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
   734   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
Processing 00000000.tx.183: (A) RIPA lysates were probed for total levels of E-cadherin and catenin proteins. 

Phrase: "(A) RIPA lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "probed for total levels of E-cadherin"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   748   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C1413274:cadherin [Gene or Genome]
   714   C0182400:Probe [Medical Device]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714   C1704681:Probe [Gene or Genome]
   714   C2347609:Probe [Chemical Viewed Functionally]
   714 E C2946261:Level [Pharmacologic Substance]
   714   C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "catenin proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1564904:Catenin Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.184: (B) E-cadherin immunoprecipitates from Triton lysates were probed for associated catenins. 

Phrase: "(B) E-cadherin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1413274:cadherin [Gene or Genome]

Phrase: "immunoprecipitates from Triton lysates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0242759:Triton [Geographic Area]
   770   C0301871:Immunoprecipitate [Immunologic Factor]
   737   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "probed for associated catenins."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0332281:Associated [Qualitative Concept]
   770   C1564904:Catenins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737   C0182400:Probe [Medical Device]
   737 E C0750490:Associate [Idea or Concept]
   737   C1704681:Probe [Gene or Genome]
   737 E C1706221:Associate [Professional or Occupational Group]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.185: (C) Levels of E-cadherin in the Triton-soluble (TS) and Triton-insoluble (TI) lysate fractions were assayed. 

Phrase: "(C) Levels of E-cadherin"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the Triton-soluble (TS)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1749467:soluble [Cell Component]
   861   C1948047:Soluble [Qualitative Concept]

Phrase: "and"

Phrase: "Triton-insoluble (TI) lysate fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1264633:Fractions [Quantitative Concept]
   779 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "assayed."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.186: Actin is shown as a control for equal protein loading.  

Phrase: "Actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "is"

Phrase: "shown as a control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C1547282:Show [Intellectual Product]

Phrase: "for equal protein loading."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708715:Loading [Activity]
Processing 00000000.tx.187: Src kinases are required for CSF-1R disruption of cellcell adhesion Stimulation of CSF-1R leads to the activation of multiple signaling effectors, including PI3K and Src, which have been implicated in the regulation of adhesion (Warren and Nelson, 1987; Roussel, 1998; Conacci-Sorrell et al., 2002). 

Phrase: "Src kinases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282625:src Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "required for CSF-1R disruption of cellcell adhesion Stimulation"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   797   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   775   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   775   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C0300500:adhesion receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C0001511:Adhesion [Pathologic Function]
   738   C0175633:Adhesion [Natural Phenomenon or Process]
   738   C0332453:Disruption [Functional Concept]
   738   C0439158:colony [Quantitative Concept]
   738   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   738   C1514873:Required [Functional Concept]
   738   C1521761:Factor [Functional Concept]
   738   C1947989:Colony [Cell]
   738   C1948023:Stimulating [Natural Phenomenon or Process]
           Stimulation
   738   C2827422:Factor [Conceptual Entity]

Phrase: "of CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "leads to the activation of multiple signaling effectors,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0037083:Signaling [Cell Function]
   744   C0181586:leads [Medical Device]
   744   C0439064:Multiple [Quantitative Concept]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C1879547:Activation [Activity]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]
   744   C3537152:signaling [Biologic Function]
   711 E C1710082:Signal [Phenomenon or Process]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "PI3K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2936824:PI-3K [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Src,"

Phrase: "which"

Phrase: "have"

Phrase: "been"

Phrase: "implicated in the regulation of adhesion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0001511:Adhesion [Pathologic Function]
   753   C0175633:Adhesion [Natural Phenomenon or Process]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "(Warren"

Phrase: "and"

Phrase: "Nelson,"

Phrase: "1987"

Phrase: "; Roussel,"

Phrase: "1998"

Phrase: "; Conacci-Sorrell et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.188: To address which CSF-1R signaling pathways were responsible for the observed architectural disruption, we generated mutant variants of the constitutively active CSF-1R that encoded single tyrosine-to-phenylalanine substitutions at various autophosphorylation sites on the receptor (Y561, Y699, Y708, Y723, and Y923). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "which CSF-1R signaling pathways"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   810   C0037080:Signal Pathways [Molecular Function]
   810   C0037083:signaling pathway [Cell Function]
   810   C0086982:Signaling Pathway [Molecular Function]
   799   C1704259:Pathways [Molecular Function]
   799   C1705987:Pathways [Conceptual Entity]
   734   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "were"

Phrase: "responsible for the observed architectural disruption,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]

Phrase: "we"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "mutant variants of the constitutively active CSF-1R"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205419:variants [Qualitative Concept]

Phrase: "that encoded single tyrosine-to-phenylalanine substitutions at various autophosphorylation sites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   704   C1555721:Substitution [Idea or Concept]
   704   C1706204:Substitution [Activity]

Phrase: "on the receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(Y561,"

Phrase: "Y699,"

Phrase: "Y708,"

Phrase: "Y723,"

Phrase: "and"

Phrase: "Y923"

Phrase: ")."
Processing 00000000.tx.189: MCF-10As infected with each mutant receptor were examined in 3D culture for their ability to recapitulate the discohesive phenotype. 

Phrase: "MCF-10As"

Phrase: "infected with each mutant receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439663:Infected [Functional Concept]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "were"

Phrase: "examined in 3D culture"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0010453:Culture [Idea or Concept]
   770   C0220814:culture [Functional Concept]
   770   C0332128:Examined [Finding]
   770   C0430400:Culture [Laboratory Procedure]
   770   C0450363:3D [Spatial Concept]
   770   C2242979:Culture [Laboratory Procedure]
   770   C2986797:3D [Functional Concept]

Phrase: "for their ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "recapitulate"

Phrase: "the discohesive phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.190: While the majority of these substitutions were insufficient to prevent perturbation of adhesion, mutation of Y561 significantly attenuated junctional disruption without impeding proliferation (Fig. 8 A). 

Phrase: "While"

Phrase: "the majority of these substitutions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "were"

Phrase: "insufficient to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205412:Insufficient [Qualitative Concept]
   861   C0231180:Insufficient [Qualitative Concept]
   789 E C0231179:Insufficiency [Functional Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "perturbation of adhesion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332453:perturbation [Functional Concept]

Phrase: "mutation of Y561 significantly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026882:Mutation [Genetic Function]
   770   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: "junctional disruption without impeding proliferation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332453:Disruption [Functional Concept]

Phrase: "(Fig. 8 A"

Phrase: ")."
Processing 00000000.tx.191: Mutation of the corresponding residue in the murine receptor substantially reduced binding and activation of Src upon receptor activation, and phosphopeptides spanning this region of the human receptor were shown to bind Src in vitro (Alonso et al., 1995; Marks et al., 1999). 

Phrase: "Mutation of the corresponding residue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the murine receptor substantially reduced binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0597358:Receptor Binding [Molecular Function]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "activation of Src"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "upon receptor activation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514758:Receptor Activation [Cell Function]
   861   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "phosphopeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031684:Phosphopeptides [Amino Acid, Peptide, or Protein]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "this region of the human receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]

Phrase: "were"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "Src"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(Alonso et al.,"

Phrase: "1995"

Phrase: "; Marks et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.192: In agreement with these findings, we observed a decreased association of Src with the Y561F mutant receptor (Fig. 8 B). 

Phrase: "In agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with these findings,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a decreased association of Src"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with the Y561F mutant receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(Fig. 8 B"

Phrase: ")."
Processing 00000000.tx.193: In addition, using an antibody specific for the activation loop phosphorylation site (Y419 in human Src), we observed that at least two Src family kinases are activated by CSF-1R: Src (Mr60K) and Lyn (Mr53 and 56K). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an antibody specific for the activation loop phosphorylation site"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   762   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0449604:Specific site [Spatial Concept]
   762   C1516004:Antibody Activation [Physiologic Function]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0205369:Specific [Qualitative Concept]
   742   C1552740:specific [Intellectual Product]

Phrase: "(Y419 in human Src"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that at least two Src family kinases"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0282625:src-Family Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           src Kinases
   757   C0031727:Kinase Family [Amino Acid, Peptide, or Protein,Enzyme]
           Kinases
   748   C0015576:Family [Family Group]
   748   C0205448:Two [Quantitative Concept]
   748   C1704727:Family [Conceptual Entity]

Phrase: "are"

Phrase: "activated by CSF-1R"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   882   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   833   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0439158:colony [Quantitative Concept]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1521761:Factor [Functional Concept]
   753   C1879547:Activated [Activity]
   753   C1947989:Colony [Cell]
   753   C1948023:Stimulating [Natural Phenomenon or Process]
   753   C2827422:Factor [Conceptual Entity]
   719 E C1515877:Activate [Functional Concept]

Phrase: ":"

Phrase: "Src (Mr60K"

Phrase: ")"

Phrase: "and"

Phrase: "Lyn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812307:LYN [Gene or Genome]
  1000   C1442804:LYN [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Mr53"

Phrase: "and"

Phrase: "56K"

Phrase: ")."
Processing 00000000.tx.194: Phosphorylation of both proteins was reduced to basal levels in cells expressing the Y561F mutant receptor (Fig. 8 C), while autophosphorylation of CSF-1R was unaffected (not depicted). 

Phrase: "Phosphorylation of both proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   770   C0031715:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "reduced to basal levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0205112:Basal [Spatial Concept]
   770   C0392756:Reduced [Qualitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "the Y561F mutant receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(Fig. 8 C),"

Phrase: "while"

Phrase: "autophosphorylation of CSF-1R"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0813988:autophosphorylation [Molecular Function]
   716   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "was"

Phrase: "unaffected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986417:Unaffected [Conceptual Entity]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "depicted"

Phrase: ")."
Processing 00000000.tx.195: This suggested that the ability of constitutive CSF-1R signaling to perturb cellcell adhesion might be dependent on Src family kinases. 

Phrase: "This"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the ability of constitutive CSF-1R signaling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0085732:Ability [Organism Attribute]

Phrase: "to"

Phrase: "perturb"

Phrase: "cellcell adhesion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001511:Adhesion [Pathologic Function]
   861   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "might"

Phrase: "be"

Phrase: "dependent on Src family kinases."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]
Processing 00000000.tx.196: View larger version (41K): [in this window] [in a new window]  Figure 8. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(41K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 8."
Processing 00000000.tx.197: The ability of CSF-1R to promote junctional disruption is Src dependent. 

Phrase: "The ability of CSF-1R to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0085732:Ability [Organism Attribute]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "junctional disruption"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332453:Disruption [Functional Concept]

Phrase: "is"

Phrase: "Src"

Phrase: "dependent."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]
Processing 00000000.tx.198: (A) MCF-10A cells expressing active CSF-1R (right and center), or active CSF-1R including a point mutation at the Src binding site (Y561F, left), were cultured in MatrigelTM. 

Phrase: "(A) MCF-10A cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "active CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   937   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: "and"

Phrase: "center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205099:Center [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "active CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   937   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "a point mutation at the Src binding site"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   770   C2924612:A point [Body Location or Region]
   744   C0026882:Mutation [Genetic Function]
   744   C1552961:Point [Quantitative Concept]
   744   C1705285:Mutation [Cell or Molecular Dysfunction]
   744   C2347617:point [Quantitative Concept]

Phrase: "(Y561F,"

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "cultured in MatrigelTM."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.199: Cultures were treated every 48 h with Src inhibitor SU6656 (2 m) where noted. 

Phrase: "Cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "every 48 h with Src inhibitor SU6656"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441932:H+ [Classification]
   748   C0564385:/h [Quantitative Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "m)"

Phrase: "where"

Phrase: "noted."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]
Processing 00000000.tx.200: Brightfield images of day 15 acini are shown. 

Phrase: "Brightfield images of day 15 acini"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1704254:Image [Intellectual Product]
   719   C1704922:Image [Entity]
   719   C3542466:Image [Intellectual Product]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.201: (B) CSF-1R immunoprecipitates from MCF-10As expressing active CSF-1R or active CSF-1R with the Y561F mutation were probed for Src association with the receptor. 

Phrase: "(B) CSF-1R"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   708   C0033453:b factor [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   708   C0046774:B-factor [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "immunoprecipitates from MCF-10As"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0008015:MCF [Immunologic Factor]
   770   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "expressing"

Phrase: "active CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   937   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or"

Phrase: "active CSF-1R with the Y561F mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   818   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "were"

Phrase: "probed for Src association"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]
   737   C0182400:Probe [Medical Device]
   737   C1704681:Probe [Gene or Genome]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737   C3536729:Probe [Manufactured Object]

Phrase: "with the receptor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.202: (C) MCF-10As expressing CSF-1R and vector control (CSF-1R/Vector) or CSF-1 (CSF-1R/CSF-1), active CSF-1R, or active CSF-1R with the Y561F mutation were starved overnight in assay media. 

Phrase: "(C) MCF-10As"

Phrase: "expressing"

Phrase: "CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "vector control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0031249:vector control [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243148:control [Qualitative Concept]
   861   C0442335:Vector [Spatial Concept]
   861   C1550141:Control [Substance]
   861   C1705099:Vector [Idea or Concept]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(CSF-1R/Vector"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0442335:Vector [Spatial Concept]
   804   C1705099:Vector [Idea or Concept]
   771   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   717   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: "or"

Phrase: "CSF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "(CSF-1R/CSF-1"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   919   C0079784:Colony-Stimulating Factor 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
           CSF-1
   919   C1332789:COLONY-STIMULATING FACTOR 1 [Gene or Genome]
   901   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   861   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1150625:CSF-1 [Molecular Function]
   799   C0439158:colony [Quantitative Concept]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C1521761:Factor [Functional Concept]
   799   C1947989:Colony [Cell]
   799   C1948023:Stimulating [Natural Phenomenon or Process]
   799   C2827422:Factor [Conceptual Entity]
   799   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: ","

Phrase: "active CSF-1R,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   937   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or"

Phrase: "active CSF-1R with the Y561F mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   818   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "were"

Phrase: "starved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2348531:Starve [Activity]

Phrase: "overnight in assay media."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C0243073:assay [Qualitative Concept]
   770   C0439583:Overnight [Temporal Concept]
   770   C1254021:Media [Tissue]
   770   C1510438:Assay [Laboratory Procedure]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.203: Cells were treated with 10 ng/ml CSF-1 before lysis where noted. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 10 ng/ml CSF-1"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   778   C0439275:ng/mL [Quantitative Concept]
   778   C1150625:CSF-1 [Molecular Function]
   774   C0964553:NG.1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C1334110:NG.1 [Gene or Genome]
   748   C0439526:/mL [Quantitative Concept]
   748   C1522326:Treated [Functional Concept]
   748   C3540512:CSF [Therapeutic or Preventive Procedure]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "before lysis where"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0024348:Lysis [Pathologic Function]
   861   C1536403:lysis [Cell Function]
   789 E C0439680:Lytic [Qualitative Concept]

Phrase: "noted."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]
Processing 00000000.tx.204: Lysates were probed for Src tyrosine 419 phosphorylation and total Src levels. 

Phrase: "Lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "probed for Src tyrosine 419 phosphorylation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C1519726:Tyrosine Phosphorylation [Molecular Function]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C1158886:Phosphorylation [Molecular Function]
   719   C0182400:Probe [Medical Device]
   719   C1704681:Probe [Gene or Genome]
   719   C2347609:Probe [Chemical Viewed Functionally]
   719   C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "total Src levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.205: (D) MCF-10As coexpressing CSF-1R and CSF-1 along with vector control or DN-Src (K295R) were cultured in MatrigelTM. 

Phrase: "("

Phrase: "D)"

Phrase: "MCF-10As"

Phrase: "coexpressing"

Phrase: "CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "CSF-1 along with vector control"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0031249:vector control [Occupational Activity]
   790   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C1150625:CSF-1 [Molecular Function]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243148:control [Qualitative Concept]
   753   C0442335:Vector [Spatial Concept]
   753   C1550141:Control [Substance]
   753   C1705099:Vector [Idea or Concept]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   753   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "DN-Src (K295R"

Phrase: ")"

Phrase: "were"

Phrase: "cultured in MatrigelTM."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.206: Phase-contrast images of day 16 acini are shown. 

Phrase: "Phase-contrast images of day 16 acini"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1704254:Image [Intellectual Product]
   714   C1704922:Image [Entity]
   714   C3542466:Image [Intellectual Product]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.207: (E) Levels of E-cadherin in the Triton-soluble (TS) and Triton-insoluble (TI) lysate fractions of MCF-10As expressing active CSF-1R or active CSF-1R with the Y561F mutation were assayed. 

Phrase: "(E) Levels of E-cadherin"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the Triton-soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1749467:soluble [Cell Component]
   861   C1948047:Soluble [Qualitative Concept]

Phrase: "(TS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1749467:soluble [Cell Component]
   861   C1948047:Soluble [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "Triton-insoluble"

Phrase: "(TI"

Phrase: ")"

Phrase: "lysate fractions of MCF-10As"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1264633:Fraction of [Quantitative Concept]
           Fractions
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "expressing"

Phrase: "active CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   937   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or"

Phrase: "active CSF-1R with the Y561F mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   818   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "were"

Phrase: "assayed."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.208: Actin is shown as a control for equal protein loading.  

Phrase: "Actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "is"

Phrase: "shown as a control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C1547282:Show [Intellectual Product]

Phrase: "for equal protein loading."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708715:Loading [Activity]
Processing 00000000.tx.209: To determine whether Src catalytic activity is necessary for this perturbation, 3D cultures of cells expressing active CSF-1R were treated from day 6 with SU6656, which selectively inhibits Src at concentrations under 5 M and does not impact CSF-1R kinase activity (Blake et al., 2000). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "Src catalytic activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0243102:catalytic activity [Molecular Function]
   901   C1264638:Catalytic activity [Functional Concept]
   901   C1547012:*Catalytic Activity [Quantitative Concept]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "necessary for this perturbation,"

Phrase: "3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450363:3D [Spatial Concept]
  1000   C2986797:3D [Functional Concept]

Phrase: "cultures of cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   858   C0007585:cells culture [Laboratory Procedure]
   790   C0007634:Cells [Cell]
   790   C0010453:Culture [Idea or Concept]
   790   C0220814:culture [Functional Concept]
   790   C0430400:Culture [Laboratory Procedure]
   790   C2242979:Culture [Laboratory Procedure]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "active CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   937   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "were"

Phrase: "treated from day 6"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0332173:/day [Temporal Concept]
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C0439228:day [Temporal Concept]
   770   C0439505:/day [Temporal Concept]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "with SU6656,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0962522:SU6656 [Organic Chemical,Pharmacologic Substance]

Phrase: "which selectively"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Src at concentrations"

Phrase: "under 5 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "does"

Phrase: "not impact CSF-1R kinase activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   822   C1152633:receptor activity [Molecular Function]
   812   C1150423:kinase activity [Molecular Function]
   793   C0205177:Activity [Functional Concept]
   793   C0439167:% activity [Quantitative Concept]
   793   C0441655:Activity [Activity]
   793   C1561536:*Activity [Idea or Concept]

Phrase: "(Blake et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.210: While structures treated with vehicle exhibited a progressive disruption of cell adhesion, periodic treatment with the Src inhibitor preserved acinar integrity (Fig. 8 A). 

Phrase: "While"

Phrase: "structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "treated with vehicle"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0042444:Vehicle [Biomedical or Dental Material]
   790   C0348005:Vehicle [Manufactured Object]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]
   718 E C0445373:Vehicular [Functional Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a progressive disruption of cell adhesion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332453:Disruption [Functional Concept]

Phrase: "periodic treatment with the Src inhibitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "preserved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033085:Preserved [Laboratory Procedure]

Phrase: "acinar integrity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205266:integrity [Qualitative Concept]
   861   C0872403:integrity [Individual Behavior]
   861   C1947912:Integrity [Qualitative Concept]

Phrase: "(Fig. 8 A"

Phrase: ")."
Processing 00000000.tx.211: Furthermore, overexpression of a kinase inactive, dominant-interfering variant of Src (K295R) in MCF-10As coexpressing CSF-1R and CSF-1 also prevented junctional disruption in acinar cultures (Fig. 8 D). 

Phrase: "Furthermore,"

Phrase: "overexpression of a kinase inactive, dominant-interfering variant of Src (K295R"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1514559:Overexpression [Genetic Function]

Phrase: ")"

Phrase: "in MCF-10As"

Phrase: "coexpressing"

Phrase: "CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "CSF-1 also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C1150625:CSF-1 [Molecular Function]
   827   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "junctional disruption in acinar cultures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332453:Disruption [Functional Concept]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "D)."
Processing 00000000.tx.212: Finally, levels of E-cadherin in the Triton-insoluble fraction were restored in Y561F cells (Fig. 8 E). 

Phrase: "Finally,"

Phrase: "levels of E-cadherin"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the Triton-insoluble fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "restored in Y561F cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 8 E"

Phrase: ")."
Processing 00000000.tx.213: Collectively, these data suggest that Src activity is essential for the destabilization of cell adhesion induced by chronic CSF-1R signaling. 

Phrase: "Collectively,"

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that Src activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "essential for the destabilization of cell adhesion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205224:Essential [Qualitative Concept]

Phrase: "induced by chronic CSF-1R signaling."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   800   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1514762:Receptor Signaling [Molecular Function]
   744   C0037083:Signaling [Cell Function]
   744   C0205191:chronic [Temporal Concept]
   744   C0205263:Induced [Functional Concept]
   744   C0439158:colony [Quantitative Concept]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1521761:Factor [Functional Concept]
   744   C1947989:Colony [Cell]
   744   C1948023:Stimulating [Natural Phenomenon or Process]
   744   C2827422:Factor [Conceptual Entity]
   744   C3537152:signaling [Biologic Function]
Processing 00000000.tx.214: Constitutive c-Met stimulation does not persistently disrupt adhesion despite comparable levels of Src activation Several RTKs have been implicated in regulation of adhesive contacts through mechanisms that involve Src activity (Conacci-Sorrell et al., 2002). 

Phrase: "Constitutive c-Met stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   812   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "does"

Phrase: "not persistently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750508:persistently [Idea or Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "adhesion despite comparable levels of Src activation Several RTKs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C0300500:adhesion receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C0001511:Adhesion [Pathologic Function]
   738   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "have"

Phrase: "been"

Phrase: "implicated in regulation of adhesive contacts"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0001516:Adhesive [Manufactured Object]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]
   753   C2982905:Adhesive [Manufactured Object]
   719   C0332158:contact [Functional Concept]
   719   C0337611:Contact [Population Group]
   719   C1705415:Contact [Idea or Concept]

Phrase: "through mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "involve"

Phrase: "Src activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(Conacci-Sorrell et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.215: Activation of c-Met, which can alter the composition of adherens junction complexes, induces the extension of hollow tubules from MDCK cysts (Pollack et al., 1998). 

Phrase: "Activation of c-Met,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "which"

Phrase: "can"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the composition of adherens junction complexes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0486616:Composition [Clinical Attribute]
   753   C1555710:composition [Idea or Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the extension of hollow tubules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0231448:Extension [Functional Concept]
   760   C1880641:Extension [Conceptual Entity]

Phrase: "from MDCK cysts"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0010709:Cysts [Disease or Syndrome]
   827 E C0686883:Cyst [Eukaryote]
   777 E C0205207:Cystic [Qualitative Concept]

Phrase: "(Pollack et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.216: To determine whether the discohesive phenotype elicited by constitutive CSF-1R activation in MCF-10A acini was a consequence of chronic activation of other RTKs, we assessed the morphology of acinar structures formed by MCF-10As overexpressing c-Met alone or in conjunction with HGF. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the discohesive phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "elicited by constitutive CSF-1R activation"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   822   C1516703:Colony Stimulating Factor Activation [Physiologic Function]
   800   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0449265:Elicited by [Qualitative Concept]
           elicited
   770   C1514758:Receptor Activation [Cell Function]
   744   C0439158:colony [Quantitative Concept]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1521761:Factor [Functional Concept]
   744   C1879547:Activation [Activity]
   744   C1947989:Colony [Cell]
   744   C1948023:Stimulating [Natural Phenomenon or Process]
   744   C2827422:Factor [Conceptual Entity]

Phrase: "in MCF-10A acini"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C0935597:Acinus [Body Part, Organ, or Organ Component]
   793   C1442495:ACINUS [Gene or Genome]
   743 E C0332207:Acinar [Spatial Concept]

Phrase: "was"

Phrase: "a consequence of chronic activation of other RTKs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "we"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "the morphology of acinar structures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0332437:Morphology [Qualitative Concept]
   760   C0543482:morphology [Spatial Concept]
   760   C0700329:Morphology, NOS [Finding]
   760   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "formed by MCF-10As"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0008015:MCF [Immunologic Factor]
   770   C0205431:Formed [Functional Concept]
   737 E C0348078:Form [Qualitative Concept]
   737 E C0376315:Form [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "c-Met alone"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205171:Alone [Quantitative Concept]
   827   C0439044:alone [Finding]
   827   C0679994:alone [Group Attribute]
   734   C1456828:C-MET [Amino Acid, Peptide, or Protein,Receptor]
   734   C1704823:C-MET [Gene or Genome]

Phrase: "or in conjunction with HGF."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2699427:Conjunction [Idea or Concept]
Processing 00000000.tx.217: When cells expressing c-Met were grown in 3D culture in the presence of exogenous HGF (40 ng/ml), a small proportion of structures developed multiple branching tubules (Fig. 9 A). 

Phrase: "When"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "c-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Met"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Meet [Idea or Concept]

Phrase: "were"

Phrase: "grown in 3D culture"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0010453:Culture [Idea or Concept]
   770   C0220814:culture [Functional Concept]
   770   C0430400:Culture [Laboratory Procedure]
   770   C0450363:3D [Spatial Concept]
   770   C2242979:Culture [Laboratory Procedure]
   770   C2986797:3D [Functional Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of exogenous HGF (40 ng/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0439275:ng/mL [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "a small proportion of structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709707:Proportion [Quantitative Concept]

Phrase: "developed"

Phrase: "multiple branching tubules"

Phrase: "(Fig. 9 A"

Phrase: ")."
Processing 00000000.tx.218: Both the frequency and extent of tubule formation were increased by HGF coexpression; 

Phrase: "Both"

Phrase: "the frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0376249:frequency [Quantitative Concept]
  1000   C0439603:Frequency [Temporal Concept]
  1000   C0871396:Frequency [Quantitative Concept]
  1000   C1561548:Frequency [Qualitative Concept]
  1000   C1705502:Frequency [Quantitative Concept]
   928 E C0332183:Frequent [Temporal Concept]

Phrase: "and"

Phrase: "extent of tubule formation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439792:Extent [Spatial Concept]

Phrase: "were"

Phrase: "increased by HGF coexpression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]

Phrase: ";"
Processing 00000000.tx.219: however, no additional alterations in acinar architecture were observed. 

Phrase: "however,"

Phrase: "no additional alterations in acinar architecture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1515926:Alteration [Idea or Concept]

Phrase: "were"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.220: Notably, despite chronic activation of c-Met, membrane localization of E-cadherin remained intact (Fig. 9 B). 

Phrase: "Notably,"

Phrase: "despite chronic activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "of c-Met, membrane localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0475264:Localisation [Functional Concept]
   812   C1744691:localisation [Biologic Function]

Phrase: "of E-cadherin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0042172:E-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0694872:E-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413274:cadherin [Gene or Genome]

Phrase: "remained"

Phrase: "intact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205266:Intact [Qualitative Concept]
  1000   C1554187:Intact [Idea or Concept]

Phrase: "(Fig. 9 B"

Phrase: ")."
Processing 00000000.tx.221: Thus the discohesive phenotype elicited by CSF-1R activation is a relatively distinct feature of this receptor. 

Phrase: "Thus"

Phrase: "the discohesive phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "elicited by CSF-1R activation"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   853   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   840   C1516703:Colony Stimulating Factor Activation [Physiologic Function]
   814   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   778   C0449265:Elicited by [Qualitative Concept]
           elicited
   778   C1514758:Receptor Activation [Cell Function]
   748   C0439158:colony [Quantitative Concept]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1521761:Factor [Functional Concept]
   748   C1879547:Activation [Activity]
   748   C1947989:Colony [Cell]
   748   C1948023:Stimulating [Natural Phenomenon or Process]
   748   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "a relatively distinct feature of this receptor."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1521970:Feature [Qualitative Concept]
   748   C1706388:Feature [Conceptual Entity]
   748   C2346469:Feature [Qualitative Concept]
   748   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.222: To determine whether this distinction correlated with differing capacities of c-Met and CSF-1R to activate Src family kinases, we assessed the level of Src activation in response to acute or autocrine activation of each receptor. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "this distinction"

Phrase: "correlated with differing capacities of c-Met"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1707520:Correlated [Qualitative Concept]
   714   C1516240:Capacity [Quantitative Concept]

Phrase: "and"

Phrase: "CSF-1R to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   937   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "Src family kinases,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0282625:src-Family Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           src Kinases
   827   C0015576:Family [Family Group]
   827   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]

Phrase: "we"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "the level of Src activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to acute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205178:acute [Temporal Concept]

Phrase: "or"

Phrase: "autocrine activation of each receptor."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1514758:Receptor Activation [Cell Function]
   760   C1879547:Activation [Activity]
Processing 00000000.tx.223: Acute stimulation of c-Met or CSF-1R resulted in equivalent levels of Src phosphorylation; 

Phrase: "Acute stimulation of c-Met"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "or"

Phrase: "CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "resulted in equivalent levels of Src phosphorylation"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C0205163:Equivalent [Qualitative Concept]
   748   C0439185:equivalent [Quantitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C1158886:Phosphorylation [Molecular Function]
   714 E C0456079:Level [Classification]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714 E C1547707:Level [Geographic Area]
   714   C2825142:Result [Finding]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.224: upon chronic stimulation of either receptor, levels of Src activation were again comparable (Fig. 9 C). 

Phrase: "upon chronic stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "of either receptor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "levels of Src activation"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "again comparable"

Phrase: "(Fig. 9 C)."
Processing 00000000.tx.225: View larger version (49K): [in this window] [in a new window]  Figure 9. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(49K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 9."
Processing 00000000.tx.226: Autocrine stimulation of c-Met does not persistently disrupt acinar adhesion despite comparable activation of Src. 

Phrase: "Autocrine stimulation of c-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "Met"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Meet [Idea or Concept]

Phrase: "does"

Phrase: "not persistently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750508:persistently [Idea or Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "acinar adhesion despite comparable activation of Src."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0001511:Adhesion [Pathologic Function]
   748   C0175633:Adhesion [Natural Phenomenon or Process]
Processing 00000000.tx.227: (A) MCF-10A cells expressing c-Met and vector control (c-Met/Vector) or HGF (c-Met/HGF) were cultured in MatrigelTM in assay media with 40 ng/ml HGF where noted (HGF). 

Phrase: "(A) MCF-10A cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "c-Met"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456828:C-MET [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1704823:C-MET [Gene or Genome]

Phrase: "and"

Phrase: "vector control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0031249:vector control [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243148:control [Qualitative Concept]
   861   C0442335:Vector [Spatial Concept]
   861   C1550141:Control [Substance]
   861   C1705099:Vector [Idea or Concept]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(c-Met/Vector"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]
   734   C1456828:C-MET [Amino Acid, Peptide, or Protein,Receptor]
   734   C1704823:C-MET [Gene or Genome]

Phrase: ")"

Phrase: "or"

Phrase: "HGF (c-Met/HGF)"

Phrase: "were"

Phrase: "cultured in MatrigelTM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "in assay media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "with 40 ng/ml HGF where"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "(HGF"

Phrase: ")."
Processing 00000000.tx.228: Brightfield images of day 5 and day 17 acini are shown. 

Phrase: "Brightfield images of day 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1704254:Image [Intellectual Product]
   726   C1704922:Image [Entity]
   726   C3542466:Image [Intellectual Product]

Phrase: "and"

Phrase: "day 17 acini"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C0935597:Acinus [Body Part, Organ, or Organ Component]
   793   C1442495:ACINUS [Gene or Genome]
   743 E C0332207:Acinar [Spatial Concept]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.229: (B) 3D cultures of MCF-10As expressing c-Met and HGF were stained with DAPI (blue) and E-cadherin (green). 

Phrase: "(B) 3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450363:3D [Spatial Concept]
   861   C2986797:3D [Functional Concept]

Phrase: "cultures of MCF-10As"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0008015:MCF [Immunologic Factor]
   770   C0010453:Culture [Idea or Concept]
   770   C0220814:culture [Functional Concept]
   770   C0430400:Culture [Laboratory Procedure]
   770   C2242979:Culture [Laboratory Procedure]

Phrase: "expressing"

Phrase: "c-Met"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456828:C-MET [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1704823:C-MET [Gene or Genome]

Phrase: "and"

Phrase: "HGF"

Phrase: "were"

Phrase: "stained with DAPI (blue"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0057142:DAPI [Organic Chemical,Pharmacologic Substance]
   770   C1260957:Blue [Qualitative Concept]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: ")"

Phrase: "and"

Phrase: "E-cadherin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0042172:E-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0694872:E-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413274:cadherin [Gene or Genome]

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.230: Confocal image of day 19 structure is shown. 

Phrase: "Confocal image of day 19 structure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1704254:Image [Intellectual Product]
   753   C1704922:Image [Entity]
   753   C3542466:Image [Intellectual Product]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.231: (C) MCF-10As expressing CSF-1R and vector control or CSF-1, or c-Met and vector control or HGF were starved overnight in assay media. 

Phrase: "(C) MCF-10As"

Phrase: "expressing"

Phrase: "CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "vector control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0031249:vector control [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243148:control [Qualitative Concept]
   861   C0442335:Vector [Spatial Concept]
   861   C1550141:Control [Substance]
   861   C1705099:Vector [Idea or Concept]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "or"

Phrase: "CSF-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "c-Met"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456828:C-MET [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1704823:C-MET [Gene or Genome]

Phrase: "and"

Phrase: "vector control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0031249:vector control [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243148:control [Qualitative Concept]
   861   C0442335:Vector [Spatial Concept]
   861   C1550141:Control [Substance]
   861   C1705099:Vector [Idea or Concept]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "or"

Phrase: "HGF"

Phrase: "were"

Phrase: "starved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2348531:Starve [Activity]

Phrase: "overnight in assay media."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C0243073:assay [Qualitative Concept]
   770   C0439583:Overnight [Temporal Concept]
   770   C1254021:Media [Tissue]
   770   C1510438:Assay [Laboratory Procedure]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.232: Cells were treated with 10 ng/ml CSF-1 or 40 ng/ml HGF before lysis where noted. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 10 ng/ml CSF-1"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   778   C0439275:ng/mL [Quantitative Concept]
   778   C1150625:CSF-1 [Molecular Function]
   774   C0964553:NG.1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C1334110:NG.1 [Gene or Genome]
   748   C0439526:/mL [Quantitative Concept]
   748   C1522326:Treated [Functional Concept]
   748   C3540512:CSF [Therapeutic or Preventive Procedure]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "40 ng/ml HGF before lysis where"

Phrase: "noted."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]
Processing 00000000.tx.233: Lysates were probed for Src tyrosine 419 phosphorylation and total Src levels.   

Phrase: "Lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "probed for Src tyrosine 419 phosphorylation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C1519726:Tyrosine Phosphorylation [Molecular Function]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C1158886:Phosphorylation [Molecular Function]
   719   C0182400:Probe [Medical Device]
   719   C1704681:Probe [Gene or Genome]
   719   C2347609:Probe [Chemical Viewed Functionally]
   719   C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "total Src levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.234: Discussion Top Abstract Introduction Results Discussion Materials and methods References  Despite significant evidence supporting a role for CSF-1R in epithelial tumorigenesis, little is known about the mechanisms by which autocrine CSF-1 activation may contribute to tumor progression. 

Phrase: "Discussion Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References  Despite significant evidence"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0237881:significant [Quantitative Concept]
   770   C0332120:Evidence [Functional Concept]
   770   C0750502:Significant [Idea or Concept]
   770   C1514811:Reference [Idea or Concept]
   770   C1546944:Significant [Qualitative Concept]
   770   C1706462:Reference [Conceptual Entity]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "a role for CSF-1R"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in epithelial tumorigenesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0007621:Tumorigenesis [Neoplastic Process]
   861   C0596263:Tumorigenesis [Neoplastic Process]

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "is"

Phrase: "known about the mechanisms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0205309:Known [Qualitative Concept]
   770   C0441712:Mechanisms [Functional Concept]
   737 E C1706376:Mechanism [Manufactured Object]

Phrase: "by which autocrine CSF-1 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "may"

Phrase: "contribute to tumor progression."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0178874:Tumor Progression [Neoplastic Process]
   770   C0027651:Tumor [Neoplastic Process]
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]
   770   C1578706:Tumor [Intellectual Product]
   770   C1880177:Contribute [Activity]
   770   C3273930:Tumor [Finding]
Processing 00000000.tx.235: We have used the MCF-10A mammary epithelial cell line to assess the effects of ligand and receptor coexpression on epithelial motility and morphogenesis. 

Phrase: "We"

Phrase: "have"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the MCF-10A mammary epithelial cell line to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   845   C0230087:Mammary line [Body Location or Region]
   818   C0007600:Cell Line [Cell]
   795   C0205132:Line [Spatial Concept]
   795   C1550648:Line [Substance]
   795   C1552960:Line [Quantitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the effects of ligand"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "receptor coexpression on epithelial motility"

Phrase: "and"

Phrase: "morphogenesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026559:Morphogenesis [Organism Function]
Processing 00000000.tx.236: We have found that constitutive CSF-1R signaling causes uncontrolled proliferation, allowing these cells to subvert growth-suppressive mechanisms typically operative in monolayer and 3D cultures. 

Phrase: "We"

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that constitutive CSF-1R signaling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1514762:Receptor Signaling [Molecular Function]
   799   C0037083:Signaling [Cell Function]
   799   C3537152:signaling [Biologic Function]
   734   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "uncontrolled proliferation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "these cells to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "subvert"

Phrase: "growth-suppressive mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: "typically operative in monolayer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1882154:Operative [Temporal Concept]

Phrase: "and"

Phrase: "3D cultures."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.237: Furthermore, we observed a profound perturbation of cellcell adhesion, resulting in a striking disintegration of 3D acinar structures and likely contributing to enhanced motility in MCF-10A monolayers. 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a profound perturbation of cellcell adhesion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332453:perturbation [Functional Concept]

Phrase: "resulting in a striking disintegration of 3D acinar structures"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   764   C0332294:Resulting in [Functional Concept]
   742   C0038452:striking [Occupational Activity]
   742   C0332207:Acinar [Spatial Concept]
   742   C0450363:3D [Spatial Concept]
   742   C0678226:resulting [Functional Concept]
   742   C0678594:structures [Spatial Concept]
   742   C1265875:Disintegration [Acquired Abnormality]
   742   C2986797:3D [Functional Concept]
   708 E C1274040:Result [Functional Concept]
   708 E C1546471:Result [Idea or Concept]
   708 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "likely contributing to enhanced motility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880177:Contributing [Activity]

Phrase: "in MCF-10A monolayers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0872351:monolayers [Clinical Drug]
Processing 00000000.tx.238: Using immunolocalization and fractionation studies, we have demonstrated that autocrine CSF-1R signaling can dramatically disrupt adherens junctionmediated adhesion. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "immunolocalization"

Phrase: "and"

Phrase: "fractionation studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that autocrine CSF-1R signaling"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   895   C0525010:Autocrine Signaling [Cell Function]
   827   C1514762:Receptor Signaling [Molecular Function]
   799   C0037083:Signaling [Cell Function]
   799   C3537152:signaling [Biologic Function]
   734   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "can"

Phrase: "dramatically"

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "adherens junctionmediated adhesion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001511:Adhesion [Pathologic Function]
   827   C0175633:Adhesion [Natural Phenomenon or Process]
Processing 00000000.tx.239: The formation of adherens junctions, directed by homophilic interactions between the extracellular domains of E-cadherin molecules on neighboring cells, is essential for epithelial cellcell adhesion; 

Phrase: "The formation of adherens junctions,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C2247934:adherens junction formation [Cell Function]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "directed by homophilic interactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0439851:Direct [Qualitative Concept]
   737   C1704675:Interaction [Functional Concept]
   737   C1947931:Direct [Qualitative Concept]

Phrase: "between the extracellular domains"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C1517050:Extracellular Domain [Spatial Concept]
   861   C0521119:Extracellular [Cell Component]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "of E-cadherin molecules"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]
   734   C0042172:E-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0694872:E-CADHERIN [Gene or Genome]

Phrase: "on neighboring cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "essential for epithelial cellcell adhesion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205224:Essential [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.240: other adhesive interactions are limited in their absence. 

Phrase: "other adhesive interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "are"

Phrase: "limited in their absence."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0332197:absence [Quantitative Concept]
   770   C0439801:Limited [Functional Concept]
   770   C1689985:Absence [Anatomical Abnormality]
   770   C3542948:Limited [Intellectual Product]
   737 E C1549649:Limit [Idea or Concept]
   737 E C2349209:Limit [Conceptual Entity]
Processing 00000000.tx.241: The cytoplasmic tail of E-cadherin interacts with -catenin, which strengthens adhesive contacts by tethering E-cadherin to the actin cytoskeleton via interaction with -catenin (Herrenknecht et al., 1991; McCrea et al., 1991). 

Phrase: "The cytoplasmic tail of E-cadherin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1511625:Cytoplasmic Tail [Cell Component]
   753   C0010834:Cytoplasmic [Cell Component]
   753   C0039259:Tail [Body Part, Organ, or Organ Component]
   753   C0521449:Cytoplasmic [Body Location or Region]

Phrase: "interacts with -catenin,"

Phrase: "which"

Phrase: "strengthens"

Phrase: "adhesive contacts by tethering E-cadherin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0332158:contact [Functional Concept]
   719   C0337611:Contact [Population Group]
   719   C1705415:Contact [Idea or Concept]

Phrase: "to the actin cytoskeleton"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025979:Actin Cytoskeleton [Cell Component]
   861   C0010853:Cytoskeleton [Cell Component]
   861   C1748451:Cytoskeleton [Cell Component]

Phrase: "via interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "with -catenin"

Phrase: "(Herrenknecht et al.,"

Phrase: "1991"

Phrase: "; McCrea et al.,"

Phrase: "1991"

Phrase: ")."
Processing 00000000.tx.242: Loss of cadherin function has been associated with migratory behavior in vitro, and is a common hallmark of invasive carcinoma in vivo (Kowalski et al., 2003). 

Phrase: "Loss of cadherin function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "associated with migratory behavior"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0004927:Behavior [Individual Behavior]
   770   C0232901:Migratory [Functional Concept]
   770   C2707008:Behavior [Clinical Attribute]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "is"

Phrase: "a common hallmark of invasive carcinoma"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(Kowalski et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.243: While cellular remodeling involved in the formation of glandular structures requires transient disruption of adhesive contacts, the preservation of tissue architecture relies on stable intercellular interaction. 

Phrase: "While"

Phrase: "cellular remodeling"

Phrase: "involved in the formation of glandular structures"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0220781:formation [Biologic Function]
   748   C0225353:Glandular [Qualitative Concept]
   748   C0439634:formation [Spatial Concept]
   748   C0678594:structures [Spatial Concept]
   748   C1285092:Glandular [Body Part, Organ, or Organ Component]
   748   C1314939:Involved [Functional Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "requires"

Phrase: "transient disruption of adhesive contacts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332453:Disruption [Functional Concept]

Phrase: "the preservation of tissue architecture"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0040295:Tissue Preservation [Therapeutic or Preventive Procedure]
   760   C0033085:Preservation [Laboratory Procedure]
   760   C1514402:Preservation [Laboratory Procedure]

Phrase: "relies on stable intercellular interaction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205360:Stable [Qualitative Concept]
   760   C1547311:Stable [Intellectual Product]
   760   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.244: Tubule formation in response to the activation of c-Met in MDCK cysts involves local redistribution of cadherin complexes without dissolution of cellcell contacts (Pollack et al., 1998). 

Phrase: "Tubule formation in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1718420:Tubule Formation [Organism Attribute]
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "to the activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of c-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Met in MDCK cysts"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0010709:Cysts [Disease or Syndrome]
   737 E C0686883:Cyst [Eukaryote]
   737   C1550543:Meet [Idea or Concept]

Phrase: "involves"

Phrase: "local redistribution of cadherin complexes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332620:Redistribution [Functional Concept]

Phrase: "without dissolution"

Phrase: "of cellcell contacts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332158:contact [Functional Concept]
   827   C0337611:Contact [Population Group]
   827   C1705415:Contact [Idea or Concept]

Phrase: "(Pollack et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.245: In contrast to this discrete morphogenetic response to an appropriate growth factor signal, we have found that autocrine CSF-1R activation can dramatically and persistently disrupt cellcell adhesion in mammary epithelial structures in vitro. 

Phrase: "In contrast to this discrete morphogenetic response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "to an appropriate growth factor signal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1710082:Signal [Phenomenon or Process]

Phrase: "we"

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that autocrine CSF-1R activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1516703:Colony Stimulating Factor Activation [Physiologic Function]
   827   C1514758:Receptor Activation [Cell Function]
   799   C1879547:Activation [Activity]
   734   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "can"

Phrase: "dramatically"

Phrase: "and"

Phrase: "persistently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750508:persistently [Idea or Concept]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "cellcell adhesion in mammary epithelial structures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0001511:Adhesion [Pathologic Function]
   753   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.246: The resulting disintegration of acinar integrity culminates in the release of individual cells into the surrounding matrix. 

Phrase: "The resulting disintegration of acinar integrity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265875:Disintegration [Acquired Abnormality]

Phrase: "culminates in the release of individual cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   748   C0007634:Cells [Cell]
   748   C0027361:Individual [Population Group]
   748   C0030685:Release [Health Care Activity]
   748   C0237401:Individual [Human]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1963578:Release [Therapeutic or Preventive Procedure]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "into the surrounding matrix."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]
Processing 00000000.tx.247: Cellcell adhesion functions not only to maintain the physical integrity of the epithelial cell layer as a barrier between glandular and stromal compartments, but also contributes to the maintenance of cell polarity and suppression of proliferation (Watabe et al., 1994). 

Phrase: "Cellcell adhesion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001511:Adhesion [Pathologic Function]
   861   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "functions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "not only to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205171:Only [Quantitative Concept]
   827   C1518422:Not [Functional Concept]
   827   C1720467:Only [Intellectual Product]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "the physical integrity of the epithelial cell layer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0205266:integrity [Qualitative Concept]
   744   C0872403:integrity [Individual Behavior]
   744   C1947912:Integrity [Qualitative Concept]

Phrase: "as a barrier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706912:BARRIER [Medical Device]

Phrase: "between glandular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0225353:Glandular [Qualitative Concept]
  1000   C1285092:Glandular [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "stromal compartments,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1185625:Compartments [Body Space or Junction]
   861   C1382196:Compartments [Natural Phenomenon or Process]
   827 E C2986730:Compartment [Spatial Concept]

Phrase: "but"

Phrase: "also"

Phrase: "contributes to the maintenance of cell polarity"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   853   C1156006:maintenance of cell polarity [Cell Function]
   778   C0085304:Cell Polarity [Spatial Concept]
   774   C1516348:Cell Maintenance [Cell Function]
   748   C0007634:Cell [Cell]
   748   C0024501:Maintenance [Activity]
   748   C0596963:Polarity [Quantitative Concept]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1880177:Contribute [Activity]
   748   C1948049:Cell [Spatial Concept]
   738 E C2331651:Polar Cell [Cell]
   728 E C2262962:cell pole [Cell Component]

Phrase: "and"

Phrase: "suppression of proliferation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0221103:Suppression [Pathologic Function]
   790   C0301625:Suppression [Organism Function]
   790   C0439181:% suppression [Quantitative Concept]
   790   C0728721:suppression [Mental Process]

Phrase: "(Watabe et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.248: Loss of membrane E-cadherin in MCF-10A acini consistently correlated with increased Ki67 staining, suggesting that compromised cell adhesion may influence the uncontrolled proliferation observed. 

Phrase: "Loss of membrane E-cadherin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "in MCF-10A acini consistently"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C0935597:Acinus [Body Part, Organ, or Organ Component]
   779   C1442495:ACINUS [Gene or Genome]
   729 E C0332207:Acinar [Spatial Concept]

Phrase: "correlated with increased Ki67 staining,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]
   760   C1707520:Correlated [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that compromised cell adhesion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "may"

Phrase: "influence"

Phrase: "the uncontrolled proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.249: Furthermore, perturbations of cellcell contact have been shown to promote migratory behavior, and appear to play a role in tumor progression (Nollet et al., 1999). 

Phrase: "Furthermore,"

Phrase: "perturbations of cellcell contact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0332453:perturbation [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "migratory behavior,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0004927:Behavior [Individual Behavior]
   861   C2707008:Behavior [Clinical Attribute]
   789 E C2986890:Behavioral [Idea or Concept]

Phrase: "and"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in tumor progression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "(Nollet et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.250: In agreement with this, autocrine CSF-1R also accelerated MCF-10A wound closure, not only increasing the rate of cell motility, but also disrupting the sheet-like character of epithelial cell movement. 

Phrase: "In agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with this,"

Phrase: "autocrine CSF-1R also accelerated MCF-10A wound closure,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   801   C0450015:Wound closure [Functional Concept]
   801   C1112446:Wound closure [Therapeutic or Preventive Procedure]
   788   C0185003:Closure [Therapeutic or Preventive Procedure]
   788   C1521802:Closure [Research Activity]
   733 E C0447303:Occlusal [Body Location or Region]
   733 E C0591895:occlusal [Organic Chemical,Pharmacologic Substance]
   733 E C1947917:Occlusal [Functional Concept]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the rate of cell motility,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "but"

Phrase: "also"

Phrase: "disrupting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupting [Qualitative Concept]

Phrase: "the sheet-like character of epithelial cell movement."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0007952:Character [Mental Process]
   744   C0486537:Character [Organism Attribute]
   744   C2350015:Character [Qualitative Concept]
Processing 00000000.tx.251: Enhanced motility likewise correlated with reduced membrane E-cadherin staining. 

Phrase: "Enhanced motility likewise"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0007608:Motility [Cell Function]
   827   C0678835:Motility [Laboratory or Test Result]
   827   C1510470:Motility [Organism Function]
   755 E C1979933:Motile [Finding]

Phrase: "correlated with reduced membrane E-cadherin staining."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0025255:Membrane [Tissue]
   748   C0392756:Reduced [Qualitative Concept]
   748   C0487602:Staining [Laboratory Procedure]
   748   C0596901:Membrane [Cell Component]
   748   C1413274:cadherin [Gene or Genome]
   748   C1704680:Staining [Finding]
   748   C1706182:Membrane [Manufactured Object]
   748   C1707520:Correlated [Qualitative Concept]
Processing 00000000.tx.252: Despite the capacity of CSF-1 to promote migration in this context, it was unable to elicit invasive behavior through intact basement membrane, as individual cells did not actively disperse from disrupted acini. 

Phrase: "Despite the capacity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516240:Capacity [Quantitative Concept]

Phrase: "of CSF-1 to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C1150625:CSF-1 [Molecular Function]
   827   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "migration in this context,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0600210:Migration [Social Behavior]
   770   C1533574:Migration [Physiologic Function]
   770   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "it"

Phrase: "was"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "elicit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "invasive behavior through intact basement membrane,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0004927:Behavior [Individual Behavior]
   753   C2707008:Behavior [Clinical Attribute]

Phrase: "as"

Phrase: "individual cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "did"

Phrase: "not actively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "disperse from disrupted acini."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332454:Disrupted [Qualitative Concept]
   737   C0935597:Acinus [Body Part, Organ, or Organ Component]
   737   C1442495:ACINUS [Gene or Genome]
Processing 00000000.tx.253: This suggests that cooperation with additional factors may be required for CSF-1R activation to promote invasion within the tumor microenvironment. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that cooperation with additional factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392337:cooperation [Social Behavior]

Phrase: "may"

Phrase: "be"

Phrase: "required for CSF-1R activation to"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   822   C1516703:Colony Stimulating Factor Activation [Physiologic Function]
   800   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1514758:Receptor Activation [Cell Function]
   744   C0439158:colony [Quantitative Concept]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1514873:Required [Functional Concept]
   744   C1521761:Factor [Functional Concept]
   744   C1879547:Activation [Activity]
   744   C1947989:Colony [Cell]
   744   C1948023:Stimulating [Natural Phenomenon or Process]
   744   C2827422:Factor [Conceptual Entity]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "invasion within the tumor microenvironment."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1269955:Tumor invasion [Finding]
           Invasion
   760   C2699153:Invasion [Pathologic Function]
Processing 00000000.tx.254: The disruption of adhesion resulting from autocrine CSF-1R activation correlates with the translocation of E-cadherin to intracellular vesicles and loss of Triton insolubility rather than a decrease in total E-cadherin. 

Phrase: "The disruption of adhesion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332453:Disruption [Functional Concept]

Phrase: "resulting from autocrine CSF-1R activation"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   833   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   822   C1516703:Colony Stimulating Factor Activation [Physiologic Function]
   800   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1514758:Receptor Activation [Cell Function]
   744   C0439158:colony [Quantitative Concept]
   744   C0596138:Autocrine [Organ or Tissue Function]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C0678226:resulting [Functional Concept]
   744   C1521761:Factor [Functional Concept]
   744   C1879547:Activation [Activity]
   744   C1947989:Colony [Cell]
   744   C1948023:Stimulating [Natural Phenomenon or Process]
   744   C2827422:Factor [Conceptual Entity]
   711 E C1274040:Result [Functional Concept]
   711 E C1546471:Result [Idea or Concept]
   711 E C2825142:Result [Finding]

Phrase: "correlates with the translocation of E-cadherin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0040715:Translocation [Cell or Molecular Dysfunction]
   748   C1413274:cadherin [Gene or Genome]
   748   C2987521:Translocation [Activity]

Phrase: "to intracellular vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "and"

Phrase: "loss of Triton insolubility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "rather than"

Phrase: "a decrease in total E-cadherin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.255: These findings are consistent with the possibility that the adhesive defect results from dissociation of junctional complexes from the actin cytoskeleton and their concomitant internalization. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "consistent with the possibility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that"

Phrase: "the adhesive defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1457869:Defect [Functional Concept]
   861   C1861101:DEFECT [Disease or Syndrome]

Phrase: "results from dissociation of junctional complexes"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   756   C0230612:Junctional complex [Cell Component]
   753   C0086168:Dissociation [Mental or Behavioral Dysfunction]
   753   C0205144:Junctional [Spatial Concept]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C1704241:Complexes [Chemical Viewed Structurally]
   753   C2825142:Result [Finding]
   719 E C0439855:Complex [Qualitative Concept]

Phrase: "from the actin cytoskeleton"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025979:Actin Cytoskeleton [Cell Component]
   861   C0010853:Cytoskeleton [Cell Component]
   861   C1748451:Cytoskeleton [Cell Component]

Phrase: "and"

Phrase: "their concomitant internalization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0871786:internalization [Mental Process]
Processing 00000000.tx.256: Recent data suggests that multiple regulators of cytoskeletal dynamics impinge upon the assembly and maturation of adherens junctions, and this interface may play as important a role in regulation of adhesion as modulation of the composition of junctional complexes (Braga et al., 1997). 

Phrase: "Recent data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that multiple regulators of cytoskeletal dynamics"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0182953:regulators [Medical Device]
   719 E C1704734:Regulator [Medical Device]
   719 E C1704735:Regulator [Conceptual Entity]

Phrase: "impinge upon the assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1706853:Assembly [Activity]
   770   C1879748:Assembly [Manufactured Object]

Phrase: "and"

Phrase: "maturation of adherens junctions,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0678723:Maturation [Organism Function]
   770   C0870861:maturation [Phenomenon or Process]
   770   C1254042:Maturation [Physiologic Function]

Phrase: "and"

Phrase: "this interface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708533:Interface [Manufactured Object]
  1000   C2698172:Interface [Intellectual Product]

Phrase: "may"

Phrase: "play as important"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032214:Play [Daily or Recreational Activity]
   790   C0600138:play [Finding]

Phrase: "a role in regulation of adhesion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "as modulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulation [Spatial Concept]

Phrase: "of the composition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0486616:Composition [Clinical Attribute]
  1000   C1555710:composition [Idea or Concept]

Phrase: "of junctional complexes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   966   C0230612:Junctional complex [Cell Component]
   861   C0205144:Junctional [Spatial Concept]
   861   C1704241:Complexes [Chemical Viewed Structurally]
   827 E C0439855:Complex [Qualitative Concept]
   789 E C1706311:Junction [Medical Device]

Phrase: "(Braga et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.257: Association of adherens junction complexes with the cytoskeleton might further act as an important determinant in controlling the rate of cadherin endocytosis and recycling. 

Phrase: "Association of adherens junction complexes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with the cytoskeleton"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010853:Cytoskeleton [Cell Component]
  1000   C1748451:Cytoskeleton [Cell Component]

Phrase: "might"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "act as an important determinant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C1521761:Determinant [Functional Concept]

Phrase: "in controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332298:controlling [Functional Concept]
  1000   C2587213:Controlling [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "the rate of cadherin endocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "recycling."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282114:Recycling [Human-caused Phenomenon or Process]
Processing 00000000.tx.258: The effects of autocrine CSF-1R signaling on cellcell adhesion are exquisitely dependent upon the sustained activation of Src kinases. 

Phrase: "The effects of autocrine CSF-1R signaling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C1280500:effects [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "on cellcell adhesion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001511:Adhesion [Pathologic Function]
   861   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "are"

Phrase: "exquisitely dependent upon the sustained activation of Src kinases."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0851827:Dependent [Qualitative Concept]
   742   C1701901:Dependent [Qualitative Concept]
   742   C3244310:dependent [Functional Concept]
Processing 00000000.tx.259: Interfering with Src activity by pharmacological inhibition or expression of a dominant-inhibitory Src mutant, or by mutation of the Src binding site on the receptor, resulted in a complete preservation of acinar integrity. 

Phrase: "Interfering with Src activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C0521102:interfering [Qualitative Concept]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "by pharmacological inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "or"

Phrase: "expression of a dominant-inhibitory Src mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or by mutation of the Src binding site"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0005456:Binding Site [Receptor]
   770   C0682969:Binding Site [Amino Acid Sequence]
   767   C2945843:Site of [Qualitative Concept]
   744   C0026882:Mutation [Genetic Function]
   744   C0205145:Site [Spatial Concept]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1515974:Site [Body Location or Region]
   744   C1705285:Mutation [Cell or Molecular Dysfunction]
   744   C2825164:Site [Spatial Concept]

Phrase: "on the receptor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "resulted in a complete preservation of acinar integrity."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0033085:Preservation [Laboratory Procedure]
   744   C0205197:Complete [Qualitative Concept]
   744   C0205266:integrity [Qualitative Concept]
   744   C0332207:Acinar [Spatial Concept]
   744   C0725685:COMPLEAT [Food]
   744   C0872403:integrity [Individual Behavior]
   744   C1514402:Preservation [Laboratory Procedure]
   744   C1947912:Integrity [Qualitative Concept]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]
Processing 00000000.tx.260: Furthermore, Src inhibition restored the ability of cells in suspension to undergo adhesive compaction, as well as the controlled, sheet-like migration of cells in a wounded monolayer (unpublished data). 

Phrase: "Furthermore,"

Phrase: "Src inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "restored"

Phrase: "the ability of cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085732:Ability [Organism Attribute]

Phrase: "in suspension to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0038960:Suspension [Biomedical or Dental Material]
   861   C1382107:Suspension [Substance]
   861   C1705537:Suspension [Functional Concept]

Phrase: "undergo"

Phrase: "adhesive compaction,"

Phrase: "as well as"

Phrase: "the controlled, sheet-like migration of cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1622501:cells migration [Cell Function]
   748   C0600210:Migration [Social Behavior]
   748   C1533574:Migration [Physiologic Function]
   748   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "in a wounded monolayer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0872351:monolayer [Clinical Drug]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.261: Src can phosphorylate -catenin in vitro, and v-Src has been shown to destabilize the association of -catenin with E-cadherin, an effect that correlated with phosphorylation of both proteins (Behrens et al., 1993; Roura et al., 1999). 

Phrase: "Src"

Phrase: "can"

Phrase: "phosphorylate -"

Phrase: "catenin"

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "v-Src"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0029009:v src [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0080298:V-SRC [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "destabilize"

Phrase: "the association of -catenin with E-cadherin,"

Phrase: "an effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "that"

Phrase: "correlated with phosphorylation of both proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   753   C0031715:Phosphorylation [Molecular Function]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1707520:Correlated [Qualitative Concept]

Phrase: "(Behrens et al.,"

Phrase: "1993"

Phrase: "; Roura et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.262: In addition, p120 catenin was initially identified as a Src substrate and was shown to be phosphorylated after RTK activation (Reynolds et al., 1989; Downing and Reynolds, 1991). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "p120 catenin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2699128:p120-catenin [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "identified as a Src substrate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205396:Identified [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "phosphorylated after RTK activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0206364:RTK [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   770   C1879547:Activation [Activity]

Phrase: "(Reynolds et al.,"

Phrase: "1989"

Phrase: "; Downing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205104:Down [Spatial Concept]

Phrase: "and"

Phrase: "Reynolds,"

Phrase: "1991"

Phrase: ")."
Processing 00000000.tx.263: However, v-Src retained the ability to disrupt cadherin cytoskeletal association in cells expressing an E-cadherin/-catenin fusion protein, excluding -catenin as the relevant target and suggesting that Src activity may also influence adherens junction stability indirectly (Takeda et al., 1995). 

Phrase: "However,"

Phrase: "v-Src"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0029009:v src [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0080298:V-SRC [Gene or Genome]

Phrase: "retained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retained [Functional Concept]

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "cadherin cytoskeletal association in cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "expressing"

Phrase: "an E-cadherin/-catenin fusion protein,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C0599561:E protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332466:Fusion [Functional Concept]
   804   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "excluding -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0332196:Exclude [Functional Concept]
   966   C2828389:Exclude [Activity]

Phrase: "catenin as the relevant target"

Phrase: "and"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that Src activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "may"

Phrase: "also"

Phrase: "influence"

Phrase: "adherens junction stability indirectly"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0205360:Stability [Qualitative Concept]
   812   C2347098:Stability [Qualitative Concept]
   741 E C1547311:Stable [Intellectual Product]

Phrase: "(Takeda et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.264: Src-mediated junctional disruption in MCF-10As is likely to occur via such an indirect mechanism, as we were unable to detect catenin phosphorylation unless cells were treated with phosphatase inhibitors before lysis, and levels were not enhanced by CSF-1R activation (unpublished data). 

Phrase: "Src-mediated junctional disruption in MCF-10As"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332453:Disruption [Functional Concept]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "occur via such"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "an indirect mechanism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "as"

Phrase: "we"

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "catenin phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "unless"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with phosphatase inhibitors"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   816   C0597217:phosphatase inhibitor [Pharmacologic Substance]
   770   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   770   C1149880:phosphatase [Molecular Function]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]
   737 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "before lysis,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0024348:Lysis [Pathologic Function]
  1000   C1536403:lysis [Cell Function]
   928 E C0439680:Lytic [Qualitative Concept]

Phrase: "and"

Phrase: "levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "enhanced by CSF-1R activation"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   853   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   840   C1516703:Colony Stimulating Factor Activation [Physiologic Function]
   814   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   778   C1514758:Receptor Activation [Cell Function]
   748   C0439158:colony [Quantitative Concept]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1521761:Factor [Functional Concept]
   748   C1879547:Activation [Activity]
   748   C1947989:Colony [Cell]
   748   C1948023:Stimulating [Natural Phenomenon or Process]
   748   C2349975:Enhanced [Activity]
   748   C2827422:Factor [Conceptual Entity]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.265: Candidate Src targets include proteins that are localized to cell junctions and influence but do not directly participate in the adherens junction complex, such as ZO-1 or ezrin (Pujuguet et al., 2003). 

Phrase: "Candidate Src targets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521840:Target [Functional Concept]
   793   C2986546:TARGET [Diagnostic Procedure]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "are"

Phrase: "localized to cell junctions"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0021721:Cell Junctions [Body Space or Junction]
   770   C0007634:Cell [Cell]
   770   C0392752:Localized [Spatial Concept]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   737   C0205144:Junction [Spatial Concept]
   737   C1706311:Junction [Medical Device]

Phrase: "and"

Phrase: "influence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0021399:influential [Idea or Concept]

Phrase: "but"

Phrase: "do"

Phrase: "not directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1518422:Not [Functional Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "participate in the adherens junction complex,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0230613:Adherens Junction [Cell Component]
   790   C0887872:Adherens Junction [Cell Component]
   790   C2984274:Adherens junction [Functional Concept]
   754   C0230612:Junctional complex [Cell Component]
   753   C0205144:Junction [Spatial Concept]
   753   C0439855:Complex [Qualitative Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]
   753   C1706311:Junction [Medical Device]

Phrase: "such as ZO-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420744:ZO-1 [Gene or Genome]

Phrase: "or"

Phrase: "ezrin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0059973:ezrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1421450:EZRIN [Gene or Genome]

Phrase: "(Pujuguet et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.266: Alternatively, Src could exert its effects by targeting a regulator of cadherin endocytosis, which would account for the punctate accumulation of E-cadherin observed upon autocrine CSF-1R activation. 

Phrase: "Alternatively,"

Phrase: "Src"

Phrase: "could"

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "its effects by targeting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "a regulator of cadherin endocytosis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0182953:REGULATOR [Medical Device]
   760   C1704734:Regulator [Medical Device]
   760   C1704735:Regulator [Conceptual Entity]

Phrase: "which"

Phrase: "would"

Phrase: "account for the punctate accumulation of E-cadherin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205330:Punctate [Qualitative Concept]
   744   C1413274:cadherin [Gene or Genome]
   744   C1551359:account [Idea or Concept]
   744   C2741673:Account # [Clinical Attribute]
   744   C2981730:Account [Classification]

Phrase: "observed upon autocrine CSF-1R activation."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   822   C1516703:Colony Stimulating Factor Activation [Physiologic Function]
   800   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1514758:Receptor Activation [Cell Function]
   744   C0439158:colony [Quantitative Concept]
   744   C0596138:Autocrine [Organ or Tissue Function]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1441672:Observed [Functional Concept]
   744   C1521761:Factor [Functional Concept]
   744   C1879547:Activation [Activity]
   744   C1947989:Colony [Cell]
   744   C1948023:Stimulating [Natural Phenomenon or Process]
   744   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.267: PKC has been shown to stabilize adhesion by limiting cadherin endocytosis, and the ability of Src to mediate its degradation could play a role (Blake et al., 1999; Le et al., 2002). 

Phrase: "PKC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539645:PKC [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stabilize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:stabilize [Qualitative Concept]

Phrase: "adhesion by limiting cadherin endocytosis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0001511:Adhesion [Pathologic Function]
   760   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "the ability of Src to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "its degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "could"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]

Phrase: "(Blake et al.,"

Phrase: "1999"

Phrase: "; Le et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.268: Moreover, the GTPase ARF6 has been shown to act downstream of v-Src to promote cadherin endocytosis, and CSF-1 stimulation of macrophages induces its translocation to the plasma membrane (Zhang et al., 1999; Palacios et al., 2001). 

Phrase: "Moreover,"

Phrase: "the GTPase ARF6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412511:ARF6 [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "act downstream of v-Src to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0029009:v src [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0080298:V-SRC [Gene or Genome]
   753   C0079613:ACT [Therapeutic or Preventive Procedure]
   753   C0522506:Downstream [Spatial Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cadherin endocytosis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014139:Endocytosis [Cell Function]
   861   C2984285:Endocytosis [Functional Concept]

Phrase: "and"

Phrase: "CSF-1 stimulation of macrophages"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "its translocation to the plasma membrane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040715:Translocation [Cell or Molecular Dysfunction]
   753   C2987521:Translocation [Activity]

Phrase: "(Zhang et al.,"

Phrase: "1999"

Phrase: "; Palacios et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.269: The inability of c-Met to elicit a similar disruption of acinar architecture, despite its capacity to induce comparable levels of Src activity, suggests that additional factors are involved in CSF-1Rmediated perturbation of adhesion. 

Phrase: "The inability of c-"

Phrase: "Met"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Meet [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "elicit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "a similar disruption of acinar architecture,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332453:Disruption [Functional Concept]

Phrase: "despite its capacity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "comparable levels of Src activity,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   797   C0683317:activity levels [Finding]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that additional factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "are"

Phrase: "involved in CSF-1Rmediated perturbation of adhesion."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0001511:Adhesion [Pathologic Function]
   748   C0175633:Adhesion [Natural Phenomenon or Process]
   748   C0332453:perturbation [Functional Concept]
   748   C1314939:Involved [Functional Concept]
   748   C3540512:CSF [Therapeutic or Preventive Procedure]
Processing 00000000.tx.270: Accessory pathways activated by the receptor may be required to collaborate with Src; 

Phrase: "Accessory pathways"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0264897:accessory pathways [Pathologic Function]
   966 E C0006383:Accessory pathway [Body Part, Organ, or Organ Component]
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "activated by the receptor"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "collaborate with Src"

Phrase: ";"
Processing 00000000.tx.271: alternatively, CSF-1R may be uniquely poised to colocalize active Src and its relevant target(s). 

Phrase: "alternatively,"

Phrase: "CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "may"

Phrase: "be"

Phrase: "uniquely"

Phrase: "poised"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1551084:Poise [Quantitative Concept]
   966   C2937256:Poise [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "colocalize"

Phrase: "active Src"

Phrase: "and"

Phrase: "its relevant target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1521840:Target [Functional Concept]
   861   C2986546:TARGET [Diagnostic Procedure]

Phrase: "("

Phrase: "s)."
Processing 00000000.tx.272: Studies to address this distinction and the aforementioned potential targets are currently underway. 

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this distinction"

Phrase: "and"

Phrase: "the aforementioned potential targets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521840:Target [Functional Concept]
   793   C2986546:TARGET [Diagnostic Procedure]

Phrase: "are"

Phrase: "currently underway."
Processing 00000000.tx.273: Coexpression of CSF-1R and CSF-1 is most often detected in invasive tumors, and elevated serum levels of CSF-1 correlate with metastatic progression and poor prognosis (Kacinski et al., 1991; Price et al., 1993). 

Phrase: "Coexpression of CSF-1R"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   716   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "and"

Phrase: "CSF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "most often"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205393:Most [Quantitative Concept]
   861   C0332183:Often [Temporal Concept]

Phrase: "detected in invasive tumors,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0027651:Tumors [Neoplastic Process]
   770   C0205281:Invasive [Qualitative Concept]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   737 E C1578706:Tumor [Intellectual Product]
   737 E C3273930:Tumor [Finding]

Phrase: "and"

Phrase: "elevated serum levels of CSF-1"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   767   C0456947:Level 1 [Intellectual Product]
   753   C0229671:Serum [Body Substance]
   753   C0441889:Levels [Qualitative Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "correlate with metastatic progression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0036525:Metastatic [Functional Concept]
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]
   770   C1522484:metastatic [Quantitative Concept]

Phrase: "and"

Phrase: "poor prognosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0278252:Poor prognosis [Finding]
   861   C0033325:Prognosis [Health Care Activity]

Phrase: "(Kacinski et al.,"

Phrase: "1991"

Phrase: "; Price et al.,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.274: The ability of CSF-1R to disrupt cellcell adhesion, coupled with its capacity to promote cell motility and proliferation, corroborates that constitutive receptor signaling can coordinately promote multiple biological activities associated with tumor progression and invasion. 

Phrase: "The ability of CSF-1R to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0085732:Ability [Organism Attribute]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "cellcell adhesion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001511:Adhesion [Pathologic Function]
   861   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "coupled with its capacity to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C1516240:Capacity [Quantitative Concept]
   760   C1948027:Coupled [Functional Concept]
   726 E C0010222:couple [Family Group]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cell motility"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0007608:cell motility [Cell Function]
           Motility
   861   C0678835:Motility [Laboratory or Test Result]
   861   C1510470:Motility [Organism Function]
   789 E C1979933:Motile [Finding]

Phrase: "and"

Phrase: "proliferation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "corroborates"

Phrase: "that constitutive receptor signaling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1514762:Receptor Signaling [Molecular Function]
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]

Phrase: "can"

Phrase: "coordinately"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "multiple biological activities"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0005532:Biological [Biomedical Occupation or Discipline]
   827   C0205460:biological [Qualitative Concept]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "associated with tumor progression"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0178874:Tumor Progression [Neoplastic Process]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0027651:Tumor [Neoplastic Process]
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]
   770   C1578706:Tumor [Intellectual Product]
   770   C3273930:Tumor [Finding]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "invasion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1269955:Invasion [Finding]
  1000   C2699153:Invasion [Pathologic Function]
Processing 00000000.tx.275: Furthermore, our findings, in conjunction with those of Ide et al. 

Phrase: "Furthermore,"

Phrase: "our findings,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "in conjunction with those"

Phrase: "of Ide et al."
Processing 00000000.tx.276: (2002), suggest that inhibition of epithelial CSF-1R signaling may prove to be a valuable strategy in the treatment of invasive tumors. 

Phrase: "(2002"

Phrase: ")"

Phrase: ","

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that inhibition of epithelial CSF-1R signaling"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C1514761:Receptor Inhibition [Cell Function]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]

Phrase: "may"

Phrase: "prove"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a valuable strategy in the treatment of invasive tumors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0679199:strategy [Mental Process]
Processing 00000000.tx.277: This may be of particular relevance to malignancies that exhibit a discohesive phenotype. 

Phrase: "This"

Phrase: "may"

Phrase: "be of particular relevance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C2347946:Relevance [Qualitative Concept]
   770   C2987476:Be [Conceptual Entity]

Phrase: "to malignancies"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0006826:MALIGNANCIES [Neoplastic Process]
   966 E C1306459:Malignancy [Finding]
   916 E C0205282:Malignant [Qualitative Concept]
   916 E C0334590:MALIGNANT [Neoplastic Process]
   916 E C1533592:MALIGNANT [Neoplastic Process]

Phrase: "that"

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a discohesive phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.278: Although often attributable to loss or silencing of the CDH1 locus, a loss of membrane E-cadherin in tumors has also been observed in the absence of a genetic lesion, suggesting that in vivo perturbations of cell adhesion may also involve posttranslational mechanisms (Kowalski et al., 2003).  

Phrase: "Although"

Phrase: "often attributable to loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596130:Attributable [Mental Process]

Phrase: "or"

Phrase: "silencing of the CDH1 locus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0858952:silence [Mental or Behavioral Dysfunction]

Phrase: "a loss of membrane E-cadherin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "in tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027651:Tumors [Neoplastic Process]
   966 E C1578706:Tumor [Intellectual Product]
   966 E C3273930:Tumor [Finding]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "observed in the absence of a genetic lesion,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   771   C0449402:Origin of lesion [Finding]
   744   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   744   C0221198:Lesion [Finding]
   744   C0314603:Genetic [Functional Concept]
   744   C0332197:absence [Quantitative Concept]
   744   C1441672:Observed [Functional Concept]
   744   C1546698:Lesion [Intellectual Product]
   744   C1689985:Absence [Anatomical Abnormality]
   729   C0744369:Genital Lesion [Finding]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that in vivo perturbations of cell adhesion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0332453:perturbation [Functional Concept]

Phrase: "may"

Phrase: "also"

Phrase: "involve"

Phrase: "posttranslational mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "(Kowalski et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.279: Materials and methods Top Abstract Introduction Results Discussion Materials and methods References  Cell culture and reagents MCF-10A cells were obtained from American Type Culture Collection and cultured in DME/F12 (Invitrogen) supplemented with 5% donor horse serum, 20 ng/ml EGF, 10 g/ml insulin, 0.5 g/ml hydrocortisone, 100 ng/ml cholera toxin, 50 U/ml penicillin, and 50 mg/ml streptomycin. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cell culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "reagents MCF-10A cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "obtained from American Type Culture Collection"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   882   C0598079:American Type Culture Collection [Intellectual Product]
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0332307:Type [Qualitative Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C0596070:American [Population Group]
   753   C1301820:Obtained [Functional Concept]
   753   C1516698:Collection [Functional Concept]
   753   C1547052:*Type [Quantitative Concept]
   753   C1704814:Collection [Idea or Concept]
   753   C2242979:Culture [Laboratory Procedure]
   719 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "cultured in DME/F12 (Invitrogen"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0058217:DME [Hazardous or Poisonous Substance,Organic Chemical]
   760   C0641456:dme [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C1414499:F12 [Gene or Genome]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: ")"

Phrase: "supplemented with 5% donor horse serum,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C1518416:Serum, Horse [Immunologic Factor]
   753   C0013018:Donor [Population Group]
   753   C0019944:Horse [Mammal]
   753   C0040288:Donor [Population Group]
   753   C0229671:Serum [Body Substance]
   753   C0242616:Horse [Mammal]
   753   C1265527:Horse [Mammal]
   753   C1527169:Donor NOS [Finding]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "20 ng/ml EGF,"

Phrase: "10 g/ml insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "0.5 g/ml hydrocortisone,"
Meta Candidates (Total=7; Excluded=6; Pruned=0; Remaining=1)
   804   C0020268:Hydrocortisone [Hormone,Pharmacologic Substance,Steroid]
   748 E C0699383:Cortenema [Pharmacologic Substance,Steroid]
   748 E C0699388:Cort-Dome [Hormone,Pharmacologic Substance,Steroid]
   748 E C0699389:Cortef [Hormone,Pharmacologic Substance,Steroid]
   748 E C0699393:Eldecort [Hormone,Pharmacologic Substance,Steroid]
   748 E C0699396:Hydrocortone [Hormone,Pharmacologic Substance,Steroid]
   748 E C0699402:Cortril [Hormone,Pharmacologic Substance,Steroid]

Phrase: "100 ng/ml cholera toxin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0008356:Cholera Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   804   C0008354:Cholera [Disease or Syndrome]
   804   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "50 U/ml penicillin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030842:Penicillin [Antibiotic,Organic Chemical]
   812   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "50 mg/ml streptomycin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038425:Streptomycin [Antibiotic,Carbohydrate]
Processing 00000000.tx.280: Growth factorreduced MatrigelTM (BD Biosciences) with protein concentrations between 9 and 11 mg/ml was used. 

Phrase: "Growth factorreduced MatrigelTM"

Phrase: "(BD Biosciences"

Phrase: ")"

Phrase: "with protein concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427716:Protein concentration [Laboratory Procedure]
   983   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "between 9"

Phrase: "and"

Phrase: "11 mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439294:mg ml [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.281: Antibodies to CSF-1R and c-Met were obtained from Santa Cruz Biotechnology, Inc.; 

Phrase: "Antibodies to CSF-1R"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   783   C0034805:antibodies receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   716   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "and"

Phrase: "c-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Met"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Meet [Idea or Concept]

Phrase: "were"

Phrase: "obtained from Santa Cruz Biotechnology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "Inc."

Phrase: ";"
Processing 00000000.tx.282: laminin 5 from Chemicon; 

Phrase: "laminin 5 from Chemicon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0171955:laminin-5 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.283: E-cadherin, -catenin, -catenin, and p120ctn from BD Transduction Labs; 

Phrase: "E-cadherin, -"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0042172:E-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0694872:E-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413274:cadherin [Gene or Genome]

Phrase: "catenin, -"

Phrase: "catenin,"

Phrase: "and"

Phrase: "p120ctn from BD Transduction Labs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1413800:p120ctn [Gene or Genome]
   760   C2698947:P120CTN [Gene or Genome]
   760   C2699128:p120ctn [Amino Acid, Peptide, or Protein]

Phrase: ";"
Processing 00000000.tx.284: Ki-67 from Zymed Laboratories; 

Phrase: "Ki-67 from Zymed Laboratories"

Phrase: ";"
Processing 00000000.tx.285: phospho-Src(Y416) from New England Biolabs, Inc.; 

Phrase: "phospho-Src"

Phrase: "(Y416"

Phrase: ")"

Phrase: "from New England Biolabs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027965:New England [Geographic Area]

Phrase: "Inc."

Phrase: ";"
Processing 00000000.tx.286: and cleaved caspase-3 and phospho-CSF-1R(Y723) from Cell Signaling Technologies. 

Phrase: "and"

Phrase: "cleaved caspase-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "phospho-CSF-1R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   937   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(Y723"

Phrase: ")"

Phrase: "from Cell Signaling Technologies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0039421:technologies [Occupation or Discipline]
   734   C0037083:Cell Signaling [Cell Function]
Processing 00000000.tx.287: Src Mo327 has been previously described (Lipsich et al., 1983). 

Phrase: "Src Mo327"

Phrase: "has"

Phrase: "been"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Lipsich et al.,"

Phrase: "1983"

Phrase: ")."
Processing 00000000.tx.288: Src inhibitor SU6656 (Sugen, Inc.) was used at 2 M. 

Phrase: "Src inhibitor SU6656"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0962522:SU6656 [Organic Chemical,Pharmacologic Substance]

Phrase: "(Sugen,"

Phrase: "Inc.)"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "at 2 M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.289: Retroviral vectors pBabe-puro CSF-1 was constructed using an EcoRI fragment of pSMX human CSF-1 4.0 (Roussel et al., 1987). 

Phrase: "Retroviral vectors pBabe-puro CSF-1"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   827   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1150625:CSF-1 [Molecular Function]
   827   C1514926:retroviral vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0035366:Retroviral [Virus]
   799   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0442335:Vectors [Spatial Concept]
   799   C3540512:CSF [Therapeutic or Preventive Procedure]
   766 E C1705099:Vector [Idea or Concept]

Phrase: "was"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an EcoRI fragment of pSMX human CSF-1 4.0"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0332255:fragment [Functional Concept]
   739   C1708096:Fragment [Qualitative Concept]

Phrase: "(Roussel et al.,"

Phrase: "1987"

Phrase: ")."
Processing 00000000.tx.290: pMSCV human CSF-1R and CSF-1R L301S/Y969F were provided by O. 

Phrase: "pMSCV human CSF-1R"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "CSF-1R L301S/Y969F"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "were"

Phrase: "provided by O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1999230:Provided [Activity]
Processing 00000000.tx.291: Witte (University of California, Los Angeles, CA). 

Phrase: "Witte"

Phrase: "(University of California,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006754:California [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
   827   C3146274:California [Plant]

Phrase: "Los Angeles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024015:Los Angeles [Geographic Area]

Phrase: "CA)."
Processing 00000000.tx.292: The Y561F mutant receptor was generated by QuickChange (Stratagene) site-directed mutagenesis using the following primers: forward, 5'-gagggcaacagttTtactttcatcgaccc-3'; 

Phrase: "The Y561F mutant receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "was"

Phrase: "generated by QuickChange"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3146294:Generated [Activity]

Phrase: "(Stratagene"

Phrase: ")"

Phrase: "site-directed mutagenesis"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
  1000   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   827   C0079866:Mutagenesis [Molecular Function]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   827   C3146302:Mutagenesis [Laboratory Procedure]
   793   C0439851:Direct [Qualitative Concept]
   793   C1947931:Direct [Qualitative Concept]
   755 E C0439755:Directions [Spatial Concept]
   755 E C0449738:Direction [Spatial Concept]
   711 E C1707761:Directionality [Functional Concept]
   711 E C3274524:Directionality [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the following primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "forward, 5'-gagggcaacagttTtactttcatcgaccc-3'"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439780:Forward [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.293: reverse, 5'-gggtcgatgaaagtaAaactgttgccctc-3'. 

Phrase: "reverse, 5'-gggtcgatgaaagtaAaactgttgccctc-3'."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.294: pBabe-puro c-Met was constructed from pSP64 c-Met (Iyer et al., 1990). 

Phrase: "pBabe-puro"

Phrase: "c-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Met"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Meet [Idea or Concept]

Phrase: "was"

Phrase: "constructed from pSP64 c-Met (Iyer et al.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C2827421:Construct [Classification]

Phrase: "1990"

Phrase: ")."
Processing 00000000.tx.295: pBabe-puro HGF was obtained from the Harvard Institute of Proteomics FLEX library. 

Phrase: "pBabe-puro HGF"

Phrase: "was"

Phrase: "obtained from the Harvard Institute of Proteomics FLEX library."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   742   C0021622:institute [Organization]
   742   C0023621:Library [Manufactured Object,Organization]
   742   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0872252:Proteomics [Biomedical Occupation or Discipline]
   742   C1272753:Institute [Idea or Concept]
   742   C1301820:Obtained [Functional Concept]
   708 E C1706701:Obtain [Activity]
Processing 00000000.tx.296: pLNCX DN-Src(K295R) has been previously described (Mukhopadhyay et al., 1995). 

Phrase: "pLNCX DN-Src(K295R"

Phrase: ")"

Phrase: "has"

Phrase: "been"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Mukhopadhyay et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.297: Ecotropic retroviruses were produced by transfection of the PhoenixTM ECO packaging line (Swift et al., 1999) with 15 g of DNA using Lipofectamine 2000TM (Invitrogen). 

Phrase: "Ecotropic retroviruses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035366:Retroviruses [Virus]

Phrase: "were"

Phrase: "produced by transfection of the PhoenixTM ECO packaging line"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   742   C0013194:Packaging [Medical Device]
   742   C0030176:Packaging [Human-caused Phenomenon or Process]
   742   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   742   C0205132:Line [Spatial Concept]
   742   C1550648:Line [Substance]
   742   C1552960:Line [Quantitative Concept]
   742   C2675227:ECO [Disease or Syndrome]
   742   C2828395:Packaging [Activity]
   708 E C2700580:Package [Manufactured Object]

Phrase: "(Swift et al.,"

Phrase: "1999"

Phrase: ")"

Phrase: "with 15 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "of DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Lipofectamine 2000TM"

Phrase: "(Invitrogen"

Phrase: ")."
Processing 00000000.tx.298: Viral supernatants were collected on day 4 after transfection and passed through a 0.45-m filter before storage at 80C. 

Phrase: "Viral supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "collected on day 4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0332173:/day [Temporal Concept]
   770   C0439228:day [Temporal Concept]
   770   C0439505:/day [Temporal Concept]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]

Phrase: "after transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "passed through a 0.45-m filter"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0180860:Filter [Manufactured Object]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C0581406:Filter [Medical Device]
   748   C1522664:Filter [Intellectual Product]
   748   C1704449:Filter [Conceptual Entity]
   748   C1704684:Filter [Medical Device]
   748   C1875155:FILTER [Medical Device]
   748   C2828386:Passed [Finding]

Phrase: "before storage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0337174:Storage [Spatial Concept]
  1000   C1698986:Storage [Functional Concept]
  1000   C1753314:storage [Cell Component]

Phrase: "at 80C."
Processing 00000000.tx.299: Generation of MCF-10A cell lines MCF-10A cells expressing the ecotropic receptor (derived by infection with pWZLneo mEcoR retrovirus, obtained from G. Daley, Harvard Medical School, Boston, MA) were plated at 4 x 105 cells per 10-cm dish and infected with the above retroviruses. 

Phrase: "Generation of MCF-10A cell lines MCF-10A cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0079411:Generation [Temporal Concept]
   742   C3146294:Generation [Activity]

Phrase: "expressing"

Phrase: "the ecotropic receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "("

Phrase: "derived by infection"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0009450:Infection, NOS [Disease or Syndrome]
   790   C1441547:Derived [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]
   718 E C0439663:Infected [Functional Concept]

Phrase: "with pWZLneo mEcoR retrovirus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035366:Retrovirus [Virus]

Phrase: "obtained from G. Daley,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0439267:g% [Quantitative Concept]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "Harvard Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA)"

Phrase: "were"

Phrase: "plated at 4 x 105 cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   767   C1166718:cells plate [Cell Component]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719   C0005971:Plate [Medical Device]
   719   C1139930:plate [Medical Device]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
   719   C3537155:Plate [Manufactured Object]

Phrase: "per 10-cm dish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020498:DISH [Disease or Syndrome]

Phrase: "and"

Phrase: "infected with the above retroviruses."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035366:Retroviruses [Virus]
   760   C0439663:Infected [Functional Concept]
Processing 00000000.tx.300: Stable populations were obtained by selection with 2 g/ml puromycin or 200 g/ml G418 (Sigma-Aldrich). 

Phrase: "Stable populations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038116:Stable Population [Quantitative Concept]
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "were"

Phrase: "obtained by selection"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0036576:selection [Genetic Function]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "with 2 g/ml puromycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0034145:Puromycin [Antibiotic,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "200 g/ml G418"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0052009:G418 [Antibiotic,Organic Chemical]

Phrase: "(Sigma-Aldrich"

Phrase: ")."
Processing 00000000.tx.301: CSF-1R, c-Met, and Src overexpression were confirmed by immunoblotting. 

Phrase: "CSF-1R,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "c-Met,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456828:C-MET [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1704823:C-MET [Gene or Genome]

Phrase: "and"

Phrase: "Src overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514559:Overexpression [Genetic Function]

Phrase: "were"

Phrase: "confirmed by immunoblotting."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0750484:Confirmed [Idea or Concept]
   756 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.302: Conditioned media from cells expressing CSF-1 was assayed for ligand activity using the Quantikine CSF-1 ELISA Kit (R&D Systems). 

Phrase: "Conditioned media from cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "expressing"

Phrase: "CSF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "assayed for ligand activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0023688:Ligand [Chemical]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Quantikine CSF-1 ELISA Kit (R&D Systems"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   855   C0080092:CSF-1-R [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor,Receptor]
   793   C0205090:R- [Spatial Concept]
   793   C0684010:R. [Professional or Occupational Group]
   793   C2603358:R' [Clinical Attribute]
   760   C0449913:System [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]
   710 E C0205373:Systemic [Functional Concept]

Phrase: ")."
Processing 00000000.tx.303: Immunoprecipitation and immunoblotting Monolayers were washed once in PBS and lysed in 1 ml Triton lysis buffer (0.5% Triton X-100, 25 mM Tris pH 7.5, 150 mM NaCl, 2 mM CaCl2) or RIPA buffer (1% Triton X-100, 1% NaDOC, 0.1% SDS, 20 mM Tris, pH 7.5, 150 mM NaCl, 1 mM EDTA) supplemented with protease and phosphatase inhibitors (1 g/ml leupeptin, 1 g/ml aprotinin, 1 g/ml pepstatin, 10 g/ml PMSF, 1 mM NaVO4, 1 mM NaF) for 15 or 30 min at 4C, respectively. 

Phrase: "Immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "immunoblotting Monolayers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0872351:monolayers [Clinical Drug]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "once in PBS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720092:Once [Intellectual Product]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C1948045:Once [Temporal Concept]

Phrase: "and"

Phrase: "lysed in 1 ml Triton lysis buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0024348:Lysis [Pathologic Function]
           lysed
   748   C0242759:Triton [Geographic Area]
   748   C0439526:/mL [Quantitative Concept]
   748   C1536403:lysis [Cell Function]

Phrase: "(0.5% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "25 mM Tris pH 7.5,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C1882074:pH 7 [Qualitative Concept]
   799   C0020283:[pH] [Quantitative Concept]
   799   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   799   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   799   C0450407:ph+ [Finding]
   799   C0450408:ph++ [Finding]
   799   C0450409:ph+++ [Finding]
   799   C0814229:TRI [Intellectual Product]

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "2 mM CaCl2"

Phrase: ")"

Phrase: "or"

Phrase: "RIPA buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "1% NaDOC,"

Phrase: "0.1% SDS,"

Phrase: "20 mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "1 mM EDTA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "supplemented with protease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C1947941:Protease [Enzyme]
   756   C0242295:Supplement [Food]
   756   C1947943:Supplement [Intellectual Product]
   756   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "phosphatase inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0597217:phosphatase inhibitor [Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(1 g/ml leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "1 g/ml aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "1 g/ml pepstatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "10 g/ml PMSF,"

Phrase: "1 mM NaVO4,"

Phrase: "1 mM NaF) for 15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0037508:NaF [Biomedical or Dental Material,Inorganic Chemical]
   760   C1366571:NAF [Gene or Genome]
   760   C1705592:NAF [Gene or Genome]

Phrase: "or"

Phrase: "30 min at 4C,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "respectively."
Processing 00000000.tx.304: Lysates were cleared 15 min at 13,000 rpm and supernatants were collected. 

Phrase: "Lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "cleared"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521097:cleared [Functional Concept]
   966 E C2963144:Clear [Qualitative Concept]

Phrase: "15 min at 13,000 rpm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "collected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]
Processing 00000000.tx.305: Triton-insoluble (TI) pellets were resuspended in 2x SDS sample buffer. 

Phrase: "Triton-insoluble"

Phrase: "(TI"

Phrase: ")"

Phrase: "pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0993610:pellets [Biomedical or Dental Material]
   966 E C0441436:Pellet [Manufactured Object]
   966 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "resuspended in 2x SDS sample buffer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0370003:Sample [Substance]
   753   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.306: For immunoprecipitations, 500 g total protein in 500 l total volume was incubated with 1 g primary antibody for 1 h at 4C with rocking. 

Phrase: "For immunoprecipitations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "500 g total protein in 500 l total volume"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   764   C0555903:Total protein [Laboratory Procedure]
   764   C1261360:total protein [Laboratory or Test Result]
   762   C0060916:protein g [Amino Acid, Peptide, or Protein]
   762   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   762 E C0439177:Protein.total [Quantitative Concept]
   762   C0449468:Total Volume [Quantitative Concept]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0439175:% total [Quantitative Concept]
   742   C0439810:Total [Qualitative Concept]

Phrase: "was"

Phrase: "incubated with 1 g primary antibody"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C0369247:G Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0205225:Primary [Qualitative Concept]
   753   C0439267:g% [Quantitative Concept]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "with rocking."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005899:Rocking [Individual Behavior]
Processing 00000000.tx.307: 40 l of a protein G Sepharose slurry (Amersham Biosciences) was added for an additional 40 min. 

Phrase: "40 l of a protein G Sepharose slurry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   767   C0439294:g l [Quantitative Concept]

Phrase: "(Amersham Biosciences"

Phrase: ")"

Phrase: "was"

Phrase: "added for an additional 40 min."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0439509:/40 [Temporal Concept]
   753   C0702093:/min [Temporal Concept]
   753   C1524062:Added [Functional Concept]
           Additional
   719 E C1883712:Add [Functional Concept]
Processing 00000000.tx.308: Immune complexes were washed four times in lysis buffer before elution in 60 l 2x SDS sample buffer. 

Phrase: "Immune complexes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003313:Immune Complexes [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439662:Immune [Functional Concept]
   861   C1704241:Complexes [Chemical Viewed Structurally]
   827 E C0439855:Complex [Qualitative Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "four times in lysis buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "before elution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441565:Elution [Laboratory Procedure]

Phrase: "in 60 l 2x SDS sample buffer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.309: Immunoprecipitates or cell lysates were resolved by 810% SDS-PAGE and immunoblotted using standard techniques. 

Phrase: "Immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "or"

Phrase: "cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "resolved by 810% SDS-PAGE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C1514893:Resolved [Idea or Concept]
   760   C1704732:Page [Intellectual Product]
   760   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "immunoblotted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "standard techniques."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025664:techniques [Intellectual Product]
   861   C0449851:Techniques [Functional Concept]
Processing 00000000.tx.310: For fractionation experiments, equivalent amounts of supernatant (TS) protein were loaded along with a proportionate volume of each TI sample. 

Phrase: "For fractionation experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "equivalent amounts of supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "(TS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1749467:soluble [Cell Component]
   861   C1948047:Soluble [Qualitative Concept]

Phrase: ")"

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "loaded along with a proportionate volume of each TI sample."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   772   C0427785:Volume of sample [Laboratory Procedure]
   738   C0205351:Proportionate [Qualitative Concept]
   738   C0242759:Triton [Geographic Area]
   738   C0370003:Sample [Substance]
   738   C0449468:*Volume [Quantitative Concept]
   738   C1690016:% volume [Qualitative Concept]
   738   C1705102:Volume [Intellectual Product]
   738   C1708715:Loaded [Activity]
   738   C2347026:Sample [Conceptual Entity]
   738   C2700258:Volume [Laboratory Procedure]
   704 E C1550025:Load [Idea or Concept]
   704 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.311: Morphogenesis assay The 3D culture of MCF-10A cells on basement membrane was performed as previously described (Debnath et al., 2003). 

Phrase: "Morphogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026559:Morphogenesis [Organism Function]

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "The 3D culture of MCF-10A cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0007585:cells culture [Laboratory Procedure]
   748   C0010453:Culture [Idea or Concept]
   748   C0220814:culture [Functional Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C2242979:Culture [Laboratory Procedure]

Phrase: "on basement membrane"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0004799:Basement membrane [Tissue]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   861   C1979853:Basement [Cell Component]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "performed as previously"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Debnath et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.312: Assay media (DME/F12 supplemented with 2% donor horse serum, 10 g/ml insulin, 0.5 g/ml hydrocortisone, 100 ng/ml cholera toxin, 50 U/ml penicillin, and 50 mg/ml streptomycin) containing 5 ng/ml EGF, 10 ng/ml CSF-1 (R&D Systems), or 40 ng/ml HGF (Van Andel Institute) was replaced every 4 d unless otherwise noted. 

Phrase: "Assay media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "(DME/F12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1414499:F12 [Gene or Genome]

Phrase: "supplemented with 2% donor horse serum,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C1518416:Serum, Horse [Immunologic Factor]
   753   C0013018:Donor [Population Group]
   753   C0019944:Horse [Mammal]
   753   C0040288:Donor [Population Group]
   753   C0229671:Serum [Body Substance]
   753   C0242616:Horse [Mammal]
   753   C1265527:Horse [Mammal]
   753   C1527169:Donor NOS [Finding]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "10 g/ml insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "0.5 g/ml hydrocortisone,"
Meta Candidates (Total=7; Excluded=6; Pruned=0; Remaining=1)
   804   C0020268:Hydrocortisone [Hormone,Pharmacologic Substance,Steroid]
   748 E C0699383:Cortenema [Pharmacologic Substance,Steroid]
   748 E C0699388:Cort-Dome [Hormone,Pharmacologic Substance,Steroid]
   748 E C0699389:Cortef [Hormone,Pharmacologic Substance,Steroid]
   748 E C0699393:Eldecort [Hormone,Pharmacologic Substance,Steroid]
   748 E C0699396:Hydrocortone [Hormone,Pharmacologic Substance,Steroid]
   748 E C0699402:Cortril [Hormone,Pharmacologic Substance,Steroid]

Phrase: "100 ng/ml cholera toxin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0008356:Cholera Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   804   C0008354:Cholera [Disease or Syndrome]
   804   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "50 U/ml penicillin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030842:Penicillin [Antibiotic,Organic Chemical]
   812   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "50 mg/ml streptomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5 ng/ml EGF,"

Phrase: "10 ng/ml CSF-1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   875   C0964553:NG.1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C1334110:NG.1 [Gene or Genome]
   840   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C0439275:ng/mL [Quantitative Concept]
   840   C1150625:CSF-1 [Molecular Function]
   804   C0439526:/mL [Quantitative Concept]
   804   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "(R&D Systems"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "40 ng/ml HGF (Van Andel Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0021622:institute [Organization]
   795   C1272753:Institute [Idea or Concept]

Phrase: ")"

Phrase: "was"

Phrase: "replaced"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0559956:Replaced [Functional Concept]
  1000   C1299987:replaced [Functional Concept]
   966 E C1554078:Replace [Idea or Concept]

Phrase: "every 4 d"

Phrase: "unless"

Phrase: "otherwise"

Phrase: "noted."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]
Processing 00000000.tx.313: Where noted, SU6656 (2 M) was added every 48 h without replacement of media. 

Phrase: "Where"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: ","

Phrase: "SU6656"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0962522:SU6656 [Organic Chemical,Pharmacologic Substance]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "M)"

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "every 48 h without replacement of media."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441932:H+ [Classification]
   748   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.314: Cell compaction assay Monolayers were harvested by treatment with 0.05% trypsin or 5 mM EDTA in PBS for 30 min. 

Phrase: "Cell compaction assay Monolayers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0872351:monolayers [Clinical Drug]

Phrase: "were"

Phrase: "harvested by treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   756   C1512335:Harvest [Health Care Activity]

Phrase: "with 0.05% trypsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "or"

Phrase: "5 mM EDTA in PBS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "for 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.315: 3 x 105 cells were resuspended in 1.5 ml assay media  10 ng/ml CSF-1 and incubated for up to 12 h in 35-mm dishes precoated with polyHEMA (6 mg/ml in 95% ethanol). 

Phrase: "3 x 105 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "resuspended"

Phrase: "in 1.5 ml assay media  10 ng/ml CSF-1"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   846   C1623737:mL/mL [Quantitative Concept]
   846   C3539687:mL/mL [Quantitative Concept]
   804   C0450316:1/5 [Quantitative Concept]
   790   C0005507:Assay [Laboratory Procedure]
   790   C0009458:Media [Intellectual Product]
   790   C0162867:Media [Tissue]
   790   C0243073:assay [Qualitative Concept]
   790   C0439526:/mL [Quantitative Concept]
   790   C1254021:Media [Tissue]
   790   C1510438:Assay [Laboratory Procedure]
   790   C2827734:1+ [Quantitative Concept]
   790   C2981698:1+ [Classification]
   790   C3540512:CSF [Therapeutic or Preventive Procedure]
   756 E C0439536:Medium [Quantitative Concept]
   756 E C1705217:Medium [Substance]
   756 E C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "incubated for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "up to 12 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "in 35-mm dishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0020498:DISH [Disease or Syndrome]

Phrase: "precoated with polyHEMA"

Phrase: "(6 mg/ml in 95% ethanol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439294:mg ml [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.316: Cell aggregates were harvested by centrifugation at 200 rpm and washed once in PBS before suspension in molten 0.5% agarose. 

Phrase: "Cell aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "were"

Phrase: "harvested by centrifugation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   756   C1512335:Harvest [Health Care Activity]

Phrase: "at 200 rpm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0582523:rpm [Quantitative Concept]

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "once in PBS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720092:Once [Intellectual Product]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C1948045:Once [Temporal Concept]

Phrase: "before suspension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038960:Suspension [Biomedical or Dental Material]
  1000   C1382107:Suspension [Substance]
  1000   C1705537:Suspension [Functional Concept]

Phrase: "in molten 0.5% agarose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0036681:Agarose [Carbohydrate]
Processing 00000000.tx.317: Aliquots of resuspended aggregates were dropped onto 1-mm glass slides and allowed to solidify. 

Phrase: "Aliquots of resuspended aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "dropped onto 1-mm glass slides"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   783   C1418486:MM-1 [Gene or Genome]
   753   C0017596:Glass [Manufactured Object]
   753   C0444330:slides [Research Device]
   753   C1705648:Dropped [Activity]
   753   C1947936:Glass [Medical Device]
   719 E C1321095:Drop [Quantitative Concept]
   719 E C1705201:Slide [Manufactured Object]
   719 E C2347093:Drop [Quantitative Concept]
   719 E C2348338:Drop [Quantitative Concept]

Phrase: "and"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "solidify."
Processing 00000000.tx.318: DIC imaging was performed on a Nikon TE300 equipped with a CCD camera; 

Phrase: "DIC"

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "was"

Phrase: "performed on a Nikon TE300"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "equipped with a CCD camera"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0598124:CCD camera [Manufactured Object]
   760   C0179533:Camera [Medical Device]
   760   C1654607:Camera [Eukaryote]
   760   C1706254:CAMERA [Medical Device]

Phrase: ";"
Processing 00000000.tx.319: images were acquired using MetaMorph Version 4.6r6. 

Phrase: "images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "acquired"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0439661:Acquired [Temporal Concept]
  1000   C3245488:acquired [Intellectual Product]
   966 E C1706701:Acquire [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "MetaMorph Version 4.6r6."
Processing 00000000.tx.320: Wound healing assay MCF-10A cells were seeded on glass coverslips at 5 x 104 cells per well and grown to confluence before overnight starvation in assay media. 

Phrase: "Wound healing assay MCF-10A cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded on glass coverslips"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0017596:Glass [Manufactured Object]
   770   C1947936:Glass [Medical Device]
   737   C0036563:Seed [Plant]
   737   C1705192:Seed [Laboratory Procedure]
   737   C1882540:{Seed} [Quantitative Concept]
   737   C2346495:Seed [Conceptual Entity]

Phrase: "at 5 x 104 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "per well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "grown to confluence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0205200:Confluent [Qualitative Concept]

Phrase: "before overnight starvation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038187:Starvation [Finding]

Phrase: "in assay media."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.321: A single wound was introduced in the monolayer using a micropipette tip, and the media replaced with assay media  10 ng/ml CSF-1 containing 1 g/ml mitomycin C (Sigma-Aldrich). 

Phrase: "A single wound"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043250:Wound [Injury or Poisoning]

Phrase: "was"

Phrase: "introduced in the monolayer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0872351:monolayer [Clinical Drug]
   737   C1292748:introduce [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a micropipette tip,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1710425:Tip [Medical Device]
   861   C3282898:Tip [Qualitative Concept]

Phrase: "and"

Phrase: "the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "replaced with assay media  10 ng/ml CSF-1"
Meta Candidates (Total=19; Excluded=4; Pruned=0; Remaining=15)
   764   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   764   C0439275:ng/mL [Quantitative Concept]
   764   C1150625:CSF-1 [Molecular Function]
   762   C0964553:NG.1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C1334110:NG.1 [Gene or Genome]
   742   C0005507:Assay [Laboratory Procedure]
   742   C0009458:Media [Intellectual Product]
   742   C0162867:Media [Tissue]
   742   C0243073:assay [Qualitative Concept]
   742   C0439526:/mL [Quantitative Concept]
   742   C0559956:Replaced [Functional Concept]
   742   C1254021:Media [Tissue]
   742   C1299987:replaced [Functional Concept]
   742   C1510438:Assay [Laboratory Procedure]
   742   C3540512:CSF [Therapeutic or Preventive Procedure]
   708 E C0439536:Medium [Quantitative Concept]
   708 E C1554078:Replace [Idea or Concept]
   708 E C1705217:Medium [Substance]
   708 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1 g/ml mitomycin C"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   840   C0002475:Mitomycin C [Antibiotic,Organic Chemical]
           Mitomycin
   804   C0026254:mitomycin [Organic Chemical,Pharmacologic Substance]
   748 E C0702051:Mutamycin [Antibiotic,Organic Chemical]

Phrase: "(Sigma-Aldrich"

Phrase: ")."
Processing 00000000.tx.322: Wound closure was monitored for 48 h. 

Phrase: "Wound closure"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0450015:Wound closure [Functional Concept]
  1000   C1112446:Wound closure [Therapeutic or Preventive Procedure]
   861   C0185003:Closure [Therapeutic or Preventive Procedure]
   861   C1521802:Closure [Research Activity]
   805 E C0447303:Occlusal [Body Location or Region]
   805 E C0591895:occlusal [Organic Chemical,Pharmacologic Substance]
   805 E C1947917:Occlusal [Functional Concept]

Phrase: "was"

Phrase: "monitored for 48 h."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]
Processing 00000000.tx.323: Immunofluorescence analysis and image acquisition Monolayers were fixed 8 h after wounding for 20 min in 2% formalin, permeabilized 5 min with 0.2% Triton at 4C, and washed three times in PBS. 

Phrase: "Immunofluorescence analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "image acquisition Monolayers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0872351:monolayers [Clinical Drug]
   734   C1708464:Image Acquisition [Machine Activity]

Phrase: "were"

Phrase: "fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: "8 h after wounding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "for 20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "in 2% formalin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0949307:Formalin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "permeabilized"

Phrase: "5 min with 0.2% Triton"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0702093:/min [Temporal Concept]

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "and"

Phrase: "washed three times in PBS."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.324: Coverslips were blocked for 30 min in PBS + 10% goat serum and incubated 45 min each in primary and secondary antibody diluted 1:100 in block, followed by three PBS washes. 

Phrase: "Coverslips"

Phrase: "were"

Phrase: "blocked for 30 min"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C0702093:/min [Temporal Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "in PBS + 10% goat serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0229671:Serum [Body Substance]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "45 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "each in primary"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205225:Primary [Qualitative Concept]
   790   C0439631:Primary [Therapeutic or Preventive Procedure]
   790   C1457900:Each [Quantitative Concept]

Phrase: "and"

Phrase: "secondary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100 in block,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0028778:Block [Pathologic Function]
   790   C0332206:Block [Functional Concept]
   790   C1533157:Block [Substance]
   790   C1706084:Block [Geographic Area]
   790   C2828370:Block [Quantitative Concept]
   718 E C2983591:BLOCKED [Research Activity]

Phrase: "followed by three PBS washes."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0205449:Three [Quantitative Concept]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]
   726   C0441648:Wash [Activity]
   726 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.325: Cells were stained with DAPI, washed, and mounted on 1-mm glass slides with ProLong Antifade (Molecular Probes). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stained with DAPI,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0057142:DAPI [Organic Chemical,Pharmacologic Substance]
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "and"

Phrase: "mounted on 1-mm glass"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   797   C1418486:MM-1 [Gene or Genome]
   760   C0017596:Glass [Manufactured Object]
   760   C0449878:mounted [Finding]
   760   C1947936:Glass [Medical Device]
   726 E C0181909:Mount [Medical Device]

Phrase: "slides with"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0444330:Slide [Research Device]
   833   C1705201:Slide [Manufactured Object]

Phrase: "ProLong"

Phrase: "Antifade"

Phrase: "(Molecular Probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.326: Images were acquired on a Nikon TE300 using MetaMorph Version 4.6r6. 

Phrase: "Images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "acquired on a Nikon TE300"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0439661:Acquired [Temporal Concept]
   760   C3245488:acquired [Intellectual Product]
   726 E C1706701:Acquire [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "MetaMorph Version 4.6r6."
Processing 00000000.tx.327: Immunostaining of acinar structures was performed as previously described (Debnath et al., 2002). 

Phrase: "Immunostaining of acinar structures"

Phrase: "was"

Phrase: "performed as previously"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Debnath et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.328: Confocal analyses were performed using either the Nikon E800 Bio-Rad Laboratories or Carl Zeiss MicroImaging, Inc. 

Phrase: "Confocal analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "either"

Phrase: "the Nikon E800 Bio-Rad Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0022877:Laboratories [Manufactured Object,Organization]
   804   C1619828:Laboratories [Intellectual Product]
   771 E C3244292:laboratory [Functional Concept]

Phrase: "or"

Phrase: "Carl Zeiss MicroImaging,"

Phrase: "Inc."
Processing 00000000.tx.329: LSM410 confocal microscopy systems. 

Phrase: "LSM410 confocal microscopy systems."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   779   C0449913:System [Functional Concept]
   779   C1553451:System [Manufactured Object]
   779   C1704459:System [Medical Device]
   729 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.330: Composite images were generated using MetaMorph Version 4.6r6 software. 

Phrase: "Composite images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "MetaMorph Version 4.6r6 software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.331: Online supplemental material The online supplemental material (Figs. S1 and S2) is available at http://www.jcb.org/cgi/content/full/jcb.200309102/DC1. 

Phrase: "Online supplemental material"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   851   C2936424:Supplementary Material [Intellectual Product]
   827   C0520510:Material [Substance]

Phrase: "The online supplemental material"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   851   C2936424:Supplementary Material [Intellectual Product]
   827   C0520510:Material [Substance]

Phrase: "(Figs. S1"

Phrase: "and"

Phrase: "S2)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1179705:S2 [Body Location or Region]
  1000   C1419032:S2 [Gene or Genome]
  1000   C1419718:S2 [Gene or Genome]

Phrase: "is"

Phrase: "available at http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: ":"

Phrase: "//www.jcb.org/cgi/content/full/jcb.200309102/DC1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C1415570:DC1 [Gene or Genome]
Processing 00000000.tx.332: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.333: S1 shows images that illustrate the progressive nature of the architectural disruption of MCF-10A acini expressing CSF-1 and CSF-1R. 

Phrase: "S1"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "that"

Phrase: "illustrate"

Phrase: "the progressive nature of the architectural disruption of MCF-10A acini"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0349590:Nature [Idea or Concept]
   738   C1262865:Nature [Functional Concept]

Phrase: "expressing"

Phrase: "CSF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "CSF-1R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.334: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.335: S2 shows images that illustrate that daily EGF treatment does not elicit the discohesive phenotype induced by similar treatment with CSF-1.  

Phrase: "S2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1179705:S2 [Body Location or Region]
  1000   C1419032:S2 [Gene or Genome]
  1000   C1419718:S2 [Gene or Genome]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "that"

Phrase: "illustrate"

Phrase: "that daily EGF treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "elicit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "the discohesive phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "induced by similar treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0205263:Induced [Functional Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C2348205:Similar [Qualitative Concept]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with CSF-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]
Processing 00000000.tx.336: Acknowledgments  We are grateful to Owen Witte for the CSF-1R retroviral constructs, Mina Bissell for contributions to the establishment of 3D acinar culture, and Charles J. 

Phrase: "Acknowledgments"

Phrase: "We"

Phrase: "are"

Phrase: "grateful to Owen Witte"

Phrase: "for the CSF-1R retroviral constructs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   766   C2827421:Construct [Classification]
   734   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "Mina Bissell for contributions"

Phrase: "to the establishment"

Phrase: "of 3D acinar culture,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "Charles J."
Processing 00000000.tx.337: Sherr for pioneering work on CSF-1R autocrine signaling in fibroblasts. 

Phrase: "Sherr for pioneering work"

Phrase: "on CSF-1R autocrine signaling"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   839   C1514762:Receptor Signaling [Molecular Function]
   827   C0525010:Autocrine Signaling [Cell Function]
   799   C0037083:Signaling [Cell Function]
   799   C3537152:signaling [Biologic Function]
   734   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "in fibroblasts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]
Processing 00000000.tx.338: We also thank George Vande Woude and Margaret Gustafson (Van Andel Research Institute, Grand Rapids, MI) for the generous gift of the c-Met cDNA and discussions of c-Met biology, and Barry Kacinski and Jeffrey Pollard for helpful discussions of CSF-1R signaling. 

Phrase: "We also"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "George Vande Woude"

Phrase: "and"

Phrase: "Margaret Gustafson"

Phrase: "(Van Andel Research Institute,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035172:Research Institute [Organization]
   812   C0021622:institute [Organization]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1272753:Institute [Idea or Concept]

Phrase: "Grand Rapids,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439831:Rapid [Qualitative Concept]

Phrase: "MI) for the generous gift of the c-Met cDNA"

Phrase: "and"

Phrase: "discussions of c-Met biology,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0557061:discussions [Therapeutic or Preventive Procedure]
   726 E C2584313:Discussion [Social Behavior]

Phrase: "and"

Phrase: "Barry Kacinski"

Phrase: "and"

Phrase: "Jeffrey Pollard for helpful discussions of CSF-1R signaling."
Processing 00000000.tx.339: This research was supported by grants from the American Cancer Society and the Department of Defense (J.S. Brugge), grants from the National Cancer Institute (J.S. Brugge and M.F. Roussel), a gift from the Virginia and D.K. 

Phrase: "This research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the American Cancer Society"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0002455:American Cancer Society [Professional Society]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0037455:society [Organization]
   827   C0596070:American [Population Group]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]

Phrase: "and"

Phrase: "the Department of Defense"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1511775:Department of Defense [Organization]
  1000   C3496101:Department of Defense [Health Care Related Organization]
   827   C1704729:Department [Organization]
   827   C1880266:Defense [Conceptual Entity]

Phrase: "(J.S. Brugge"

Phrase: ")"

Phrase: ","

Phrase: "grants from the National Cancer Institute"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0018173:Grants [Quantitative Concept]
   719 E C1548284:Grant [Idea or Concept]

Phrase: "(J.S. Brugge"

Phrase: "and"

Phrase: "M."

Phrase: "F. Roussel"

Phrase: ")"

Phrase: ","

Phrase: "a gift from the Virginia"

Phrase: "and"

Phrase: "D."

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.340: Ludwig Fund for Cancer Research (InterVivos) to Harvard Medical School (J.S. Brugge), contributions from the American Lebanese Syrian Associated Charities of St. 

Phrase: "Ludwig Fund for Cancer Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0681805:research fund [Research Activity]
   760   C0016820:Fund [Quantitative Concept]

Phrase: "(InterVivos"

Phrase: ")"

Phrase: "to Harvard Medical School"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "(J.S. Brugge"

Phrase: ")"

Phrase: ","

Phrase: "contributions from the American Lebanese Syrian Associated Charities of St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C1880177:Contribution [Activity]
Processing 00000000.tx.341: Jude Children's Research Hospital (M.F. Roussel), a Howard Hughes Medical Institute (HHMI) Predoctoral Fellowship (C.N. Wrobel), and an HHMI Physician Postdoctoral Fellowship (J. Debnath). 

Phrase: "Jude Children's Research Hospital"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   875   C0020017:Children's hospital [Health Care Related Organization]
   812   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   812   C1510665:Hospital [Qualitative Concept]
   729 E C1609061:Hospitals [Intellectual Product]

Phrase: "("

Phrase: "M."

Phrase: "F. Roussel"

Phrase: ")"

Phrase: ","

Phrase: "a Howard Hughes Medical Institute (HHMI) Predoctoral Fellowship"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0015770:Fellowship [Educational Activity]

Phrase: "(C.N. Wrobel"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "an HHMI Physician Postdoctoral Fellowship"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0015770:Fellowship [Educational Activity]

Phrase: "(J. Debnath"

Phrase: ")."
Processing 00000000.tx.342: Submitted: 17 September 2003 Accepted: 12 March 2004  References Top Abstract Introduction Results Discussion Materials and methods References  Adams, C.L., and W.J. 

Phrase: "Submitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]

Phrase: ":"

Phrase: "17 September 2003"

Phrase: "Accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: ":"

Phrase: "12 March 2004"

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Adams,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331762:Adams [Health Care Related Organization]

Phrase: "C.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "W.J."
Processing 00000000.tx.343: Nelson. 

Phrase: "Nelson."
Processing 00000000.tx.344: 1998. 

Phrase: "1998."
Processing 00000000.tx.345: Cytomechanics of cadherin-mediated cell-cell adhesion. 

Phrase: "Cytomechanics of cadherin-mediated cell-cell adhesion."
Processing 00000000.tx.346: Curr. 

Phrase: "Curr."
Processing 00000000.tx.347: Opin. 

Phrase: "Opin."
Processing 00000000.tx.348: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.349: 10:572577.[CrossRef][Medline] Adams, C.L., Y.T. 

Phrase: "10"

Phrase: ":"

Phrase: "572577."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Adams,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331762:Adams [Health Care Related Organization]

Phrase: "C.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Y.T."
Processing 00000000.tx.350: Chen, S.J. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "S."

Phrase: "J."
Processing 00000000.tx.351: Smith, and W.J. 

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "and"

Phrase: "W.J."
Processing 00000000.tx.352: Nelson. 

Phrase: "Nelson."
Processing 00000000.tx.353: 1998. 

Phrase: "1998."
Processing 00000000.tx.354: Mechanisms of epithelial cellcell adhesion and cell compaction revealed by high-resolution tracking of E-cadheringreen fluorescent protein. 

Phrase: "Mechanisms of epithelial cellcell adhesion"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "cell compaction"

Phrase: "revealed by high-resolution tracking of E-cadheringreen fluorescent protein."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   760   C1719039:High resolution [Laboratory Procedure]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205250:High [Qualitative Concept]
   739   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   739   C0443289:Revealed [Qualitative Concept]
   739   C0546881:Tracking [Spatial Concept]
   739   C1299351:High [Qualitative Concept]
   739   C1514893:Resolution [Idea or Concept]
   739   C1706463:Resolution [Quantitative Concept]
   739   C2699488:Resolution [Conceptual Entity]
   739   C2700149:HIGH [Intellectual Product]
   706 E C0040594:Track [Manufactured Object]
Processing 00000000.tx.355: J. 

Phrase: "J."
Processing 00000000.tx.356: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.357: 142:11051119.[Abstract/Free FullText] Alford, D., and J. 

Phrase: "142"

Phrase: ":"

Phrase: "11051119."

Phrase: "[Abstract/Free FullText"

Phrase: "] Alford,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.358: Taylor-Papadimitriou. 

Phrase: "Taylor-Papadimitriou."
Processing 00000000.tx.359: 1996. 

Phrase: "1996."
Processing 00000000.tx.360: Cell adhesion molecules in the normal and cancerous mammary gland. 

Phrase: "Cell adhesion molecules in the normal"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0007578:Cell Adhesion Molecules [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   790   C0007577:Cell Adhesion [Cell Function]
   783   C0007634:Normal cell [Cell]
           Cell
   783   C1268443:Normal cell [Cell]
   753   C0001511:Adhesion [Pathologic Function]
   753   C0175633:Adhesion [Natural Phenomenon or Process]
   753   C0567416:molecules [Substance]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "cancerous mammary gland."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0929301:Mammary gland [Body Part, Organ, or Organ Component]
           Mammary
   901   C1521747:GLAND, MAMMARY [Tissue]
   827   C0006141:Mammary [Body Part, Organ, or Organ Component]
   827   C1285092:Gland [Body Part, Organ, or Organ Component]
Processing 00000000.tx.361: J. 

Phrase: "J."
Processing 00000000.tx.362: Mammary Gland Biol. 

Phrase: "Mammary Gland Biol."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0929301:Mammary gland [Body Part, Organ, or Organ Component]
   734   C1521747:GLAND, MAMMARY [Tissue]
Processing 00000000.tx.363: Neoplasia. 

Phrase: "Neoplasia."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027651:Neoplasia [Neoplastic Process]
   928 E C1709160:Neoplastic [Qualitative Concept]
Processing 00000000.tx.364: 1:207218.[Medline] Alonso, G., M. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "207218."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Alonso,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.365: Koegl, N. 

Phrase: "Koegl,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.366: Mazurenko, and S.A. 

Phrase: "Mazurenko,"

Phrase: "and S."

Phrase: "A."
Processing 00000000.tx.367: Courtneidge. 

Phrase: "Courtneidge."
Processing 00000000.tx.368: 1995. 

Phrase: "1995."
Processing 00000000.tx.369: Sequence requirements for binding of Src family tyrosine kinases to activated growth factor receptors. 

Phrase: "Sequence requirements for binding of Src family tyrosine kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1514873:Requirement [Functional Concept]

Phrase: "to activated growth factor receptors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0206454:Growth Factor Receptors [Amino Acid, Peptide, or Protein,Receptor]
   812   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.370: J. 

Phrase: "J."
Processing 00000000.tx.371: Biol. 

Phrase: "Biol."
Processing 00000000.tx.372: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.373: 270:98409848.[Abstract/Free FullText] Barcellos-Hoff, M.H., J. 

Phrase: "270"

Phrase: ":"

Phrase: "98409848."

Phrase: "[Abstract/Free FullText"

Phrase: "] Barcellos-Hoff,"

Phrase: "M."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.374: Aggeler, T.G. 

Phrase: "Aggeler,"

Phrase: "T.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.375: Ram, and M.J. 

Phrase: "Ram,"

Phrase: "and"

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.376: Bissell. 

Phrase: "Bissell."
Processing 00000000.tx.377: 1989. 

Phrase: "1989."
Processing 00000000.tx.378: Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. 

Phrase: "Functional differentiation"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C2752631:functional differentiation [Cell Function]
   861   C0007589:Differentiation [Cell Function]
   861   C0205245:Functional [Functional Concept]
   861   C0542341:Functional [Functional Concept]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2700217:Functional [Conceptual Entity]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "alveolar morphogenesis of primary mammary cultures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0026559:Morphogenesis [Organism Function]

Phrase: "on reconstituted basement membrane."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0004799:Basement membrane [Tissue]
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C1979853:Basement [Cell Component]
   755 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.379: Development. 

Phrase: "Development."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.380: 105:223235.[Abstract] Behrens, J., L. 

Phrase: "105"

Phrase: ":"

Phrase: "223235."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Behrens,"

Phrase: "J.,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.381: Vakaet, R. 

Phrase: "Vakaet,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.382: Friis, E. 

Phrase: "Friis,"

Phrase: "E."
Processing 00000000.tx.383: Winterhager, F. 

Phrase: "Winterhager,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.384: Van Roy, M.M. 

Phrase: "Van Roy,"

Phrase: "M."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.385: Mareel, and W. 

Phrase: "Mareel,"

Phrase: "and"

Phrase: "W."
Processing 00000000.tx.386: Birchmeier. 

Phrase: "Birchmeier."
Processing 00000000.tx.387: 1993. 

Phrase: "1993."
Processing 00000000.tx.388: Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. 

Phrase: "Loss of epithelial differentiation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "gain of invasiveness correlates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517378:Gain [Quantitative Concept]

Phrase: "with tyrosine phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519726:Tyrosine Phosphorylation [Molecular Function]
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "of the E-cadherin/-catenin complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167214:catenin complex [Cell Component]
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "transformed with a temperature-sensitive v-SRC gene."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   800   C0080298:v-src Gene [Gene or Genome]
           SRC gene
           V-SRC
   770   C0029009:v src [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0038085:src Gene [Gene or Genome]
   770   C0079073:SRC Gene [Gene or Genome]
   767   C0231966:V A [Clinical Attribute]
   744   C0005903:temperature [Organism Attribute]
   744   C0017337:Gene [Gene or Genome]
   744   C0039476:*Temperature [Quantitative Concept]
   744   C0332324:Sensitive [Functional Concept]
   744   C1510411:Transformed [Pathologic Function]
   744   C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.389: J. 

Phrase: "J."
Processing 00000000.tx.390: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.391: 120:757766.[Abstract] Blake, R.A., P. 

Phrase: "120"

Phrase: ":"

Phrase: "757766."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Blake,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A.,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.392: Garcia-Paramio, P.J. 

Phrase: "Garcia-Paramio,"

Phrase: "P.J."
Processing 00000000.tx.393: Parker, and S.A. 

Phrase: "Parker,"

Phrase: "and S."

Phrase: "A."
Processing 00000000.tx.394: Courtneidge. 

Phrase: "Courtneidge."
Processing 00000000.tx.395: 1999. 

Phrase: "1999."
Processing 00000000.tx.396: Src promotes PKCdelta degradation. 

Phrase: "Src"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "PKCdelta degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]
Processing 00000000.tx.397: Cell Growth Differ. 

Phrase: "Cell Growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007595:Cell Growth [Cell Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "Differ."
Processing 00000000.tx.398: 10:231241.[Abstract/Free FullText] Blake, R.A., M.A. 

Phrase: "10"

Phrase: ":"

Phrase: "231241."

Phrase: "[Abstract/Free FullText"

Phrase: "] Blake,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A.,"

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.399: Broome, X. 

Phrase: "Broome,"

Phrase: "X."
Processing 00000000.tx.400: Liu, J. 

Phrase: "Liu,"

Phrase: "J."
Processing 00000000.tx.401: Wu, M. 

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.402: Gishizky, L. 

Phrase: "Gishizky,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.403: Sun, and S.A. 

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "and S."

Phrase: "A."
Processing 00000000.tx.404: Courtneidge. 

Phrase: "Courtneidge."
Processing 00000000.tx.405: 2000. 

Phrase: "2000."
Processing 00000000.tx.406: SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. 

Phrase: "SU6656,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0962522:SU6656 [Organic Chemical,Pharmacologic Substance]

Phrase: "a selective src family kinase inhibitor,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   840   C3537023:kinase inhibitor [Molecular Function]
   840   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C1999216:Inhibitor [Qualitative Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "growth factor signaling."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]
   734   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.407: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.408: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.409: Biol. 

Phrase: "Biol."
Processing 00000000.tx.410: 20:90189027.[Abstract/Free FullText] Boterberg, T., K.M. 

Phrase: "20"

Phrase: ":"

Phrase: "90189027."

Phrase: "[Abstract/Free FullText"

Phrase: "] Boterberg,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "K.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.411: Vennekens, M. 

Phrase: "Vennekens,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.412: Thienpont, M.M. 

Phrase: "Thienpont,"

Phrase: "M."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.413: Mareel, and M.E. 

Phrase: "Mareel,"

Phrase: "and"

Phrase: "M."

Phrase: "E."
Processing 00000000.tx.414: Bracke. 

Phrase: "Bracke."
Processing 00000000.tx.415: 2000. 

Phrase: "2000."
Processing 00000000.tx.416: Internalization of the E-cadherin/catenin complex and scattering of human mammary carcinoma cells MCF-7/AZ after treatment with conditioned medium from human skin squamous carcinoma cells COLO 16. 

Phrase: "Internalization of the E-cadherin/catenin complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0871786:internalization [Mental Process]

Phrase: "and"

Phrase: "scattering of human mammary carcinoma cells MCF-7/AZ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0439742:Scattering [Spatial Concept]

Phrase: "after treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with conditioned medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "from human skin squamous carcinoma cells COLO 16."
Meta Candidates (Total=23; Excluded=6; Pruned=0; Remaining=17)
   861   C0427861:Human cells [Laboratory or Test Result]
   841   C1519354:Skin squamous cell [Cell]
   829   C0221910:Squamous Cells [Cell]
   829   C0699893:Skin carcinoma [Neoplastic Process]
   829   C0814995:Skin cell [Cell]
   818   C0007137:Carcinoma, Squamous [Neoplastic Process]
   801   C1518174:Carcinoma Cell [Cell]
   795   C0007097:Carcinoma [Neoplastic Process]
   795   C0007634:Cells [Cell]
   795   C0009368:Colo- [Body Part, Organ, or Organ Component]
   795   C0086418:Human [Human]
   795   C0444099:Skin [Body Substance]
   795   C1123023:Skin [Body System]
   795   C1182670:Squamous [Qualitative Concept]
   795   C1278993:Skin [Body System]
   795   C1638187:colo [Plant]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]
   740 E C0221912:Cutaneous [Spatial Concept]
   740 E C0221928:Dermal [Qualitative Concept]
   740 E C1522447:Cutaneous [Functional Concept]
Processing 00000000.tx.417: Cell Adhes. 

Phrase: "Cell Adhes."
Processing 00000000.tx.418: Commun. 

Phrase: "Commun."
Processing 00000000.tx.419: 7:299310.[Medline] Braga, V.M., L.M. 

Phrase: "7"

Phrase: ":"

Phrase: "299310."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Braga,"

Phrase: "V.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2349138:V/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "L.M."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.420: Machesky, A. 

Phrase: "Machesky,"

Phrase: "A."
Processing 00000000.tx.421: Hall, and N.A. 

Phrase: "Hall,"

Phrase: "and"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.422: Hotchin. 

Phrase: "Hotchin."
Processing 00000000.tx.423: 1997. 

Phrase: "1997."
Processing 00000000.tx.424: The small GTPases Rho and Rac are required for the establishment of cadherin-dependent cellcell contacts. 

Phrase: "The small GTPases Rho"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0751984:Small GTPases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Rac"

Phrase: "are"

Phrase: "required for the establishment of cadherin-dependent cellcell contacts."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0851827:Dependent [Qualitative Concept]
   742   C1413274:cadherin [Gene or Genome]
   742   C1514873:Required [Functional Concept]
   742   C1701901:Dependent [Qualitative Concept]
   742   C3244310:dependent [Functional Concept]
   708   C0332158:contact [Functional Concept]
   708   C0337611:Contact [Population Group]
   708   C1705415:Contact [Idea or Concept]
Processing 00000000.tx.425: J. 

Phrase: "J."
Processing 00000000.tx.426: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.427: 137:14211431.[Abstract/Free FullText] Conacci-Sorrell, M., J. 

Phrase: "137"

Phrase: ":"

Phrase: "14211431."

Phrase: "[Abstract/Free FullText"

Phrase: "] Conacci-Sorrell,"

Phrase: "M."

Phrase: ","

Phrase: "J."
Processing 00000000.tx.428: Zhurinsky, and A. 

Phrase: "Zhurinsky,"

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.429: Ben-Ze'ev. 

Phrase: "Ben-Ze'ev."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014522:EV [Neoplastic Process]
   827   C0560135:eV [Quantitative Concept]
Processing 00000000.tx.430: 2002. 

Phrase: "2002."
Processing 00000000.tx.431: The cadherin-catenin adhesion system in signaling and cancer. 

Phrase: "The cadherin-catenin adhesion system in signaling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0449913:System [Functional Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]

Phrase: "and"

Phrase: "cancer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]
Processing 00000000.tx.432: J. 

Phrase: "J."
Processing 00000000.tx.433: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.434: Invest. 

Phrase: "Invest."
Processing 00000000.tx.435: 109:987991.[Free FullText] Dai, X.M., G.R. 

Phrase: "109"

Phrase: ":"

Phrase: "987991."

Phrase: "[Free FullText"

Phrase: "] Dai,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0683432:DAI [Intellectual Product]
  1000   C1424053:DAI [Gene or Genome]

Phrase: "X.M.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "G.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.436: Ryan, A.J. 

Phrase: "Ryan,"

Phrase: "A.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]
Processing 00000000.tx.437: Hapel, M.G. 

Phrase: "Hapel,"

Phrase: "M."

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.438: Dominguez, R.G. 

Phrase: "Dominguez,"

Phrase: "R.G."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0439267:g% [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.439: Russell, S. 

Phrase: "Russell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979971:Russell [Laboratory Procedure]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.440: Kapp, V. 

Phrase: "Kapp,"

Phrase: "V."
Processing 00000000.tx.441: Sylvestre, and E.R. 

Phrase: "Sylvestre,"

Phrase: "and"

Phrase: "E.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.442: Stanley. 

Phrase: "Stanley."
Processing 00000000.tx.443: 2002. 

Phrase: "2002."
Processing 00000000.tx.444: Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. 

Phrase: "Targeted disruption of the mouse colony-stimulating factor 1 receptor gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0332453:Disruption [Functional Concept]

Phrase: "results in osteopetrosis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0029454:Osteopetrosis [Congenital Abnormality,Disease or Syndrome]
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]

Phrase: "mononuclear phagocyte deficiency,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0011155:Deficiency [Functional Concept]
   827   C0162429:Deficiency [Disease or Syndrome]
   827   C1623416:deficiency [Qualitative Concept]
   755 E C1636779:% deficient [Quantitative Concept]
   734   C2952444:Mononuclear phagocyte [Cell]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "primitive progenitor cell frequencies,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   812   C0439603:Frequencies [Temporal Concept]
   779 E C0376249:frequency [Quantitative Concept]
   779 E C0871396:Frequency [Quantitative Concept]
   779 E C1561548:Frequency [Qualitative Concept]
   779 E C1705502:Frequency [Quantitative Concept]
   729 E C0332183:Frequent [Temporal Concept]
   708   C0872362:primitive cell [Cell]

Phrase: "and"

Phrase: "reproductive defects."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0243067:defects [Functional Concept]
   827 E C1457869:Defect [Functional Concept]
   827 E C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.445: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.446: 99:111120.[Abstract/Free FullText] Debnath, J., K.R. 

Phrase: "99"

Phrase: ":"

Phrase: "111120."

Phrase: "[Abstract/Free FullText"

Phrase: "] Debnath,"

Phrase: "J.,"

Phrase: "K.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.447: Mills, N.L. 

Phrase: "Mills,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599997:mills [Manufactured Object]

Phrase: "N.L."
Processing 00000000.tx.448: Collins, M.J. 

Phrase: "Collins,"

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.449: Reginato, S.K. 

Phrase: "Reginato,"

Phrase: "S."

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.450: Muthuswamy, and J.S. 

Phrase: "Muthuswamy,"

Phrase: "and"

Phrase: "J.S."
Processing 00000000.tx.451: Brugge. 

Phrase: "Brugge."
Processing 00000000.tx.452: 2002. 

Phrase: "2002."
Processing 00000000.tx.453: The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. 

Phrase: "The role of apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in creating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1706214:Create [Activity]
   966   C3244320:create [Functional Concept]

Phrase: "and"

Phrase: "maintaining luminal space within normal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883067:Space [Spatial Concept]

Phrase: "and"

Phrase: "oncogene-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029016:Oncogene [Gene or Genome]

Phrase: "expressing"

Phrase: "mammary acini."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   983   C0222617:Mammary acinus [Body Part, Organ, or Organ Component]
   827   C0935597:Acinus [Body Part, Organ, or Organ Component]
   827   C1442495:ACINUS [Gene or Genome]
   777 E C0332207:Acinar [Spatial Concept]
Processing 00000000.tx.454: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.455: 111:2940.[Medline] Debnath, J., S.K. 

Phrase: "111"

Phrase: ":"

Phrase: "2940."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Debnath,"

Phrase: "J.,"

Phrase: "S."

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.456: Muthuswamy, and J.S. 

Phrase: "Muthuswamy,"

Phrase: "and"

Phrase: "J.S."
Processing 00000000.tx.457: Brugge. 

Phrase: "Brugge."
Processing 00000000.tx.458: 2003. 

Phrase: "2003."
Processing 00000000.tx.459: Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. 

Phrase: "Morphogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026559:Morphogenesis [Organism Function]

Phrase: "and"

Phrase: "oncogenesis of MCF-10A mammary epithelial acini"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0007621:Oncogenesis [Neoplastic Process]
   748   C0596263:Oncogenesis [Neoplastic Process]

Phrase: "grown in three-dimensional basement membrane cultures."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   778   C0004799:Basement membrane [Tissue]
   778   C0450363:3-Dimensional [Spatial Concept]
   748   C0010453:Cultures [Idea or Concept]
   748   C0025255:Membrane [Tissue]
   748   C0205449:Three [Quantitative Concept]
   748   C0596901:Membrane [Cell Component]
   748   C1706182:Membrane [Manufactured Object]
   748   C1979853:Basement [Cell Component]
   714 E C0220814:culture [Functional Concept]
   714 E C0430400:Culture [Laboratory Procedure]
   714 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.460: Methods. 

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.461: 30:256268.[CrossRef][Medline] Downing, J.R., and A.B. 

Phrase: "30"

Phrase: ":"

Phrase: "256268."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Downing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205104:Down [Spatial Concept]

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "A.B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440044:A,B [Immunologic Factor]
Processing 00000000.tx.462: Reynolds. 

Phrase: "Reynolds."
Processing 00000000.tx.463: 1991. 

Phrase: "1991."
Processing 00000000.tx.464: PDGF, CSF-1, and EGF induce tyrosine phosphorylation of p120, a pp60src transformation-associated substrate. 

Phrase: "PDGF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032200:PDGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "CSF-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "EGF"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "tyrosine phosphorylation of p120,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1519726:Tyrosine Phosphorylation [Molecular Function]
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "a pp60src transformation-associated substrate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.465: Oncogene. 

Phrase: "Oncogene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029016:Oncogene [Gene or Genome]
Processing 00000000.tx.466: 6:607613.[Medline] Flick, M.B., E. 

Phrase: "6"

Phrase: ":"

Phrase: "607613."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Flick,"

Phrase: "M.B.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "E."
Processing 00000000.tx.467: Sapi, and B.M. 

Phrase: "Sapi,"

Phrase: "and"

Phrase: "B.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.468: Kacinski. 

Phrase: "Kacinski."
Processing 00000000.tx.469: 2002. 

Phrase: "2002."
Processing 00000000.tx.470: Hormonal regulation of the c-fms proto-oncogene in breast cancer cells is mediated by a composite glucocorticoid response element. 

Phrase: "Hormonal regulation of the c-fms proto-oncogene in breast cancer cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0920552:hormonal regulation [Organism Function]
   736   C0851285:Regulation [Governmental or Regulatory Activity]
   736   C1327622:Regulation [Biologic Function]

Phrase: "is"

Phrase: "mediated by a composite glucocorticoid response element."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   774   C0870868:mediated response [Mental Process]
   748   C0013879:Element [Element, Ion, or Isotope]
   748   C0017710:Glucocorticoid [Hormone,Steroid]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0205199:Composite [Qualitative Concept]
   748   C0871261:Response [Organism Attribute]
   748   C1547335:Composite [Idea or Concept]
   748   C1704632:Response [Finding]
   748   C1705248:Element [Conceptual Entity]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]
Processing 00000000.tx.471: J. 

Phrase: "J."
Processing 00000000.tx.472: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.473: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.474: 85:1023.[CrossRef][Medline] Fujita, Y., G. 

Phrase: "85"

Phrase: ":"

Phrase: "1023."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fujita,"

Phrase: "Y.,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.475: Krause, M. 

Phrase: "Krause,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.476: Scheffner, D. 

Phrase: "Scheffner,"

Phrase: "D."
Processing 00000000.tx.477: Zechner, H.E. 

Phrase: "Zechner,"

Phrase: "H.E."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.478: Leddy, J. 

Phrase: "Leddy,"

Phrase: "J."
Processing 00000000.tx.479: Behrens, T. 

Phrase: "Behrens,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.480: Sommer, and W. 

Phrase: "Sommer,"

Phrase: "and"

Phrase: "W."
Processing 00000000.tx.481: Birchmeier. 

Phrase: "Birchmeier."
Processing 00000000.tx.482: 2002. 

Phrase: "2002."
Processing 00000000.tx.483: Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. 

Phrase: "Hakai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1427430:HAKAI [Gene or Genome]

Phrase: "a c-Cbl-like protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   797   C1367374:CBL Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "ubiquitinates"

Phrase: "and"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "endocytosis of the E-cadherin complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0014139:Endocytosis [Cell Function]
   753   C2984285:Endocytosis [Functional Concept]
Processing 00000000.tx.484: Nat. 

Phrase: "Nat."
Processing 00000000.tx.485: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.486: 4:222231.[CrossRef][Medline] Herrenknecht, K., M. 

Phrase: "4"

Phrase: ":"

Phrase: "222231."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Herrenknecht,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.487: Ozawa, C. 

Phrase: "Ozawa,"

Phrase: "C."
Processing 00000000.tx.488: Eckerskorn, F. 

Phrase: "Eckerskorn,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.489: Lottspeich, M. 

Phrase: "Lottspeich,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.490: Lenter, and R. 

Phrase: "Lenter,"

Phrase: "and"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.491: Kemler. 

Phrase: "Kemler."
Processing 00000000.tx.492: 1991. 

Phrase: "1991."
Processing 00000000.tx.493: The uvomorulin-anchorage protein alpha catenin is a vinculin homologue. 

Phrase: "The uvomorulin-anchorage protein alpha catenin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   840   C0108280:alpha Catenin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a vinculin homologue."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1334043:Homologue [Gene or Genome]
Processing 00000000.tx.494: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.495: Natl. 

Phrase: "Natl."
Processing 00000000.tx.496: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.497: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.498: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.499: 88:91569160.[Abstract] Ide, H., D.B. 

Phrase: "88"

Phrase: ":"

Phrase: "91569160."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "D."

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.500: Seligson, S. 

Phrase: "Seligson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.501: Memarzadeh, L. 

Phrase: "Memarzadeh,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.502: Xin, S. 

Phrase: "Xin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422556:XIN [Gene or Genome]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.503: Horvath, P. 

Phrase: "Horvath,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.504: Dubey, M.B. 

Phrase: "Dubey,"

Phrase: "M.B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.505: Flick, B.M. 

Phrase: "Flick,"

Phrase: "B.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.506: Kacinski, A. 

Phrase: "Kacinski,"

Phrase: "A."
Processing 00000000.tx.507: Palotie, and O.N. 

Phrase: "Palotie,"

Phrase: "and"

Phrase: "O.N."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.508: Witte. 

Phrase: "Witte."
Processing 00000000.tx.509: 2002. 

Phrase: "2002."
Processing 00000000.tx.510: Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression. 

Phrase: "Expression of colony-stimulating factor 1 receptor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0597360:receptor expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   731   C0080092:Colony Stimulating Factor 1 Receptor [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor,Receptor]
   731   C0879468:COLONY-STIMULATING FACTOR 1 RECEPTOR [Gene or Genome]

Phrase: "during prostate development"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1326669:prostate development [Organ or Tissue Function]
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "and"

Phrase: "prostate cancer progression."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0178874:cancer progression [Neoplastic Process]
   901   C1947901:Cancer Progression [Pathologic Function]
   827   C0242656:progression [Pathologic Function]
   827   C0449258:Progression [Functional Concept]
   734   C0376358:Prostate Cancer [Neoplastic Process]
   734   C0600139:Prostate Cancer [Neoplastic Process]
   734   C2984325:Prostate cancer [Functional Concept]
   734   C3541264:Prostate Cancer [Intellectual Product]
Processing 00000000.tx.511: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.512: Natl. 

Phrase: "Natl."
Processing 00000000.tx.513: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.514: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.515: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.516: 99:1440414409.[Abstract/Free FullText] Iyer, A., T.E. 

Phrase: "99"

Phrase: ":"

Phrase: "1440414409."

Phrase: "[Abstract/Free FullText"

Phrase: "] Iyer,"

Phrase: "A.,"

Phrase: "T.E."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.517: Kmiecik, M. 

Phrase: "Kmiecik,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.518: Park, I. 

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.519: Daar, D. 

Phrase: "Daar,"

Phrase: "D."
Processing 00000000.tx.520: Blair, K.J. 

Phrase: "Blair,"

Phrase: "K.J."
Processing 00000000.tx.521: Dunn, P. 

Phrase: "Dunn,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.522: Sutrave, J.N. 

Phrase: "Sutrave,"

Phrase: "J.N."
Processing 00000000.tx.523: Ihle, M. 

Phrase: "Ihle,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.524: Bodescot, and G.F. 

Phrase: "Bodescot,"

Phrase: "and"

Phrase: "G.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.525: Vande Woude. 

Phrase: "Vande Woude."
Processing 00000000.tx.526: 1990. 

Phrase: "1990."
Processing 00000000.tx.527: Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene. 

Phrase: "Structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "tissue-specific expression,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C1955394:Tissue specific [Body Substance]

Phrase: "and"

Phrase: "transforming activity of the mouse"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "met"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Meet [Idea or Concept]

Phrase: "protooncogene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033713:Proto-Oncogene [Gene or Genome]
Processing 00000000.tx.528: Cell Growth Differ. 

Phrase: "Cell Growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007595:Cell Growth [Cell Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "Differ."
Processing 00000000.tx.529: 1:8795.[Abstract] Kacinski, B.M. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "8795."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kacinski,"

Phrase: "B.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.530: 1995. 

Phrase: "1995."
Processing 00000000.tx.531: CSF-1 and its receptor in ovarian, endometrial and breast cancer. 

Phrase: "CSF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1150625:CSF-1 [Molecular Function]
   861   C3540512:CSF [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "its receptor in ovarian, endometrial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "breast cancer."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0006142:Breast Cancer [Neoplastic Process]
  1000   C0678222:Breast Cancer [Neoplastic Process]
   950 E C0153661:thoracic cancer [Neoplastic Process]
   861   C0006141:Breast [Body Part, Organ, or Organ Component]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0998265:Cancer [Eukaryote]
   861   C1268990:Breast [Body Part, Organ, or Organ Component]
   861   C1306459:Cancer [Finding]
   805 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   805 E C1521735:Pectoral [Qualitative Concept]
   777 E C0817096:Chest [Body Location or Region]
   777 E C1527391:Chest [Body Location or Region]
Processing 00000000.tx.532: Ann. 

Phrase: "Ann."
Processing 00000000.tx.533: Med. 

Phrase: "Med."
Processing 00000000.tx.534: 27:7985.[Medline] Kacinski, B.M., K.A. 

Phrase: "27"

Phrase: ":"

Phrase: "7985."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kacinski,"

Phrase: "B.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2347469:/B [Quantitative Concept]

Phrase: "K.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.535: Scata, D. 

Phrase: "Scata,"

Phrase: "D."
Processing 00000000.tx.536: Carter, L.D. 

Phrase: "Carter,"

Phrase: "L.D."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0475219:L/d [Quantitative Concept]
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.537: Yee, E. 

Phrase: "Yee,"

Phrase: "E."
Processing 00000000.tx.538: Sapi, B.L. 

Phrase: "Sapi,"

Phrase: "B.L."
Processing 00000000.tx.539: King, S.K. 

Phrase: "King,"

Phrase: "S."

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.540: Chambers, M.A. 

Phrase: "Chambers,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0179874:chambers [Medical Device]
   966 E C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.541: Jones, M.H. 

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "M."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.542: Pirro, E.R. 

Phrase: "Pirro,"

Phrase: "E.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.543: Stanley, and L.R. 

Phrase: "Stanley,"

Phrase: "and"

Phrase: "L.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.544: Rohrschneider. 

Phrase: "Rohrschneider."
Processing 00000000.tx.545: 1991. 

Phrase: "1991."
Processing 00000000.tx.546: FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo and in vitro. 

Phrase: "FMS (CSF-1 receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0080092:Receptor, CSF-1 [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor,Receptor]
   875   C0080095:CSF Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")"

Phrase: "and"

Phrase: "CSF-1 transcripts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   734   C1150625:CSF-1 [Molecular Function]

Phrase: "and"

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "expressed by human breast carcinomas"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   843   C1257930:Mammary Carcinomas, Human [Neoplastic Process]
   806   C0678222:breast carcinomas [Neoplastic Process]
   773 E C0006142:Breast Carcinoma [Neoplastic Process]
   760   C0006141:Breast [Body Part, Organ, or Organ Component]
   760   C0007097:Carcinomas [Neoplastic Process]
   760   C0086418:Human [Human]
   760   C1268990:Breast [Body Part, Organ, or Organ Component]
   704 E C0929301:Mammary [Body Part, Organ, or Organ Component]
   704 E C1521735:Pectoral [Qualitative Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.547: Oncogene. 

Phrase: "Oncogene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029016:Oncogene [Gene or Genome]
Processing 00000000.tx.548: 6:941952.[Medline] Kowalski, P.J., M.A. 

Phrase: "6"

Phrase: ":"

Phrase: "941952."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kowalski,"

Phrase: "P.J.,"

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.549: Rubin, and C.G. 

Phrase: "Rubin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0252873:rubin's [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "C.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.550: Kleer. 

Phrase: "Kleer."
Processing 00000000.tx.551: 2003. 

Phrase: "2003."
Processing 00000000.tx.552: E-cadherin expression in primary carcinomas of the breast and its distant metastases. 

Phrase: "E-cadherin expression in primary carcinomas of the breast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "its distant metastases."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   966   C1269798:Distant metastasis [Classification]
   861   C0027627:Metastases [Neoplastic Process]
   861   C0443203:Distant [Spatial Concept]
   861   C2939419:Metastases [Neoplastic Process]
   827 E C2939420:metastasis [Neoplastic Process]
   789 E C0012751:Distance [Quantitative Concept]
   777 E C0036525:Metastatic [Functional Concept]
   777 E C1522484:metastatic [Quantitative Concept]
Processing 00000000.tx.553: Breast Cancer Res. 

Phrase: "Breast Cancer Res."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C2347379:RES [Finding]
   734   C0006142:Breast Cancer [Neoplastic Process]
   734   C0678222:Breast Cancer [Neoplastic Process]
Processing 00000000.tx.554: 5:R217R222.[CrossRef][Medline] Langer, S.J., D.M. 

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "R217R222."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Langer,"

Phrase: "S."

Phrase: "J.,"

Phrase: "D."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.555: Bortner, M.F. 

Phrase: "Bortner,"

Phrase: "M."

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.556: Roussel, C.J. 

Phrase: "Roussel,"

Phrase: "C.J."
Processing 00000000.tx.557: Sherr, and M.C. 

Phrase: "Sherr,"

Phrase: "and"

Phrase: "M.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.558: Ostrowski. 

Phrase: "Ostrowski."
Processing 00000000.tx.559: 1992. 

Phrase: "1992."
Processing 00000000.tx.560: Mitogenic signaling by colony-stimulating factor 1 and ras is suppressed by the ets-2 DNA-binding domain and restored by myc overexpression. 

Phrase: "Mitogenic signaling by colony-stimulating factor 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0037083:Signaling [Cell Function]
   748   C3537152:signaling [Biologic Function]

Phrase: "and"

Phrase: "ras"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034678:RAS [Gene or Genome]

Phrase: "is"

Phrase: "suppressed by the ets-2 DNA-binding domain"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   800   C1511662:DNA Binding Domain [Amino Acid Sequence]
   770   C1148673:DNA Binding [Genetic Function]
   767   C1512142:ETS Domain [Amino Acid Sequence]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1260953:Suppressed [Functional Concept]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "restored by myc overexpression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]
Processing 00000000.tx.561: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.562: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.563: Biol. 

Phrase: "Biol."
Processing 00000000.tx.564: 12:53555362.[Abstract] Le, T.L., A.S. 

Phrase: "12"

Phrase: ":"

Phrase: "53555362."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Le,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439090:LE [Idea or Concept]
  1000   C1423767:LE [Gene or Genome]

Phrase: "T.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "A.S."
Processing 00000000.tx.565: Yap, and J.L. 

Phrase: "Yap,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424135:YAP [Gene or Genome]
  1000   C1538138:YAP [Gene or Genome]
  1000   C3272504:YAP [Gene or Genome]

Phrase: "and"

Phrase: "J.L."
Processing 00000000.tx.566: Stow. 

Phrase: "Stow."
Processing 00000000.tx.567: 1999. 

Phrase: "1999."
Processing 00000000.tx.568: Recycling of E-cadherin: a potential mechanism for regulating cadherin dynamics. 

Phrase: "Recycling of E-cadherin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0282114:Recycling [Human-caused Phenomenon or Process]

Phrase: ":"

Phrase: "a potential mechanism for"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "regulating"

Phrase: "cadherin dynamics."
Processing 00000000.tx.569: J. 

Phrase: "J."
Processing 00000000.tx.570: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.571: 146:219232.[Abstract/Free FullText] Le, T.L., S.R. 

Phrase: "146"

Phrase: ":"

Phrase: "219232."

Phrase: "[Abstract/Free FullText"

Phrase: "] Le,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439090:LE [Idea or Concept]
  1000   C1423767:LE [Gene or Genome]

Phrase: "T.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "S.R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.572: Joseph, A.S. 

Phrase: "Joseph,"

Phrase: "A.S."
Processing 00000000.tx.573: Yap, and J.L. 

Phrase: "Yap,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424135:YAP [Gene or Genome]
  1000   C1538138:YAP [Gene or Genome]
  1000   C3272504:YAP [Gene or Genome]

Phrase: "and"

Phrase: "J.L."
Processing 00000000.tx.574: Stow. 

Phrase: "Stow."
Processing 00000000.tx.575: 2002. 

Phrase: "2002."
Processing 00000000.tx.576: Protein kinase C regulates endocytosis and recycling of E-cadherin. 

Phrase: "Protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "regulates"

Phrase: "endocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014139:Endocytosis [Cell Function]
  1000   C2984285:Endocytosis [Functional Concept]

Phrase: "and"

Phrase: "recycling of E-cadherin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0282114:Recycling [Human-caused Phenomenon or Process]
Processing 00000000.tx.577: Am. 

Phrase: "Am."
Processing 00000000.tx.578: J. 

Phrase: "J."
Processing 00000000.tx.579: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.580: Cell Physiol. 

Phrase: "Cell Physiol."
Processing 00000000.tx.581: 283:C489C499.[Abstract/Free FullText] Lipsich, L.A., A.J. 

Phrase: "283"

Phrase: ":"

Phrase: "C489C499."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lipsich,"

Phrase: "L.A.,"

Phrase: "A.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]
Processing 00000000.tx.582: Lewis, and J.S. 

Phrase: "Lewis,"

Phrase: "and"

Phrase: "J.S."
Processing 00000000.tx.583: Brugge. 

Phrase: "Brugge."
Processing 00000000.tx.584: 1983. 

Phrase: "1983."
Processing 00000000.tx.585: Isolation of monoclonal antibodies that recognize the transforming proteins of avian sarcoma viruses. 

Phrase: "Isolation of monoclonal antibodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0204727:Isolation [Therapeutic or Preventive Procedure]
   770   C0205409:Isolation [Functional Concept]
   770   C0220862:isolation [Laboratory Procedure]

Phrase: "that"

Phrase: "recognize"

Phrase: "the transforming proteins of avian sarcoma viruses."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   848   C0029009:Avian Sarcoma Virus-Transforming Protein [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0950107:Avian Proteins [Amino Acid, Peptide, or Protein]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741   C0042736:Virus Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.586: J. 

Phrase: "J."
Processing 00000000.tx.587: Virol. 

Phrase: "Virol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0965991:virol [Lipid]
Processing 00000000.tx.588: 48:352360.[Medline] Marks, D.C., X.F. 

Phrase: "48"

Phrase: ":"

Phrase: "352360."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Marks,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522501:marks [Qualitative Concept]
   916 E C1706089:Marked [Qualitative Concept]

Phrase: "D.C.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012358:D & C [Therapeutic or Preventive Procedure]
  1000   C0012764:D.C. [Geographic Area]
  1000   C1444662:D/C [Finding]
  1000   C1512015:D.C. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "X.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.589: Csar, N.J. 

Phrase: "Csar,"

Phrase: "N.J."
Processing 00000000.tx.590: Wilson, U. 

Phrase: "Wilson,"

Phrase: "U."
Processing 00000000.tx.591: Novak, A.C. 

Phrase: "Novak,"

Phrase: "A.C."
Processing 00000000.tx.592: Ward, V. 

Phrase: "Ward,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1305702:Ward [Health Care Related Organization,Manufactured Object]
  1000   C1547134:Ward [Idea or Concept]
  1000   C2355574:Ward [Population Group]

Phrase: "V."
Processing 00000000.tx.593: Kanagasundarum, B.W. 

Phrase: "Kanagasundarum,"

Phrase: "B.W."
Processing 00000000.tx.594: Hoffmann, and J.A. 

Phrase: "Hoffmann,"

Phrase: "and"

Phrase: "J."

Phrase: "A."
Processing 00000000.tx.595: Hamilton. 

Phrase: "Hamilton."
Processing 00000000.tx.596: 1999. 

Phrase: "1999."
Processing 00000000.tx.597: Expression of a Y559F mutant CSF-1 receptor in M1 myeloid cells: a role for Src kinases in CSF-1 receptor-mediated differentiation. 

Phrase: "Expression of a Y559F mutant CSF-1 receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0597360:receptor expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in M1 myeloid cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0887899:Myeloid Cells [Cell]
   867 E C0596993:Myeloid cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0439677:Myeloid [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "a role for Src kinases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in CSF-1 receptor-mediated differentiation."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0007589:Differentiation [Cell Function]
   804   C1511938:Differentiation [Clinical Attribute]
   804   C2945687:Differentiation [Functional Concept]
   733 E C0205615:Differentiated [Qualitative Concept]
   717   C0080092:Receptor, CSF-1 [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor,Receptor]
Processing 00000000.tx.598: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.599: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.600: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.601: Commun. 

Phrase: "Commun."
Processing 00000000.tx.602: 1:144152.[CrossRef][Medline] McCrea, P.D., C.W. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "144152."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] McCrea,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "D."

Phrase: ","

Phrase: "C.W."
Processing 00000000.tx.603: Turck, and B. 

Phrase: "Turck,"

Phrase: "and"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.604: Gumbiner. 

Phrase: "Gumbiner."
Processing 00000000.tx.605: 1991. 

Phrase: "1991."
Processing 00000000.tx.606: A homolog of the armadillo protein in Drosophila (plakoglobin) associated with E-cadherin. 

Phrase: "A homolog of the armadillo protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1512488:Protein Homolog [Amino Acid, Peptide, or Protein]
   753   C1334043:Homolog [Gene or Genome]

Phrase: "in Drosophila"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013138:Drosophila [Eukaryote]
  1000   C1028876:Drosophila [Fungus]
  1000   C1504613:Drosophila [Eukaryote]

Phrase: "(plakoglobin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0137209:plakoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334295:PLAKOGLOBIN [Gene or Genome]

Phrase: ")"

Phrase: "associated with E-cadherin."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1413274:cadherin [Gene or Genome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.607: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.608: 254:13591361.[Medline] Mukhopadhyay, D., L. 

Phrase: "254"

Phrase: ":"

Phrase: "13591361."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mukhopadhyay,"

Phrase: "D."

Phrase: ","

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.609: Tsiokas, X.M. 

Phrase: "Tsiokas,"

Phrase: "X.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.610: Zhou, D. 

Phrase: "Zhou,"

Phrase: "D."
Processing 00000000.tx.611: Foster, J.S. 

Phrase: "Foster,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242298:foster [Daily or Recreational Activity]
  1000   C0344349:foster [Family Group]

Phrase: "J.S."
Processing 00000000.tx.612: Brugge, and V.P. 

Phrase: "Brugge,"

Phrase: "and"

Phrase: "V.P."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1535597:v p [Therapeutic or Preventive Procedure]
Processing 00000000.tx.613: Sukhatme. 

Phrase: "Sukhatme."
Processing 00000000.tx.614: 1995. 

Phrase: "1995."
Processing 00000000.tx.615: Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. 

Phrase: "Hypoxic induction of human vascular endothelial growth factor expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205263:Induction [Functional Concept]
   742   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "through c-Src activation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1879547:Activation [Activity]
   734   C0079073:c src [Gene or Genome]
   734   C0080298:c-src [Gene or Genome]
   734   C0138965:c src [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.616: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.617: 375:577581.[CrossRef][Medline] Muthuswamy, S.K., D. 

Phrase: "375"

Phrase: ":"

Phrase: "577581."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Muthuswamy,"

Phrase: "S."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.618: Li, S. 

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.619: Lelievre, M.J. 

Phrase: "Lelievre,"

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.620: Bissell, and J.S. 

Phrase: "Bissell,"

Phrase: "and"

Phrase: "J.S."
Processing 00000000.tx.621: Brugge. 

Phrase: "Brugge."
Processing 00000000.tx.622: 2001. 

Phrase: "2001."
Processing 00000000.tx.623: ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. 

Phrase: "ErbB2,"

Phrase: "but"

Phrase: "not ErbB1,"

Phrase: "reinitiates"

Phrase: "proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "luminal repopulation in epithelial acini."
Processing 00000000.tx.624: Nat. 

Phrase: "Nat."
Processing 00000000.tx.625: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.626: 3:785792.[CrossRef][Medline] Niemann, C., V. 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "785792."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Niemann,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "V."
Processing 00000000.tx.627: Brinkmann, E. 

Phrase: "Brinkmann,"

Phrase: "E."
Processing 00000000.tx.628: Spitzer, G. 

Phrase: "Spitzer,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.629: Hartmann, M. 

Phrase: "Hartmann,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.630: Sachs, H. 

Phrase: "Sachs,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.631: Naundorf, and W. 

Phrase: "Naundorf,"

Phrase: "and"

Phrase: "W."
Processing 00000000.tx.632: Birchmeier. 

Phrase: "Birchmeier."
Processing 00000000.tx.633: 1998. 

Phrase: "1998."
Processing 00000000.tx.634: Reconstitution of mammary gland development in vitro: requirement of c-met and c-erbB2 signaling for branching and alveolar morphogenesis. 

Phrase: "Reconstitution of mammary gland development"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: ":"

Phrase: "requirement of c-met"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514873:Requirement [Functional Concept]

Phrase: "and"

Phrase: "c-erbB2 signaling for branching"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037083:Signaling [Cell Function]
   760   C3537152:signaling [Biologic Function]

Phrase: "and"

Phrase: "alveolar morphogenesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026559:Morphogenesis [Organism Function]
Processing 00000000.tx.635: J. 

Phrase: "J."
Processing 00000000.tx.636: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.637: 143:533545.[Abstract/Free FullText] Nollet, F., G. 

Phrase: "143"

Phrase: ":"

Phrase: "533545."

Phrase: "[Abstract/Free FullText"

Phrase: "] Nollet,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.638: Berx, and F. van Roy. 

Phrase: "Berx,"

Phrase: "and"

Phrase: "F. van Roy."
Processing 00000000.tx.639: 1999. 

Phrase: "1999."
Processing 00000000.tx.640: The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer. 

Phrase: "The role of the E-cadherin/catenin adhesion complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "in the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "and"

Phrase: "progression of cancer."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C0178874:cancer progression [Neoplastic Process]
   858   C1947901:Cancer Progression [Pathologic Function]
   790   C0242656:progression [Pathologic Function]
   790   C0449258:Progression [Functional Concept]
Processing 00000000.tx.641: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.642: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.643: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.644: Commun. 

Phrase: "Commun."
Processing 00000000.tx.645: 2:7785.[CrossRef][Medline] Owens, D.W., G.W. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "7785."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Owens,"

Phrase: "D.W.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "G.W."
Processing 00000000.tx.646: McLean, A.W. 

Phrase: "McLean,"

Phrase: "A.W."
Processing 00000000.tx.647: Wyke, C. 

Phrase: "Wyke,"

Phrase: "C."
Processing 00000000.tx.648: Paraskeva, E.K. 

Phrase: "Paraskeva,"

Phrase: "E.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.649: Parkinson, M.C. 

Phrase: "Parkinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   900   C1021144:Parkinsonia [Plant]

Phrase: "M.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.650: Frame, and V.G. 

Phrase: "Frame,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0080089:Frame [Nucleotide Sequence]
  1000   C0180979:Frame [Medical Device]
  1000   C1705858:Frame [Manufactured Object]

Phrase: "and"

Phrase: "V.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.651: Brunton. 

Phrase: "Brunton."
Processing 00000000.tx.652: 2000. 

Phrase: "2000."
Processing 00000000.tx.653: The catalytic activity of the Src family kinases is required to disrupt cadherin-dependent cell-cell contacts. 

Phrase: "The catalytic activity of the Src family kinases"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0243102:catalytic activity [Molecular Function]
   770   C1264638:Catalytic activity [Functional Concept]
   770   C1547012:*Catalytic Activity [Quantitative Concept]
   750   C1150423:kinase activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "cadherin-dependent cell-cell contacts."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0332158:contact [Functional Concept]
   771   C0337611:Contact [Population Group]
   771   C1705415:Contact [Idea or Concept]
Processing 00000000.tx.654: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.655: Biol. 

Phrase: "Biol."
Processing 00000000.tx.656: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.657: 11:5164.[Abstract/Free FullText] Palacios, F., L. 

Phrase: "11"

Phrase: ":"

Phrase: "5164."

Phrase: "[Abstract/Free FullText"

Phrase: "] Palacios,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.658: Price, J. 

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.659: Schweitzer, J.G. 

Phrase: "Schweitzer,"

Phrase: "J.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.660: Collard, and C. 

Phrase: "Collard,"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.661: D'Souza-Schorey. 

Phrase: "D'"

Phrase: "Souza-Schorey."
Processing 00000000.tx.662: 2001. 

Phrase: "2001."
Processing 00000000.tx.663: An essential role for ARF6-regulated membrane traffic in adherens junction turnover and epithelial cell migration. 

Phrase: "An essential role for ARF6-regulated membrane traffic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "in adherens junction turnover"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0031227:turnover [Quantitative Concept]
   827   C0243127:turnover [Functional Concept]
   827   C0443331:Turnover [Health Care Activity]
   734   C0230613:Adherens Junction [Cell Component]
   734   C0887872:Adherens Junction [Cell Component]
   734   C2984274:Adherens junction [Functional Concept]

Phrase: "and"

Phrase: "epithelial cell migration."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2611926:epithelial cell migration [Cell Function]
   901   C1622501:Migration, Cell [Cell Function]
   827   C0600210:Migration [Social Behavior]
   827   C1533574:Migration [Physiologic Function]
   827   C1881827:MIGRATION [Phenomenon or Process]
   734   C0014597:Epithelial cell [Cell]
Processing 00000000.tx.664: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.665: 20:49734986.[Abstract/Free FullText] Pollack, A.L., R.B. 

Phrase: "20"

Phrase: ":"

Phrase: "49734986."

Phrase: "[Abstract/Free FullText"

Phrase: "] Pollack,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0328442:Pollock [Fish]
  1000   C0453004:Pollack [Food]

Phrase: "A.L., R.B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   902   C1440044:A,B [Immunologic Factor]
Processing 00000000.tx.666: Runyan, and K.E. 

Phrase: "Runyan,"

Phrase: "and"

Phrase: "K.E."
Processing 00000000.tx.667: Mostov. 

Phrase: "Mostov."
Processing 00000000.tx.668: 1998. 

Phrase: "1998."
Processing 00000000.tx.669: Morphogenetic mechanisms of epithelial tubulogenesis: MDCK cell polarity is transiently rearranged without loss of cell-cell contact during scatter factor/hepatocyte growth factor-induced tubulogenesis. 

Phrase: "Morphogenetic mechanisms of epithelial tubulogenesis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: ":"

Phrase: "MDCK cell polarity"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   901   C0085304:Cell Polarity [Spatial Concept]
   851 E C2262962:cell pole [Cell Component]
   827   C0596963:Polarity [Quantitative Concept]
   755 E C0813983:polar [Quantitative Concept]
   734   C0598829:MDCK Cell [Cell]
   727 E C0337815:Poles [Population Group]
   727 E C0935623:Pole [Body Location or Region]
   727 E C1418729:POLE [Gene or Genome]

Phrase: "is"

Phrase: "transiently"

Phrase: "rearranged without loss of cell-cell contact"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0007634:Cell [Cell]
   748   C0332158:contact [Functional Concept]
   748   C0337611:Contact [Population Group]
   748   C1269647:Cell [Cell]
   748   C1517945:Loss [Quantitative Concept]
   748   C1704653:Cell [Medical Device]
   748   C1705415:Contact [Idea or Concept]
   748   C1948049:Cell [Spatial Concept]

Phrase: "during scatter factor/hepatocyte growth factor-induced tubulogenesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1658143:tubulogenesis [Organ or Tissue Function]
Processing 00000000.tx.670: Dev. 

Phrase: "Dev."
Processing 00000000.tx.671: Biol. 

Phrase: "Biol."
Processing 00000000.tx.672: 204:6479.[CrossRef][Medline] Pollard, J.W., and L. 

Phrase: "204"

Phrase: ":"

Phrase: "6479."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pollard,"

Phrase: "J."

Phrase: "W.,"

Phrase: "and"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.673: Hennighausen. 

Phrase: "Hennighausen."
Processing 00000000.tx.674: 1994. 

Phrase: "1994."
Processing 00000000.tx.675: Colony stimulating factor 1 is required for mammary gland development during pregnancy. 

Phrase: "Colony stimulating factor 1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0079784:Colony-Stimulating Factor 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1332789:COLONY-STIMULATING FACTOR 1 [Gene or Genome]
   923   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0439158:colony [Quantitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1947989:Colony [Cell]
   812   C1948023:Stimulating [Natural Phenomenon or Process]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "required for mammary gland development"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C1326631:mammary gland development [Organ or Tissue Function]
   806   C0929301:Mammary gland [Body Part, Organ, or Organ Component]
           Mammary
   806   C1521747:GLAND, MAMMARY [Tissue]
   806   C1656975:gland development [Organ or Tissue Function]
   760   C0006141:Mammary [Body Part, Organ, or Organ Component]
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1285092:Gland [Body Part, Organ, or Organ Component]
   760   C1514873:Required [Functional Concept]
   760   C1527148:Development [Functional Concept]

Phrase: "during pregnancy."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]
Processing 00000000.tx.676: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.677: Natl. 

Phrase: "Natl."
Processing 00000000.tx.678: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.679: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.680: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.681: 91:93129316.[Abstract/Free FullText] Price, F.V., S.K. 

Phrase: "91"

Phrase: ":"

Phrase: "93129316."

Phrase: "[Abstract/Free FullText"

Phrase: "] Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "F.V.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "S."

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.682: Chambers, J.T. 

Phrase: "Chambers,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0179874:chambers [Medical Device]
   966 E C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "J.T."
Processing 00000000.tx.683: Chambers, M.L. 

Phrase: "Chambers,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0179874:chambers [Medical Device]
   966 E C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "M.L."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.684: Carcangiu, P.E. 

Phrase: "Carcangiu,"

Phrase: "P.E."
Processing 00000000.tx.685: Schwartz, E.I. 

Phrase: "Schwartz,"

Phrase: "E.I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.686: Kohorn, E.R. 

Phrase: "Kohorn,"

Phrase: "E.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.687: Stanley, and B.M. 

Phrase: "Stanley,"

Phrase: "and"

Phrase: "B.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.688: Kacinski. 

Phrase: "Kacinski."
Processing 00000000.tx.689: 1993. 

Phrase: "1993."
Processing 00000000.tx.690: Colony-stimulating factor-1 in primary ascites of ovarian cancer is a significant predictor of survival. 

Phrase: "Colony-stimulating factor-1 in primary ascites of ovarian cancer"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   806   C0079784:Colony-Stimulating Factor 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   806   C1332789:COLONY-STIMULATING FACTOR 1 [Gene or Genome]
   782   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   782   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0029925:ovarian cancer [Neoplastic Process]
   760   C1140680:Ovarian Cancer [Neoplastic Process]
   757   C1306459:primary cancer [Finding]
           Cancer
   739   C0003962:Ascites [Finding]
   739   C0006826:Cancer [Neoplastic Process]
   739   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   739   C0205225:Primary [Qualitative Concept]
   739   C0439158:colony [Quantitative Concept]
   739   C0439631:Primary [Therapeutic or Preventive Procedure]
   739   C0998265:Cancer [Eukaryote]
   739   C1521761:Factor [Functional Concept]
   739   C1947989:Colony [Cell]
   739   C1948023:Stimulating [Natural Phenomenon or Process]
   739   C2827422:Factor [Conceptual Entity]
   730   C0877550:Carcinomatous Ascites [Neoplastic Process]

Phrase: "is"

Phrase: "a significant predictor of survival."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2698872:Predictor [Idea or Concept]
Processing 00000000.tx.691: Am. 

Phrase: "Am."
Processing 00000000.tx.692: J. 

Phrase: "J."
Processing 00000000.tx.693: Obstet. 

Phrase: "Obstet."
Processing 00000000.tx.694: Gynecol. 

Phrase: "Gynecol."
Processing 00000000.tx.695: 168:520527.[Medline] Pujuguet, P., L. 

Phrase: "168"

Phrase: ":"

Phrase: "520527."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pujuguet,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.696: Del Maestro, A. 

Phrase: "Del Maestro,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1540309:MAESTRO [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.697: Gautreau, D. 

Phrase: "Gautreau,"

Phrase: "D."
Processing 00000000.tx.698: Louvard, and M. 

Phrase: "Louvard,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.699: Arpin. 

Phrase: "Arpin."
Processing 00000000.tx.700: 2003. 

Phrase: "2003."
Processing 00000000.tx.701: Ezrin regulates E-cadherindependent adherens junction assembly through Rac1 activation. 

Phrase: "Ezrin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0059973:ezrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1421450:EZRIN [Gene or Genome]

Phrase: "regulates"

Phrase: "E-cadherindependent adherens junction assembly through Rac1 activation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C2247934:adherens junction assembly [Cell Function]
   744   C1706853:Assembly [Activity]
   744   C1879748:Assembly [Manufactured Object]
Processing 00000000.tx.702: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.703: Biol. 

Phrase: "Biol."
Processing 00000000.tx.704: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.705: 14:21812191.[Abstract/Free FullText] Reynolds, A.B., D.J. 

Phrase: "14"

Phrase: ":"

Phrase: "21812191."

Phrase: "[Abstract/Free FullText"

Phrase: "] Reynolds,"

Phrase: "A.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440044:A,B [Immunologic Factor]

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.706: Roesel, S.B. 

Phrase: "Roesel,"

Phrase: "S."

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.707: Kanner, and J.T. 

Phrase: "Kanner,"

Phrase: "and"

Phrase: "J.T."
Processing 00000000.tx.708: Parsons. 

Phrase: "Parsons."
Processing 00000000.tx.709: 1989. 

Phrase: "1989."
Processing 00000000.tx.710: Transformation-specific tyrosine phosphorylation of a novel cellular protein in chicken cells expressing oncogenic variants of the avian cellular src gene. 

Phrase: "Transformation-specific tyrosine phosphorylation of a novel cellular protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C1519726:Tyrosine Phosphorylation [Molecular Function]
   762   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   742   C0031715:Phosphorylation [Molecular Function]

Phrase: "in chicken cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C1516469:Chicken Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "oncogenic variants of the avian cellular src gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205419:variants [Qualitative Concept]
Processing 00000000.tx.711: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.712: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.713: Biol. 

Phrase: "Biol."
Processing 00000000.tx.714: 9:629638.[Medline] Reynolds, A.B., J. 

Phrase: "9"

Phrase: ":"

Phrase: "629638."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Reynolds,"

Phrase: "A.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440044:A,B [Immunologic Factor]

Phrase: "J."
Processing 00000000.tx.715: Daniel, P.D. 

Phrase: "Daniel,"

Phrase: "P.D."
Processing 00000000.tx.716: McCrea, M.J. 

Phrase: "McCrea,"

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.717: Wheelock, J. 

Phrase: "Wheelock,"

Phrase: "J."
Processing 00000000.tx.718: Wu, and Z. 

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Z."
Processing 00000000.tx.719: Zhang. 

Phrase: "Zhang."
Processing 00000000.tx.720: 1994. 

Phrase: "1994."
Processing 00000000.tx.721: Identification of a new catenin: the tyrosine kinase substrate p120cas associates with E-cadherin complexes. 

Phrase: "Identification of a new catenin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: ":"

Phrase: "the tyrosine kinase substrate p120cas"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1413800:p120cas [Gene or Genome]
   812   C2698947:P120CAS [Gene or Genome]
   812   C2699128:p120cas [Amino Acid, Peptide, or Protein]

Phrase: "associates with E-cadherin complexes."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0750490:Associate [Idea or Concept]
   760   C1413274:cadherin [Gene or Genome]
   760   C1704241:Complexes [Chemical Viewed Structurally]
   760   C1706221:Associate [Professional or Occupational Group]
   726 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.722: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.723: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.724: Biol. 

Phrase: "Biol."
Processing 00000000.tx.725: 14:83338342.[Abstract] Roura, S., S. 

Phrase: "14"

Phrase: ":"

Phrase: "83338342."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Roura,"

Phrase: "S."

Phrase: ","

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.726: Miravet, J. 

Phrase: "Miravet,"

Phrase: "J."
Processing 00000000.tx.727: Piedra, A. 

Phrase: "Piedra,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031898:Piedra [Disease or Syndrome]
   944 E C3249878:Tinea nodosa [Disease or Syndrome]

Phrase: "A."
Processing 00000000.tx.728: Garcia de Herreros, and M. 

Phrase: "Garcia de Herreros,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.729: Dunach. 

Phrase: "Dunach."
Processing 00000000.tx.730: 1999. 

Phrase: "1999."
Processing 00000000.tx.731: Regulation of E-cadherin/catenin association by tyrosine phosphorylation. 

Phrase: "Regulation of E-cadherin/catenin association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "by tyrosine phosphorylation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519726:Tyrosine Phosphorylation [Molecular Function]
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.732: J. 

Phrase: "J."
Processing 00000000.tx.733: Biol. 

Phrase: "Biol."
Processing 00000000.tx.734: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.735: 274:3673436740.[Abstract/Free FullText] Roussel, M.F. 

Phrase: "274"

Phrase: ":"

Phrase: "3673436740."

Phrase: "[Abstract/Free FullText"

Phrase: "] Roussel,"

Phrase: "M."

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.736: 1998. 

Phrase: "1998."
Processing 00000000.tx.737: Key effectors of signal transduction and G1 progression. 

Phrase: "Key effectors of signal transduction"

Phrase: "and"

Phrase: "G1 progression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0242656:progression [Pathologic Function]
   861   C0449258:Progression [Functional Concept]
Processing 00000000.tx.738: Adv. 

Phrase: "Adv."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001483:ADV [Virus]
Processing 00000000.tx.739: Cancer Res. 

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.740: 74:124.[Medline] Roussel, M.F., T.J. 

Phrase: "74"

Phrase: ":"

Phrase: "124."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Roussel,"

Phrase: "M."

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "T.J."
Processing 00000000.tx.741: Dull, C.W. 

Phrase: "Dull, C.W."
Processing 00000000.tx.742: Rettenmier, P. 

Phrase: "Rettenmier,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.743: Ralph, A. 

Phrase: "Ralph,"

Phrase: "A."
Processing 00000000.tx.744: Ullrich, and C.J. 

Phrase: "Ullrich,"

Phrase: "and"

Phrase: "C.J."
Processing 00000000.tx.745: Sherr. 

Phrase: "Sherr."
Processing 00000000.tx.746: 1987. 

Phrase: "1987."
Processing 00000000.tx.747: Transforming potential of the c-fms proto-oncogene (CSF-1 receptor). 

Phrase: "Transforming potential of the c-fms proto-oncogene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C3245505:Potential [Qualitative Concept]

Phrase: "(CSF-1 receptor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0080092:Receptor, CSF-1 [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor,Receptor]
   913   C0080095:CSF Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C0079784:CSF-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   734   C1150625:CSF-1 [Molecular Function]

Phrase: ")."
Processing 00000000.tx.748: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.749: 325:549552.[CrossRef][Medline] Roussel, M.F., J.R. 

Phrase: "325"

Phrase: ":"

Phrase: "549552."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Roussel,"

Phrase: "M."

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "J.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.750: Downing, C.W. 

Phrase: "Downing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205104:Down [Spatial Concept]

Phrase: "C.W."
Processing 00000000.tx.751: Rettenmier, and C.J. 

Phrase: "Rettenmier,"

Phrase: "and"

Phrase: "C.J."
Processing 00000000.tx.752: Sherr. 

Phrase: "Sherr."
Processing 00000000.tx.753: 1988. 

Phrase: "1988."
Processing 00000000.tx.754: A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential. 

Phrase: "A point mutation in the extracellular domain of the human CSF-1 receptor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   750   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   750   C2924612:A point [Body Location or Region]
   735   C0026882:Mutation [Genetic Function]
   735   C1552961:Point [Quantitative Concept]
   735   C1705285:Mutation [Cell or Molecular Dysfunction]
   735   C2347617:point [Quantitative Concept]

Phrase: "(c-fms proto-oncogene product"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0029005:Oncogene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1514468:product [Entity]
   804   C1704444:Product [Quantitative Concept]
   771   C0079053:Proto-Oncogene, c-fms [Gene or Genome]

Phrase: ")"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "its transforming potential."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.755: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.756: 55:979988.[Medline] Sapi, E., M.B. 

Phrase: "55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ":"

Phrase: "979988."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sapi,"

Phrase: "E.,"

Phrase: "M.B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.757: Flick, S. 

Phrase: "Flick,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.758: Rodov, M. 

Phrase: "Rodov,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.759: Gilmore-Hebert, M. 

Phrase: "Gilmore-Hebert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.760: Kelley, S. 

Phrase: "Kelley,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.761: Rockwell, and B.M. 

Phrase: "Rockwell,"

Phrase: "and"

Phrase: "B.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.762: Kacinski. 

Phrase: "Kacinski."
Processing 00000000.tx.763: 1996. 

Phrase: "1996."
Processing 00000000.tx.764: Independent regulation of invasion and anchorage-independent growth by different autophosphorylation sites of the macrophage colony-stimulating factor 1 receptor. 

Phrase: "Independent regulation of invasion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "anchorage-independent growth by different autophosphorylation sites"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C1515979:Anchorage-Independent Growth [Laboratory Procedure]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2911660:Growth [Activity]
   724   C2752783:differential growth [Organism Function]

Phrase: "of the macrophage colony-stimulating factor 1 receptor."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C0080092:Macrophage Colony-Stimulating Factor 1 Receptor [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor,Receptor]
           Colony Stimulating Factor 1 Receptor
           Macrophage Colony-Stimulating Factor Receptor
   947   C0879468:COLONY-STIMULATING FACTOR 1 RECEPTOR [Gene or Genome]
   907   C0215510:Macrophage Stimulating 1 Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   907   C1364082:MACROPHAGE STIMULATING 1 RECEPTOR [Gene or Genome]
   901   C0080095:Colony-Stimulating Factor Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C0079784:Colony-Stimulating Factor 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Macrophage Colony-Stimulating Factor
   734   C1332789:COLONY-STIMULATING FACTOR 1 [Gene or Genome]
   734   C1524095:macrophage colony-stimulating factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   712   C1417377:MACROPHAGE STIMULATING 1 [Gene or Genome]
Processing 00000000.tx.765: Cancer Res. 

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.766: 56:57045712.[Abstract] Sapi, E., M.B. 

Phrase: "56"

Phrase: ":"

Phrase: "57045712."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sapi,"

Phrase: "E.,"

Phrase: "M.B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.767: Flick, S. 

Phrase: "Flick,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.768: Rodov, D. 

Phrase: "Rodov,"

Phrase: "D."
Processing 00000000.tx.769: Carter, and B.M. 

Phrase: "Carter,"

Phrase: "and"

Phrase: "B.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.770: Kacinski. 

Phrase: "Kacinski."
Processing 00000000.tx.771: 1998a. 

Phrase: "1998a."
Processing 00000000.tx.772: Expression of CSF-I and CSF-I receptor by normal lactating mammary epithelial cells. 

Phrase: "Expression of CSF-I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "CSF-I receptor by normal lactating mammary epithelial cells."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1516943:Epithelial Receptor Cell [Cell]
   762   C0080095:CSF Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   762   C2338378:Epithelial receptor [Cell Component]
   745   C1514760:Receptor Cell [Cell]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.773: J. 

Phrase: "J."
Processing 00000000.tx.774: Soc. 

Phrase: "Soc."
Processing 00000000.tx.775: Gynecol. 

Phrase: "Gynecol."
Processing 00000000.tx.776: Investig. 

Phrase: "Investig."
Processing 00000000.tx.777: 5:94101.[Medline] Sapi, E., M.B. 

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "94101."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sapi,"

Phrase: "E.,"

Phrase: "M.B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.778: Flick, S. 

Phrase: "Flick,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.779: Rodov, and B.M. 

Phrase: "Rodov,"

Phrase: "and"

Phrase: "B.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.780: Kacinski. 

Phrase: "Kacinski."
Processing 00000000.tx.781: 1998b. 

Phrase: "1998b."
Processing 00000000.tx.782: Ets-2 transdominant mutant abolishes anchorage-independent growth and macrophage colony-stimulating factor-stimulated invasion by BT20 breast carcinoma cells. 

Phrase: "Ets-2 transdominant mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "abolishes"

Phrase: "anchorage-independent growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1515979:Anchorage-Independent Growth [Laboratory Procedure]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "macrophage colony-stimulating factor-stimulated invasion by BT20 breast carcinoma cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C1269955:Invasion [Finding]
   738   C2699153:Invasion [Pathologic Function]
           Cell Invasion
Processing 00000000.tx.783: Cancer Res. 

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.784: 58:10271033.[Abstract] Schmeichel, K.L., V.M. 

Phrase: "58"

Phrase: ":"

Phrase: "10271033."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Schmeichel,"

Phrase: "K.L., V.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C2349138:V/m [Quantitative Concept]
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.785: Weaver, and M.J. 

Phrase: "Weaver,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326812:Weaver [Bird]

Phrase: "and"

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.786: Bissell. 

Phrase: "Bissell."
Processing 00000000.tx.787: 1998. 

Phrase: "1998."
Processing 00000000.tx.788: Structural cues from the tissue microenvironment are essential determinants of the human mammary epithelial cell phenotype. 

Phrase: "Structural cues from the tissue microenvironment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0010439:Cues [Idea or Concept]

Phrase: "are"

Phrase: "essential determinants of the human mammary epithelial cell phenotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1521761:Determinant [Functional Concept]
Processing 00000000.tx.789: J. 

Phrase: "J."
Processing 00000000.tx.790: Mammary Gland Biol. 

Phrase: "Mammary Gland Biol."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0929301:Mammary gland [Body Part, Organ, or Organ Component]
   734   C1521747:GLAND, MAMMARY [Tissue]
Processing 00000000.tx.791: Neoplasia. 

Phrase: "Neoplasia."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027651:Neoplasia [Neoplastic Process]
   928 E C1709160:Neoplastic [Qualitative Concept]
Processing 00000000.tx.792: 3:201213.[CrossRef][Medline] Swift, S., J. 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "201213."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Swift,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326117:Swift, NOS [Bird]

Phrase: "S."

Phrase: ","

Phrase: "J."
Processing 00000000.tx.793: Lorens, P. 

Phrase: "Lorens,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.794: Achacoso, and G.P. 

Phrase: "Achacoso,"

Phrase: "and"

Phrase: "G.P."
Processing 00000000.tx.795: Nolan. 

Phrase: "Nolan."
Processing 00000000.tx.796: 1999. 

Phrase: "1999."
Processing 00000000.tx.797: Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. 

Phrase: "Rapid production of retroviruses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]

Phrase: "for efficient gene delivery"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0872177:gene delivery [Genetic Function]
   901   C1524066:Gene Delivery [Conceptual Entity]
   827   C0011209:Delivery [Therapeutic or Preventive Procedure]
   827   C0559563:delivery [Finding]
   827   C1705822:Delivery [Activity]

Phrase: "to mammalian cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "293T cell-based systems."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   779   C0449913:System [Functional Concept]
   779   C1553451:System [Manufactured Object]
   779   C1704459:System [Medical Device]
   729 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.798: In Current Protocols in Immunology. 

Phrase: "In Current Protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442711:Protocols [Intellectual Product]
   827 E C1507394:Protocol [Intellectual Product]
   827 E C1522729:Protocol [Intellectual Product]
   827 E C2348563:Protocol [Intellectual Product]

Phrase: "in Immunology."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0152036:Immunology [Biomedical Occupation or Discipline]
  1000   C1522005:immunology [Qualitative Concept]
   928 E C0205470:Immunological [Functional Concept]
Processing 00000000.tx.799: Unit 10.28 (Suppl. 31). 

Phrase: "Unit 10.28"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439148:Unit [Quantitative Concept]
   827   C1519795:Unit [Quantitative Concept]
   827   C1704753:Unit [Manufactured Object]
   827   C1880519:Unit [Quantitative Concept]

Phrase: "(Suppl. 31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.800: Takeda, H., A. 

Phrase: "Takeda,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.801: Nagafuchi, S. 

Phrase: "Nagafuchi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.802: Yonemura, S. 

Phrase: "Yonemura,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.803: Tsukita, J. 

Phrase: "Tsukita,"

Phrase: "J."
Processing 00000000.tx.804: Behrens, and W. 

Phrase: "Behrens,"

Phrase: "and"

Phrase: "W."
Processing 00000000.tx.805: Birchmeier. 

Phrase: "Birchmeier."
Processing 00000000.tx.806: 1995. 

Phrase: "1995."
Processing 00000000.tx.807: V-src kinase shifts the cadherin-based cell adhesion from the strong to the weak state and beta catenin is not required for the shift. 

Phrase: "V-src kinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   859   C0282625:src Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0029009:v src [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0080298:V-SRC [Gene or Genome]

Phrase: "shifts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0333051:Shift [Functional Concept]
  1000   C2347509:Shift [Phenomenon or Process]

Phrase: "the cadherin-based cell adhesion from the strong"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007577:Cell Adhesion [Cell Function]
   744   C0001511:Adhesion [Pathologic Function]
   744   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "to the weak state"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "and"

Phrase: "beta catenin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0105770:beta catenin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332803:beta-catenin [Gene or Genome]
  1000   C3543835:Beta Catenin [Laboratory Procedure]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "required for the shift."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0333051:Shift [Functional Concept]
   770   C1514873:Required [Functional Concept]
   770   C2347509:Shift [Phenomenon or Process]
Processing 00000000.tx.808: J. 

Phrase: "J."
Processing 00000000.tx.809: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.810: 131:18391847.[Abstract] Van Nguyen, A., and J.W. 

Phrase: "131"

Phrase: ":"

Phrase: "18391847."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Van Nguyen,"

Phrase: "A.,"

Phrase: "and"

Phrase: "J.W."
Processing 00000000.tx.811: Pollard. 

Phrase: "Pollard."
Processing 00000000.tx.812: 2002. 

Phrase: "2002."
Processing 00000000.tx.813: Colony stimulating factor-1 is required to recruit macrophages into the mammary gland to facilitate mammary ductal outgrowth. 

Phrase: "Colony stimulating factor-1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0079784:Colony-Stimulating Factor 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1332789:COLONY-STIMULATING FACTOR 1 [Gene or Genome]
   923   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0439158:colony [Quantitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1947989:Colony [Cell]
   812   C1948023:Stimulating [Natural Phenomenon or Process]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "recruit"

Phrase: "macrophages into the mammary gland to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0024432:Macrophages [Cell]
   753   C1546706:Macrophages [Intellectual Product]
   753   C1550652:Macrophages [Body Substance]

Phrase: "facilitate"

Phrase: "mammary ductal outgrowth."
Processing 00000000.tx.814: Dev. 

Phrase: "Dev."
Processing 00000000.tx.815: Biol. 

Phrase: "Biol."
Processing 00000000.tx.816: 247:1125.[CrossRef][Medline] Warren, S.L., and W.J. 

Phrase: "247"

Phrase: ":"

Phrase: "1125."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Warren,"

Phrase: "S.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "W.J."
Processing 00000000.tx.817: Nelson. 

Phrase: "Nelson."
Processing 00000000.tx.818: 1987. 

Phrase: "1987."
Processing 00000000.tx.819: Nonmitogenic morphoregulatory action of pp60v-src on multicellular epithelial structures. 

Phrase: "Nonmitogenic morphoregulatory action of pp60v-src"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441472:Action [Functional Concept]
   753   C3266814:Action [Activity]

Phrase: "on multicellular epithelial structures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:structures [Spatial Concept]
Processing 00000000.tx.820: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.821: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.822: Biol. 

Phrase: "Biol."
Processing 00000000.tx.823: 7:13261337.[Medline] Watabe, M., A. 

Phrase: "7"

Phrase: ":"

Phrase: "13261337."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Watabe,"

Phrase: "M."

Phrase: ","

Phrase: "A."
Processing 00000000.tx.824: Nagafuchi, S. 

Phrase: "Nagafuchi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.825: Tsukita, and M. 

Phrase: "Tsukita,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.826: Takeichi. 

Phrase: "Takeichi."
Processing 00000000.tx.827: 1994. 

Phrase: "1994."
Processing 00000000.tx.828: Induction of polarized cellcell association and retardation of growth by activation of the E-cadherincatenin adhesion system in a dispersed carcinoma line. 

Phrase: "Induction of polarized cellcell association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "retardation of growth"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   858   C0151686:Growth retardation [Pathologic Function]

Phrase: "by activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of the E-cadherincatenin adhesion system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "in a dispersed carcinoma line."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
Processing 00000000.tx.829: J. 

Phrase: "J."
Processing 00000000.tx.830: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.831: 127:247256.[Abstract] Wilhelmsen, K., S. 

Phrase: "127"

Phrase: ":"

Phrase: "247256."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Wilhelmsen,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.832: Burkhalter, and P. van der Geer. 

Phrase: "Burkhalter,"

Phrase: "and"

Phrase: "P. van der Geer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0557775:Van [Manufactured Object]
   812   C1511780:der [Cell or Molecular Dysfunction]
Processing 00000000.tx.833: 2002. 

Phrase: "2002."
Processing 00000000.tx.834: C-Cbl binds the CSF-1 receptor at tyrosine 973, a novel phosphorylation site in the receptor's carboxy-terminus. 

Phrase: "C-Cbl"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0812242:C-CBL [Gene or Genome]
  1000   C1707078:C-CBL [Gene or Genome]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "the CSF-1 receptor at tyrosine 973,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C0080092:Receptor, CSF-1 [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor,Receptor]
   774   C0080095:CSF Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   774   C0255618:tyrosine receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "a novel phosphorylation site in the receptor's carboxy-terminus."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C1519063:Phosphorylation Site [Amino Acid Sequence]
   762   C0005456:Receptor site, NOS [Receptor]
   742   C0031715:Phosphorylation [Molecular Function]
   742   C0205145:Site [Spatial Concept]
   742   C1158886:Phosphorylation [Molecular Function]
   742   C1515974:Site [Body Location or Region]
   742   C2825164:Site [Spatial Concept]
Processing 00000000.tx.835: Oncogene. 

Phrase: "Oncogene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029016:Oncogene [Gene or Genome]
Processing 00000000.tx.836: 21:10791089.[CrossRef][Medline] Zhang, Q., J. 

Phrase: "21"

Phrase: ":"

Phrase: "10791089."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zhang,"

Phrase: "Q.,"

Phrase: "J."
Processing 00000000.tx.837: Calafat, H. 

Phrase: "Calafat,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.838: Janssen, and S. 

Phrase: "Janssen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331842:Janssen [Health Care Related Organization]

Phrase: "and"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.839: Greenberg. 

Phrase: "Greenberg."
Processing 00000000.tx.840: 1999. 

Phrase: "1999."
Processing 00000000.tx.841: ARF6 is required for growth factor- and rac-mediated membrane ruffling in macrophages at a stage distal to rac membrane targeting. 

Phrase: "ARF6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412511:ARF6 [Gene or Genome]

Phrase: "is"

Phrase: "required for growth factor-"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0018270:'growth' NOS [Organism Function]
   770   C0220844:growth [Physiologic Function]
   770   C1514873:Required [Functional Concept]
   770   C1521761:Factor [Functional Concept]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C2827422:Factor [Conceptual Entity]
   770   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "rac-mediated membrane ruffling in macrophages"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C3269125:membrane ruffling [Cell Function]
   773 E C1622372:membrane ruffle [Cell Component]
   719   C1167268:Ruffle [Cell Component]

Phrase: "at a stage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205390:Stage [Temporal Concept]
  1000   C1300072:Stage [Clinical Attribute]
  1000   C1306673:Stage [Qualitative Concept]

Phrase: "distal to rac membrane targeting."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205108:Distal [Spatial Concept]
Processing 00000000.tx.842: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.843: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.844: Biol. 

Phrase: "Biol."
Processing 00000000.tx.845: 19:81588168.[Abstract/Free FullText]

Phrase: "19"

Phrase: ":"

Phrase: "81588168."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

